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1. Introduction
1.1 Imperative roles of Developmental Biology
The understanding of mechanisms of the embryonic development, in particular,
controls of differential gene expression, has grown dramatically within last two
decades. Recently two exciting topics have brought attention to the whole scientific
community and, via the media, to a wider world audience: the isolation and culture of
human stem cells (Shamblott et al. 1998; Thomson et al. 1998) for potential use in
transplantation medicine (for review, see Tiedemann et al., 2001) and the cloning of
Dolly, a sheep generated with a nucleus from an adult cell (Wilmut et al., 1997). This
increase in the understanding of embryonic development and cell differentiation will
have a tremendous impact on developmental and biomedical research and on the
way the medicine is practiced.
In the last century, the Nobel Prize for physiology and Medicine has been issued to
developmental biologists twice. Hans Spemann and his assistant Hilde Mangold
were awarded this honor in 1935 for their famous organizer transplantation
experiment (for review, see Trendelenburg and Grunz, 1996), and Edward Lewis,
Christiane Nüsslein-Volhard and Eric Wieschaus in 1995 for their discoveries in
Drosophila that led to a fundamental understanding of how genes control
development in fly embryos (for review, see Lewis, 1998). Almost 80 years after the
discovery of Spemann organizer, insights into developmental biology have been
expanded from the cellular to the molecular level. A large number of genes involved
in the early embryogenesis have been identified and characterized. And the
developmental processes can be simply explained in terms of “switching on or off”
gene expression. Moreover, with the completion of genome sequences of humans
and of several other species, one of research attentions is now focusing on the
functions of genes which are involved in developmental pathways.
The goal of this study is to isolate genes involved in early embryonic development
in Xenopus laevis, and furthermore to explore how these genes direct the complex
developmental processes and the corresponding genetic controls.
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1.2 Xenopus laevis as a model system for embryogenesis
Several animal model systems are used for studying early embryogenesis
including Xenopus laevis, Caenorhabditis elegans, Drosophila, zebrafish, the chick
and the mouse. Xenopus laevis, the South African clawed toad with large quantities
of embryos year-round, turned out be a very suitable laboratory animal which could
easily be maintained and induced to spawn with a simple gonadothropic hormone
injection. As a potential and excellent model organism for investigating the
mechanisms of development, it has large embryos which are accessible at all
developmental stages, develop rapidly in simple salt solutions at ambient conditions
and heal well after surgery, making possible the grafting and tissue explant
experiments. An added advantage is that gain-of-function experiments can be carried
out by overexpression of the injected mRNA. Despite unavailable for genetic
manipulations, loss-of-function studies are practicable in Xenopus laevis by using
dominant negative mutants of growth factors and receptors and transcription factors
fused with the known activation or repression domains. Alternatively knockout studies
in Xenopus laevis carried out with antisense oligonucleotides (Baker et al., 1990),
antisense RNA (Harland and Weintraub, 1985) and morpholino (Heasman et al.,
2000; Zhao et al., 2001) have been proved available. Moreover, the introduction of
transgenic techniques to Xenopus laevis has exploited the potential of this model
system for studying zygotic effects of the transgene expression and for characterizing
the regulatory sequences of promoters (Chan and Gurdon, 1996; Kroll and Amaya,
1996). A gene trap approach based on the transgenic techniques were also carried
out successfully to produce mutagenesis in Xenopus laevis, leading to a possibility to
identify novel genes with respect to mutant phenotypes. However, there are also
some limitations of Xenopus laevis as a model of embryogenesis which should be
considered. For example, it is a tetraploid species that does not favor genetic
analyses. While in studying early embryogenesis, it is possible to complement
deficiencies of individual systems by using a combination of different developmental
models. Xenopus tropicalis is a diploid and has a much shorter generation time,
which likely makes compensation for the disadvantages. The integration of unlimited
information from different developmental model systems will undoubtedly provide
perspectives in the elucidation of gene functions, thus aids in the understanding of
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early embryonic development.
In addition, Xenopus laevis has also been successfully employed in the study of
tumorigenesis which on the other hand sheds light for studying the embryogenesis.
For example, the viral oncogene that encodes polyoma middle T was found to induce
the formation of mesoderm in otherwise naive Xenopus tissue (Whitman and Melton,
1989). This led to the identification of the cellular proto-oncogene P21ras as a key
player in the endogenous process of mesoderm formation (Whitman and Melton,
1992). The continued examination of developmental events in Xenopus has helped
to elucidate signaling pathways that are involved in tumorigenesis (e.g. Wnt signaling
in colonrectal cancers, Pennisi et al., 1998) and has also provided mechanistic
insights into functions of previously identified proto-oncogenes (e.g. the role of
FRAT1 in T-cell lymphoma, Yost et al., 1998). Clearly, Xenopus laevis will become a
highly effective addition to the arsenal of tools for the study of human malignancies
(for review, see Wallingford, 1999).
1.3 Patterning the body plan of Xenopus laevis in the early
embryogenesis
The establishment of body axis is by far best studied in amphibians compared to
other animal models. The knowledge about the axis establishment has dramatically
increased in the last two decades.
Maternal determination of the animal–vegetal axis
The Xenopus embryo exhibits prominent external animal-vegetal polarity even
before fertilization. The animal pole sitting uppermost of Xenopus embryo has a
heavily pigmented surface, while the vegetal pole located toward the opposite end is
unpigmented and contains yolk-rich material. This polarity will influence the
subsequent cleavage pattern. As many other organisms, the proper development of
the Xenopus embryo depends on the asymmetrical distribution of maternal mRNAs
and proteins which are preexisiting cytoplasmic factors responsible for the cell fate
determination in the early embryonic development. The maternal mRNAs are
localized either in the animal or vegetal pole although the Xenopus oocyte is radially
symmetrical. The process of localization of these mRNAs in Xenopus oocyte occurs
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during the long period of oocyte differentiation and growth, which is accompanied by
the elaboration of oocyte polarity. Some of the vegetally localized mRNAs, such as
Vg1, VegT, and Xwnt11, are involved in the axial patterning and the germ layer
specification. Others, such as Xdazl and Xcat2 located in the germ plasma, are likely
to play a role in the specification of germ cell fate (Kloc et al., 2001). The differential
localization of maternal mRNAs in Xenopus oocyte follows one of two pathways: the
message transport organizer (METRO or early) pathway and the late pathway
(Forristall et al., 1995; Kloc and Etkin, 1995; Kloc et al., 2001). mRNAs that follow the
METRO pathway can be first detected at the mitochondrial cloud in stage I oocytes.
Subsequently the localized mRNAs are translocated to the cortex within the period of
late stage I or early stage II, where they remain throughout the oogenesis. Several
METRO-pathway mRNAs have been identified as possible candidates of cytoplamic
determinants, including Xwnt-11 required for the b -catenin pathway that specifies the
dorsal identity of embryo (Ku and Melton, 1993) and Xcat2 involved in germ cell
development (Mosquera et al., 1993). mRNAs following the late pathway are
excluded from the mitochondrial cloud and are found throughout the cytoplasm in
stage I oocytes. Between late stage II and early stage III, late-pathway mRNAs
localize to specific domains of the vegetal hemisphere including a crescent-shaped
region in proximity to the nucleus (Chan et al., 1999), a wedge-shaped structure in
the vegetal cytoplasm (Kloc and Etkin, 1995), and the vegetal cortical region (Melton,
1987). Vg1, a member of the transforming growth factor- b  (TGF-b ) protein super-
family which follows the late pathway, can induce dorsal mesoderm and secondary
axis (Dale et al., 1993; Thomsen and Melton, 1993). VegT, a T-box transcription
factor whose localization belongs to the late pathway too, is involved in the
specification of both endoderm and mesoderm (Zhang and King, 1996; Kofron et al.,
1999). Similar to Vg1 and VegT, Xenopus Bicaudal-C (xBic-C) mRNA also localizes
in vegetal cortex (Wessely and De Robertis, 2000).
Specification of the dorsoventral axis
The dorso-ventral axis of Xenopus embryo is trigged by sperm entry. An
unfertilized Xenopus egg is radially symmetrical along the animal-vegetal axis. Upon
fertilization, the plasma membrane and the cortex in the egg rotates about 30º
relative to the rest of the cytoplasm that remains stationary. The dorsoventral axis is
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defined by the site of sperm entry in the animal region which marks the future ventral
side of the embryo and overlaps with the first cleavage plane that divides the egg
bilaterally into right and left halves.
The crucial developmental consequence of cortical rotation is the formation of a
signaling center in the dorsal vegetal region on the side opposite sperm entry. This
signaling center is known as the Nieuwkoop center, which, lying on the dorsal vegetal
region of embryo is active from the early cleavage stage to the late blastula stage. It
exerts a special influence on surrounding tissues to induce dorsal axial structures. A
proposed function of the Nieuwkoop center is to induce the cells immediately above
the equatorial region to form the dorsal signaling center—the Spemann organizer.
Several dorsal determinants with the ability to induce a complete secondary axis
are involved in the Wnt/ b -catenin signaling pathway, such as siamois and b -catenin.
During the embryonic development, in the absence of Wnt signaling, b -catenin is
continuously phosphorylated by the glycogen synthase kinase-3 (GSK-3) complex.
Afterwards the phosphorylated b -catenin binds to a protein called b -transducin
repeat-containing protein ( b -TrCP), and is then modified by the covalent addition of a
small protein called ubiquitin. b -catenin tagged with ubiquitin finally is degraded by
proteosome via a ubiquitination-dependent pathway (Figure 1-1). The resulting low
level of b -catenin cannot induce target genes expression. Adenomatous Polyposis
Coli (APC) and Axin protein family normally facilitate the addition of phosphate
groups to b -catenin by GSK-3. The activity of GSK-3b  can be inhibited by GSK-3 b
binding protein (GBP), which however, is not a linear component of this pathway. In
contrast, when a secreted Wnt molecule is recognized by a transmembrane receptor
of the frizzled family, a cytoplasmic component called Dsh is activated. Dsh in turn
suppresses the phosphorylation of b -catenin imposed by GSK-3 b  and therefore leads
to a blockage of subsequent ubiquitination. This results in an accumulation of b -
catenin in the cytoplasm. Thereafter b -catenin translocates into the nuclei and
interacts with members of the high mobility group (HMG)-box transcription factor
family, such as Tcf/Lef1, to activate expression of target genes (Cadigan and Nusse,
1997). In Xenopus, genes responsible to dorsal determination, such as siamois
(Brannon et al., 1997), twin (Laurent et al., 1997), the TGF-b  factor Xnr-3 (McKendry
et al., 1997) and cerberus (Nelson and Gumbiner, 1999) have been shown to be
inducible by b -catenin.
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Figure 1-1. The schematic diagram of Wnt/β-catenin signaling pathway in the dorsoventral axis
patterning. In the absence of Wnt signaling, β-catenin is continuously phosphorylated by GSK-3 complex, and
subsequently degraded by proteosome via a ubiquitination pathway. In the case that a Wnt ligand binds to frizzled
receptor, the Wnt receptor transduces the signal through Dsh, resulting in the inhibition of GSK-3. The
suppression of GSK-3 activity leads to the accumulation of β-catenin. β-catenin thereafter translocates to the
nucleus, and activates the transcription of targets genes including siamois, twin, Xnr3 and cerberus. In addition,
the GBP can also inhibit GSK-3 activity but is not a linear component of the pathway (Modified from the protocol
of Cell Signaling Technology).
The functions of Spemann organizer during embryogenesis
As stated before, the Spemann organizer, lying on the dorsal blastopore lip of
gastrula, is induced by the Nieuwkoop center. Signals originating from the Spemann
organizer are involved in further patterning along both the anterior-posterior and
dorso-ventral axes and inducing the central nervous system of the embryo.
In Xenopus, the organizer is formed as a consequence of signaling by TGF-β and
β-catenin (Harland and Gerhart, 1997; Heasman, 1997; Niehrs, 1999, 2000).
Transplantation a dorsal blastopore lip to the ventral side of the blastocoel of another
embryo at the same stage led to an embryo containing a secondary body axis
(Spemann and Mangold, 1924). Meanwhile several genes specifically expressed in
the organizer have been identified, which can be primitively classified into four
groups based on the expression regions (for review, see Chan and Etkin, 2001). The
GBP
-Siamois
-twin
-Xnr3
-cerberus
Proteosome
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first group of organizer genes is transcriptional targets of the Wnt/ b -catenin pathway,
including siamois and twin. They are expressed in the dorsal vegetal region before
the appearance of dorsal lip during the blastula stage. Overexpression of either
siamois or twin induces ectopic secondary axis with a complete head (Lemaire et al.,
1995; Laurent et al., 1997). The second group of organizer genes is expressed in the
prechordal mesoderm region of head organizer at the gastrula stage and most of
them can generate ectopically incomplete secondary axes lacking anterior structures.
The members of this group include genes encoding transcription factors (gsc, Xlim-1,
Xanf-1 and Xotx2), growth factor antagonists (noggin, chordin, follistatin, frzb,
dickkopf-1 and Xolloid), as well as growth factors Xnr1-4 and anti-dorsalizing
morphogenetic protein (ADMP). The third group of organizer genes is expressed in
the anterior endomesoderm, such as Xnr-1, -2, -4, Xblimp and Xhex, which can
regulate specific genes expression in the anterior endomesoderm. Some members of
this group such as cer and dkk-1 (Glinka et al., 1998) can produce ectopic head
without a trunk by overexpression. The last group of organizer genes is expressed in
the chordamesoderm (trunk organizer), which includs chd, noggin, dkk-1, Xnot2 and
so on. Because of the overlap of expression domains, a gene may be classified into
two groups simultaneously. It should be emphasized that the organizer tissue is not a
constant population of cells but rather a dynamic structure in which considerable cell
movements and rearrangement take place during the gastrulation (Chan and Etkin,
2001).
Specifically, the organizer is a source of secreted antagonists that bind to growth
factors in the extracellular space and prevent them from binding to their cognate
receptors. Briefly the antagonists can be classified into the following groups (De
Robertis et al., 2000): (1) BMP antagonists such as chordin, noggin and follisitatin.
Chordin and noggin bind to BMPs directly in the extracellular space, preventing
BMPs from binding to and signaling through its cognate BMPs receptors. The
follisitatin binds to BMPs via different mechanisms and the resulting complex can
then bind to the BMP receptor but no further available signals arise; (2) Wnt inhibitors
encompassing the Frzbs and the Dkks two types. Frzb-1, containing a domain similar
to the Wnt-binding region of Frizzled Wnt receptors, can bind to Wnt ligands and
thereafter antagonize their activities. And DKKs, a new class of Wnt antagonists,
cooperate with Frzb-1 in the formation of head structure by combining inhibitions of
BMPs signaling. There are evidences that the Wnt antagonists expressed by the
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Spemann organizer act as different biological activities. For example, overexpression
of crescent, a frzb type protein, causes cyclopia, whereas overexpression of frzb-1
leads to enlarged eyes, indicating that different Wnt antagonists bind to overlapping
but distinct sets of Wnt signals; (3) Cerberus protein, a multivalent antagonist that
can bind to Xnrs, Xwnt-8 and BMP-4 in the extracellular space. These three signaling
pathways are required for trunk development. And secretion of cerberus by anterior
endoderm serves to maintain a trunk-free zone so that the head territory can develop
(De Robertis et al., 2000); (4) TGF-b /Nodal receptor antagonists including
Antivin/Lefty that has been isolated from frog, fish and mouse. Mouse mutants
lacking Lefty-2 form excess mesoderm, a phenotype that is partially suppressed by
heterozygosity for nodal, suggesting that the main function of Lefty-2 is to down-
regulate Nodal signaling. In Xenopus, Xnr-3 (a divergent Xnr) lacks mesoderm-
inducing activity but can induce neurulation instead. Yet it is not determined so far
that if Xnr-3 can also function as a competitive inhibitor of TGF- b  receptors.
Taken together, the organizer is crucial for the proper early embryonic development
and functions of three important aspects: self–differentiation, morphogenesis and
induction. Cells of the organizer eventually differentiate a variety of mesodermal and
endodermal tissues. Mesodermal derivatives include the notochord and prechordal
plate head mesoderm (head mesenchyme and cartilaginous rods of the skull floor),
whereas endodermal derivatives include pharyngeal endoderm (containing gill slits)
and anterior gut tissues such as liver. Organizer-dependent morphogenesis consists
of not only the movements of organizer cells but also the movements they induce in
neighbors, especially in the somatic mesoderm. The organizer’s inductions are often
called primary induction to distinguish them from secondary and tertiary induction
occurring after the gastrulation. Organizer releases inductive signals which primarily
affect all three germ layers including dorsalization of the mesoderm, neural induction
of the ectoderm and anteriorization of the endoderm (Harland and Gerhart, 1997),
although not all organizer’s factors play dorsalizing roles in early development such
as ADMP (Moos et al., 1995).
The formation of the Spemann organizer and its functional activities are
summarized as a model shown in Figure 1-2.
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Figure 1-2. A model of the Spemann organizer formation and its functions. At the midblastula
stage, higher β-catenin level on the dorsal side of embryo, together with the vegetally located
transcription factor VegT and the maternal TGF-β family growth factor Vg1, generate a gradient of
Nodal-related molecules expressed in the endoderm, in turn, this gradient induces the formation of
overlying mesoderm; low dose of Nodal-related molecules leads to the formation of ventral mesoderm,
whereas high dose leads to the establishment of the Spemann organizer. At the gastrula stage, the
organizer secretes a cocktail of factors that refine the initial patterning. The organizer secrets proteins
that bind to different growth factors in the extracellular space and block signaling through the cognate
receptors. Crescent, frzb-1 and dkk-1 are Wnt antagonists. Cerberus is a multivalent inhibitor that
antagonizes Xwnt-8, Xnrs and BMPs. Chordin, noggin and follistatin bind to and inhibit BMPs.
Lefty/antixin blocks nodal signaling through a different mechanism, i.e. by binding to the TGF-β/Nodal
receptor and acting as a competitive inhibitor. The organizer consists of two of structural regions, head
organizer (prechordal mesoderm, and anterior endomesoderm), and trunk mesoderm
(chordamesoderm). The organizer specific genes can be classified into four groups according to their
expression territories (indicated in the figure). Head development is considered a default state,
resulting from double inhibition of Wnt, BMP (dkk-1, Glinka et al., 1998) or triple inhibition of Wnt, BMP
and Nodal signal (cerberus, Piccolo et al., 1999), New evidence indicated that the IGF signaling is
required and sufficient for head formation (Pera et al., 2001). (Modified from Grunz, 1997).
The patterning of the three germ layers
The basic body plan of Xenopus is derived from three germ layers, i.e. the
endoderm, ectoderm and mesoderm. The endoderm arises from most of yolky
vegetal region of the embryo. The ectoderm is originated from the animal hemisphere
and then differentiates into epidermis and the future nervous tissue depending on the
signal gradient. The mesoderm is formed from the marginal zone. During the
gastrulation, the marginal zone moves into the interior through the dorsal blastopore
and becomes subdivided along the dorso-ventral axis of blastula. The most dorsal
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mesoderm gives rise to the notochord, followed ventrally, by somites (which gives
rise to muscle tissue), lateral plate and blood island. The dramatic change depends
on the molecular events that underlie both the specification and patterning of the
germ layers.
Fate-mapping analysis in Xenopus laevis in the 32-cell stage has indicated that
individual blastomeres can contribute to several organs (Wetts and Fraser, 1989;
Moody, 1987; Dale and Slack, 1987). The endoderm arises from the yolky cells of tier
D in the vegetal region of 32-cell embryo. These vegetally derived blastomeres later
form the lining of the gastrointestinal and respiratory tracts, liver and pancreas
(Chalmers and Slack, 1998; Wells and Melton, 1999). Many factors have been
proved to be involved in endoderm differentiation. For example, the maternal
determinant VegT is essential to endoderm differentiation (Lustig et al., 1996
Stennard et al., 1996; Zhang and King, 1996; Horb and Thomsen, 1997). Antisense
oligonucleotides complementary to VegT mRNA inhibit endoderm differentiation in
embryos (Zhang et al., 1998). Overexpression of VegT in the prospective ectoderm
activates endodermal genes including Xnr-2, Xsox17 and Mix-1. VegT and perhaps
also other maternal determinants can activate cell-autonomous expression of the
endoderm-specific genes, such as Xsox 17, Mix-1 and TGF- b  related growth factors
(derrière, activin B, Xnr-1, -2, -4). The TGF- b s activate further expression of
endoderm-specific genes and reinforce the expression of TGF-b  members in the
vegetal region. The treatment of animal cap with activin or processed Vg1, a member
of TGF-b , induces expression of the endoderm marker, XlHbox8 and IFABP (Wright
et al., 1989; Gamer and Wright, 1995; Henry et al., 1996). Maternal Vg1 induces
expression of Mixer (Henry and Melton, 1998), which can in turn activate the
endodermal markers XlHbox8, IFABP, LFABP and edd in the prospective ectodermal
tissues in the absence of mesoderm. Both Xsox17  and Xsox17  (Hudson et al.,
1997) have been shown to be able trigger endodermeral differentiation in the
prospective ectoderm.
The blastomeres from tier B and tier C of 32-cell embryo contribute to the
prospective mesoderm lineage, which is further patterned into dorsal, intermediate,
and ventral mesoderm derivatives (Dale and Slack, 1987). Cells from the dorsal
marginal zone contribute to dorsal mesoderm including head mesoderm, notochord,
and somites, whereas cells from the ventral marginal zone form somites and blood
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cells. Specification studies show that the lateral marginal zone gives rise to
intermediate mesoderm, such as somites and pronephros, only as a result of
interaction between the dorsal and ventral mesoderm, a process known as
dorsalization.
The “two-step” model has been employed to elucidate the mesoderm induction in
Xenopus laevis. According to this model, at the mid blastula stage higher level of b -
catenin on the dorsal side of embryo together with the vegetally located transcription
factor VegT and the material TGF-b  family growth factor Vg1 generate a gradient of
Nodal related molecules expressed in the endoderm, in turn this gradient induces the
formation of ventral mesoderm, whereas high doses lead to the establishment of the
Spemann organizer. The Nieuwkoop center is the very region of dorsal endoderm
that induces organizer tissue. And at the gastrula stage, the organizer secretes a
cocktail of factors that refine the initial patterning (De Robertis et al., 2000). This
model in principle is identical to the ‘three-signal’ model described elsewhere
(Munoz-Sanjuán and Hemmati-Brivanlou et al., 2001)
Some signaling pathways and molecules are involved in the mesoderm pattering.
Activins can induce the formation of different mesodermal derivatives in the
prospective ectodermal tissue including both dorsal and ventral mesoderm in a dose-
dependent fashion (Grunz 1983; Smith et al., 1995). In contrast to activin which is
required for the activation of mesodermal gene expression, FGF is required only for
maintaining the expression of these genes but not for the initial mesoderm
introduction (Isaacs et al., 1994; Schulte-Merker and Smith, 1995). Vg1 is also a
participant for dorsal mesoderm formation (Joseph and Melton, 1998).
Overexpression of Xnr-1 and Xnr-2 induces both dorsal and ventral mesoderm in the
prospective ectodermal tissues. Organizer genes such as noggin, chordin, and
siamois induce the dorsalization of ventral marginal zone tissue explants.
Xbra can induce VegT and Eomesodermin (Eomes) (Smith et al., 1991; Ryan et
al., 1996). Overexpression of Xbra lead to the formation of ventral mesodermal cell
types in the prospective ectoderm. While overexpression of zygotic VegT or eomes
induces both dorsal and ventral mesoderm in the animal cap assay in a dose-
dependent manner. Another TGF- b  member, derrière, can activate both dorsal and
ventral mesodermal marker in the animal cap assay (Sun et al., 1999). In addition to
TGF-b s and FGF, BMPs overexpression induces ventral mesoderm formation in
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prospective ectodermal tissues including blood and mesendchyme (Dale and Wardle,
1999). A high level of BMPs in the ventral marginal zone induces blood which is the
most ventral mesoderm indicated by the expression of both Xvent-1 (Gawantka et al.,
1995) and Xvent-2 (Onichtchouk et al., 1996). A lower level of BMPs in the lateral
marginal zone leads to muscle formation and only induces the expression of Xvent-2.
Wnt signaling is involved in patterning the mesodermal layer. The activin/Vg1 and
the Wnt pathways have been shown to positively and cooperatively regulated/induce
organizer genes such as goosecoid and chordin (Crease et al., 1998; Harland and
Gerhart, 1997). However, the function can be divergent in the different cell-stages. In
the dorsal side, the Wnt is inhibited by cer and dkk-1, and in the ventral marginal
zone, the sizzled activated by BMP-4 may restrict Wnt signaling to the lateral region
(Salic et al., 1997; Marom et al., 1999). Therefore, in the marginal zone Wnt signaling
is eliminated in the dorsal and ventral mesoderm by different Wnt antagonists. As a
consequence, Wnt signaling is active only in the lateral marginal region to specify the
formation of lateral mesodermal derivatives.
Blastomeres from tier A of a 32-cell embryo give rise to the prospective ectoderm,
which differentiates into neural in the dorsal side and epidermal lineages in the dorsal
side (Chang and Hemmati-Brivanlou, 1998). At the gastrula stage, the dorsal
ectoderm in proximity to the organizer develops into the neural plate and the ventral
ectoderm gives rise to the epidermis. The cement gland, various placode and neural
crest are formed at the boundary between the neural plate and the epidermal region.
It has been shown that BMPs signaling mediates the decision between neural and
epidermal cell fates (Grunz and Tacke 1989, 1990; Wilson and Hemmati-Brivanlou,
1995). Currently, the view for neural specification in vertebrates is that in the absence
of BMPs signals, ectodermal cells will differentiate into neural tissue according to the
‘default model' (for review, see Weinstein and Hemmati-Brivanlou, 1999). It has been
proposed that different levels of BMPs generate a morphogen gradient across the
dorsal-ventral axis to specify different cells in the ectoderm. A low level of BMP-4
induces neural markers expression, while intermediate and high doses activate
cement gland and epidermal keratin expression, respectively. A number of organizer
genes including chordin, noggin, follistatin, Xnr-3, cer and dkk-1 can induce
prospective ectoderm to adopt a neural fate by exerting a dorsalizing activity. In
addition, in spite of the controversial evidence that the FGF signaling is not required
to the neural induction but involved in the posterior mesoderm formation (Kroll and
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Amaya, 1996; Holowacz and Sokol, 1999), FGF signaling has been suggested to be
involved in the neural induction and the anterior neural patterning (Hongo et al.,
1999).
1.4 Gene identification from a cDNA library
Isolation of new genes and the understanding of these genes function and the
corresponding genetic controls in the processes of embryonic development are key
themes in the field of developmental biology.
Under this direction, cDNA libraries are constructed for different purposes. For
identification of genes expressed temporally, the mRNAs from embryo at a certain
stage are employed. Accordingly oocyte library (I. Dawid), gastrula cDNA library (C.
Niehrs), neurula library (C. Niehrs), tailbud stage 24-26 cDNA library (J. B. Gurdon)
and tailbud stage19-23 library (R. M. Harland) have been constructed for Xenopus
laevis. For isolation of tissue specific genes, the tissue specific mRNAs are
employed. cDNA libraries of adult retina (J. Besharse) and adult heart (R. M.
Harland) have been constructed for Xenopus laevis (Group leaders are indicated in
the parentheses). Furthermore, for identification of genes which are only expressed
temporally on a certain region of embryo, cDNA libraries are constructed rather
specifically. For example, to isolate head organizer genes, an anterior
endomesoderm (AEM) cDNA library was constructed for which the mRNAs
preparation were from the AEM of late gastrulare/early neurulae (Shibata et al.,
2001). Theoretically the rarest mRNA sequence from any tissue is likely to be
represented in a cDNA library containing 107 recombinants; however, practically its
identification is very difficult. Thus, for a variety of purpose, it is advantageous to
prepare the normalized cDNA library. Based on this consideration, the normalized
cDNA libraries for Xenopus early gastrula, neurula and tailbud have been
constructed, which bring the frequency of each clone within a narrow range
(Kitayama et al., 2001 GeneBank cDNA library list).
Screening cDNA library has been proved to be an efficient approach to identify
genes involved in Xenopus development (Gawantka et al., 1998). Successful
screening requires a straightforward assay that can be scaled up for a high
throughput. To date, mainly there are two methods used to screen Xenopus cDNA
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libraries. One is the functional screen based on the phenotype shift after
microinjections to embryos with mRNA from a single clone or clones pool. The
potential promising clones are justified by morphologic changes of the injected
embryos. Mixer (Henry et al., 1998) was identified in this way. The other approach to
the study of embryonic patterning at large-scale is to use a randomly isolated cDNA
and analyze expression pattern of the mRNA by in situ hybridization which allows
direct access to the DNA sequence and reflects endogenous genes expression. The
expression pattern often implies important clues for assessing the gene function and
makes readily testable predications. Moreover, analyses of genes expression have
led to spectacular discoveries regarding embryonic patterning which had not been
revealed by morphology or experimental embryology (Levin et al., 1998). Several
genes involved in the mesoderm pattern such as Xvent-1, Xvent-2 and Xblimp-1
have been identified by this method. The combination of these two methods was also
exploited to identify genes involved in organogenesis (Grammer et al., 2000). In this
approach, to assay maximally the activities of injection, the injected embryos were
monitored throughout early embryo and tadpole stages, which was followed by the
analyses of internal development of multiple tissues and organs by in situ
hybridization with markers—such as nrp-1 (general neural marker), krox-20
(hindbrain marker), Hoxb9 (spinal cord marker), MyoD (somite marker for stage 21
embryo), Pax-8 (kidney marker), Nkx-2.5 (heart marker) and -globin (blood island
marker for stage 28). Clones which profoundly affect cell fate and embryonic were
further characterized.
Some other new approaches have also been developed to identify secreted
signaling molecules that play very important roles during the embryonic development.
For example, Xenopus Kielin (Matsui et al., 2000) has been isolated from a signal
trap cDNA library with yeast selection system. Alternatively, crescent was isolated as
follows. The colonies pool from cDNA libraries constructed in cytomegalovirus (CMV)
promoter-based expression plasmide was expressed in 293T cells grown in serum
free medium containing 35S methionine and cysteine, and positive clones were
individualized in a second transfection step by sib-selection after the antoradiography
detection of proteins secreted into the culture medium (Pera and De Robertis, 2000).
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1.5 In this thesis
Activin plays important roles in mesoderm and endoderm patterning during the
embryonic development. The cells from disaggregated animal caps which have been
treated with low concentration of activin will differentiate into mesoderm, while with
higher concentrations of activin, the cells will even differentiate into endoderm cell
(Grunz 1983, Ariizumi et al., 1991). A cDNA library prepared with activin treated
ectoderm under this direction would be more efficient to isolate genes involved in the
mesoderm and endoderm patterning.
In this study, I have screened such an activin-treated ectoderm cDNA library of
Xenopus laevis using the approach of large-scale whole-mount in situ hybridization
introduced above. 51 new genes were isolated, and subsequently were assigned
accession numbers by GeneBank. The expression patterns of Xenopus X-box
binding protein 1 (XXBP-1), Xenopus MARCKS-like protein (XMLP) and Xenopus L-
Arginine:glycine amidinotransferase (XAT) were potentially interesting. Therefore
their functions have been further characterized.
XXBP-1 and the BMP-4 signaling pathway
As stated before, in Xenopus the patterning of the embryonic ectoderm has been
suggested to be under the control of bone morphogenetic proteins (BMPs)
(Weinstein and Hemmati-Brivanlou, 1997). Disruption of BMPs feedback loop in
ectoderm initiates the process of neural induction, resulting in the suppression of
epidermal-specific genes and the activation of regulatory and structural genes
specific to the neural tissues (Hemmati-Brivanlou and Melton, 1997). During
gastrulation, dorsalizing factors such as noggin (Zimmerman et al., 1996), Xnr3
(Smith et al., 1995), chordin (Sasai et al., 1994), Cerberus (Bouwmeester et al.,
1996) and follistatin (Fainsod et al., 1997) antagonize BMPs signaling by binding to
extracellular BMPs and preventing their interaction with cognate BMPs receptors.
Without organizer signals, the ectoderm becomes epidermis, in part due to the
activities of BMPs.
In addition to acting as a negative regulator of neural induction, BMPs are involved
in the mesodermal patterning. The mesoderm patterning starts prior to the overt
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gastrulation and can be defined into at least four mesodermal territories in the early
gastrula stages: (1) the organizer expressing genes such as gsc, Xnot, chd and
noggin; (2) a dorsolateral territory expressing genes such as Xmyf5 and Xvent2; (3) a
ventrolateral territory marked by the expression of Xvent-1 and Xvent-2 and (4) a
ventral territory expressing Xvent-1, Xvent-2 and sizzled. The expression of these
genes is regulated by BMP-4 and overexpression of BMP-2, -4 or -7 leads to the
ventralization of early mesoderm (Dale and Jones, 1999).
BMPs also play roles in limb development, tooth development and the regulation of
apoptosis. The effects diversity depends on its intracellular co-factors that participate
BMP signaling transduction, as well as crosstalk between BMPs signaling and other
signaling pathways. In general BMP-2, -4 or-7 dimers bind to the type II receptor
primarily, which then leads to phosphorylation of the type I receptor. This initiates a
signal transduction cascade that is mediated by a family of proteins collectively
known as Smads (Massagué, 1996). The activated BMPs type I receptors in turn
phosphorylates an appropriate R-Smad (Smad1, -5 or -8). This phosphorylation then
enables the R-Smad to complex with the Co-Smad (Smad4), and the R-
Smad/Smad4 complex enters the nucleus to activate or repress target genes
depending on which nuclear cofactors are present. Thus an extracellular signal is
converted to a cellular response (for review, see von Bubnoff and Cho, 2001). In
Xenopus embryos, Smad1 and Smad5 can mimic many BMPs functions and activate
BMPs-inducible genes (Graff et al., 1996; Suzuki et al., 1997), while overexpression
of Smad8 phenocopies the effect of blocking BMP-4 signaling, leading to the
induction of a secondary axis on the ventral sides of intact embryos and the neural
induction in ectodermal explants (Nakayama et al., 1998).
A large number of genes have been shown to be involved in BMPs signaling in
different cell types and tissues. In this study, it is demonstrated that XXBP-1, a basic
leucine zipper transcription factor, is involved in BMP-4 signaling pathway.
Overexpression of XXBP-1 leads to the ventralization of early embryos. Moreover,
the overexpression can rescue the neural induction in ectodermal explants as well as
the dorsalization in intact embryos imposed by a dominant negative BMPs receptors
(tBMPRs). These results suggest that XXBP-1 acts the downstream of BMP-4
receptors by mediating BMP-4 signaling pathway in the epidermal induction and the
inhibition of neural differentiation. Furthermore, it has been characterized as a
transcription activator by exploiting repressor and activator fusions.
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XMLP and the MARCKS family
Phosphorylation of intracellular substrates by protein kinase C (PKC), which
composes a family of diacylaglycerol-activated and Ca2+-dependent serine/threonine
related protein kinases, is an impetus for a wide range of cellular processes including
differentiation, mitogenesis, neurotransmission and hormone secretion. Up to now at
least 10 subtypes of this family have been found and each subtype has shown
different enzymological properties and distinct cell type distribution (for review, see
Nishizuka, 1984, 1995). In Xenopus, it has also been demonstrated that PKC is
involved in the response to endogenous inducing signals during neural induction
(David et al., 1987; Otte et al., 1988; for review, see Grunz, 1999a). One of the most
prominent intracellular substrates for PKC is the myristoylated alanine rich C kinase
substrate (MARCKS), which can be phosphorylated in many cell types by PKC. The
members of MARCKS share three conserved domains, a myristoylated consensus
following the glycine residue at position 2 in the amino terminus, the site of intron
splicing, and the phosphorylation site domain (PSD), also called effector domain (ED)
which contains three of four serines that are the only residues known to be
phosphorylated by PKC in this domain. MARCKS related proteins have also been
identified in mouse, rabbit and human, sharing striking similarity with MARCKS. They
were termed as MARCKS like protein (MLP), also known as F52 or MacMARCKS.
MARCKS is a ubiquitous 32-kDa protein, whereas MLP is mainly expressed in brain
and reproductive tissues (Aderem, 1992; Blackshear, 1993).
MARCKS behaves as a PKC substrate and binds to calmodulin in a Ca2+-
dependent manner. However, there is no direct evidence that the protein contains a
Ca2+ binding domain. Additionally it was also demonstrated that dephosphorylated
MARCKS could bind to and cross-link filamentous actin in vitro. Both functions are
correlated with the PSD domain (for review, see Blackshear, 1993).
It has been reported that the expression of MARCKS increased sharply when
Swiss 3T3 cells escaped from cell cycle and entered G0 (Herget et al., 1993).
Reduced expression of MARCKS has been described in various cell lines after
oncogenic or chemical transformation. On the other hand, overexpression of the
MARCKS in human tumor-derived choroidal melanoma cells (OCM-1) can cause the
down-regulation of cell proliferation with high percentage of cells arrested in G0-G1
phase (Manenti et al., 1998). However the effect of MARCKS on the cellular functions
is not yet well understood and even less for MLP. It is assumed that MLP has a
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similar function as MARCKS because both are sharing high sequence homology.
Recent gene knockout studies have indicated that, at least in mice, MARCKS is
essential for the normal development of the central nervous system and postnatal
survival (Stumpo et al., 1995). MARCKS gene knockout mice exhibited lethal neural
defects during the development such as defect of cerebral hemisphere fusion,
disturbance of forebrain commissures formation as well as cortical and retinal
lamination abnormalities of the cortex and retina. But by expression of the non-
myristoylated human MARCKS in this null MARCKS population all the
neuroanatomical abnormalities could be rescued (Swierczynski et al., 1996).
Expression of a transgene containing non-myristoylation and pseudo-phosphorylation
sites was able to compensate almost the entire cerebral anatomical abnormalities of
the knockout mice, however these mice also exhibited profound retinal ectopia (Kim
et al., 1998). Chen et al. (1996) found that MLP deletion in mice prevents the closure
of cranial neural tube in the developing brain characterized by embryonic
exencephaly and postnatal anencephaly. It was shown in another MLP knockout
mice system (Wu et al., 1996) that the neural tube defects caused exencephaly and
spina bifida.
In this study, a novel homologue of the MARCKS like protein (MLP) in Xenopus
was identified and characterized. It is demonstrated that XMLP is differentially
expressed during early Xenopus development. Ectopic expression of XMLP led to
eye, axis defects and apoptosis and also resulted in the disruption of expression
pattern of Krox20, suggesting that it may be correlated with a disturbed
morphogenetic movements rather than an inhibition of induction processes. While
overexpression of XCYP26 caused an alternation of the expression pattern of XMLP,
indicating that retinoic acid (RA) may play an important role for its regulation.
XAT and the AT family
The L-Arginine:glycine amidinotransferase (AT, EC2. 1. 4. 1) catalyzes the transfer
of a guanido group from arginine to glycine. The resultant guanidinoacetic acid is the
immediate precursor of creatine. Phosphorylated derivatives of creatine play
important roles in the vertebrate energy metabolism (Walker, 1973). The
phosphocreatine serves as a high-energy reservoir in mammalian tissues, especially
when the source of ATP is limited. It has been shown that the expression of AT can
be tightly regulated by growth hormones and thyroxine induction (McGuire et al.,
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1980) and is inhibited by creatine (Guthmiller et al., 1994). In Wilms tumor AT
expression is down regulated as well (Austruy et al., 1993), which suggests that it
may play an important role in the limb-girdle muscular dystrophy type 2A (LGMF2A)
(Humm et al., 1997a) (for review, see Humm et al., 1997b).
In this study, it is demonstrated that XAT is expressed in the organizer in the
gastrula stages, and the posterior and trunk in the tailbud stages. The mechanism of
its funcion and regulation during the early embryogenesis still needs to be elucidated.
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2. Materials and Methods
2.1 Materials
Enzymes
DpnI Roche, Mannheim
Lysozyme SIGMA, Taufkirchen
pfu DNA polymerase Stratagene, Amsterdam
Proteinase K SIGMA, Taufkirchen
RNase A SIGMA, Taufkirchen
RNase T1 Roche, Mannheim
RNase inhibitor Stratagene, Amsterdam
SP6 RNA polymerase Stratagene, Amsterdam
Taq DNA polymerase Genecraft, Münster
T4 DNA ligase MBI Fermentas, St. Leon-Rot
T7 RNA polymerase Stratagene, Amsterdam
T3 RNA polymerase Stratagene, Amsterdam
All other restriction enzymes MBI Fermentas, St. Leon-Rot
Chemicals and kits
Agrose peqLAB, Erlangen
acetic anhydride SIGMA, Taufkirchen
All-trans-RA SIGMA, Taufkirchen
Ampicillin SIGMA, Taufkirchen
BCIP Roche, Mannheim
BM purple Roche, Mannheim
BSA SIGMA, Taufkirchen
Cap-Scribe Roche, Mannheim
Digoxigenin RNA mix or florescein-mix Roche, Mannheim
Ficoll 400 SIGMA, Taufkirchen
Fluorescein-12-UTP Roche, Mannheim
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Formamide SIGMA, Taufkirchen
Gene Ruler ™ 1kb ladder MBI Fermentas
Goat Serum (GS) GibcoBRL, Karsruhe
HCG Schering, Berlin
Hepariin SIGMA, Taufkirchen
Kanamycin SIGMA, Taufkirchen
Leibovitz L-15 GibcoBRL, Karsruhe
NBT Roche, Mannheim
Penicillin SIGMA, Taufkirchen
Polyvinylpyrrolidone (PVP-40) SIGMA, Taufkirchen
Qiagen Midi-preparation Kit Qiagen, Hilden
Qiagen QIAquick purification kit Qiagen, Hilden
Qiagen RNeasy kit Qiagen, Hilden
RNA-Clean™ HYBAID, Egelsbach
Sephadex G50 SIGMA, Taufkirchen
streptomycine sulfate SIGMA, Taufkirchen
Torula RNA SIGMA, Taufkirchen
X-gal SIGMA, Taufkirchen
All other chemicals used in this study were from Fluka, Merck.
General stock solutions and reagents
LB broth (1L): 20 g Luria Bertani medium, SIGMA
LB agar (1L): 35 g SIGMA, Taufkirchen
NZY broth (1L): 21 g GibcoBRL, Karsruhe
NZY agar (1L): 21 g GibcoBRL, Karsruhe
NZCYM broth (1L): 22 g GibcoBRL, Karsruhe
5 ´  TBE (1L): 54 g Tris
27.5 g boric acid
20 mL EDTA (0.5 M, pH 8.0)
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TE: 10 mM Tris pH7.4
1 mM EDTA
Bacteria and animals
E.coli XL1-Blue MRF’ Stratagene, Amsterdam
E.coli XLOLR Stratagene, Amsterdam
Xenopus laevis Snake farm, South Africa
Vectors
PBK-CMV Stratagene, Amsterdam
pCS2+ Turner, 1994
pCSMTEnR Turner, 1994
Hardwares
Petriperm™Petri dish Heraeus
Microloader Eppendorf
Spectrum photometer Pharmarcia
UNOII thermo cycler Biometra
Micromanipulator Singer Comp., UK
PV830 Pneumatic PicoPump World Precision Comp., USA
Stereomicroscope Zeiss
Axioplanmicrocope Zeiss
Progressive 3 digital camera Sony
Axiocam HRC digital camera Zeiss
MC100 optical camera Zeiss
Orthomat-camera Leitz
LS-100 slide scanner Nikon
Thermal cycler Biometra
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Primers (All following primers employed for RT-PCR were synthesized by Roth).
Genes Primer sequences Authors
Fw: 5’-GCAATGGAATCCACCTCCTA-3’
XAT
Re: 5’-GGTTACTCCCCCAACTCCAT-3’
Zhao et al., 2001a
Fw: 5'-GTCTAATGGCTCCGCTGAAG-3' 
XMLP
Re: 5'-GCTTCTGGAGATGCTTCCAC-3'
Zhao et al., 2001b
Re: 5’-TCACTTGCTGTTCCAGTTCA-3'
XXBP-1
Fw: 5’-GCCCCCAAAGTGATCTTTAT-3'
Zhao et al. unpublished
Fw: 5’-AGGCACAGGACCATCTTCACCG-3'
goosecoid
Re: 5’-CACTTTTAACCTCTTCGTCCGC -3'
Blumberg et al., 1991
Fw: 5’-GAATCCGCACAGTGTTCACCCC-3'
Xnot
Re: 5’-TCCTCGTCCTCCTCAGTCTCCC-3’
von Dassow et al., 1993
Fw: 5’-GAGAGAAGAAGCTGCAAGAGGC-3'
Xwnt-8
Re: 5’-GGCAAACAAATCCACTGGCCCG-3'
Smith and Harland, 1991
Fw: 5’-GCGGCTTTGGACTTTGAGAATG-3'
Muscle actin
Re: 5’-TCAGCAATACCAGGGTACATGG-3’
Mohun et al., 1984
Fw: 5’-AACTGCTCCGATGGCATGATGGATTA-3’
MyoD b
Re: 5’-AATGCTGGGAGAAGGGATGGTGATTA-3'
Hopwood et al., 1989
Fw: 5’-GCATCTCCTTGGCATATTTGG-3’
Xvent-1
Re: 5’-TTCCCTTCAGCATGGTTCAAC-3’
Gawanka et al., 1995
Fw: 5’-GGATGGATTTGTTACATCCGTC-3’
Otx2
Re: 5’-CACTCTCCGAGCTCACTTCCC-3’
Blitz et al., 1995
Fw: 5’-GCATGTACGGATAAGTCGATC-3’
BMP-4
Re: 5’-GATCTCAGACTCAACGGCAC-3’
Dale et al., 1992
Fw: 5’-CTGACTGTCCGATCAGAC-3’
XAG1
Re: 5’-GAGTTGCTTCTCTGGCAT-3’
Sive et al., 1996
Fw: 5’-GGATCGTTATCACCTCTG-3’
Xbra
Re: 5’-GTGTAGTCTGTAGCAGCA-3’
Xenopus MMR
Fw: 5’-CACAGTTCCACCAAATGC-3’
NCAM
Re: 5’-GGAATCAAGCGGTACAGA-3’
Xenopus MMR
Fw: 5’-CGGGATAACATTCAGGGTA-3’
H4
Re: 5’-TCCATGGCGGTAACTGTC-3’
Steinbeisser et al., 1995
Fw: 5’-GGAGCTGCAAGTTGGAGA-3’
ODC
Re: 5’-ATCAGTTGCCAGTGTGGTC-3’
Xenopus MMR
Fw: 5’-TGAGACTTGGGCACTGTCTG-3’
Xvent-2
Re: 5’-CCTCTGTTGAATGGCTTGCT-3’
Onichtchouk et al., 1996
Fw: 5’-ATATGATGAGCCACGCAGCAG-3’
Xhox3
Re: 5’-CAGATGCTGCAGCTCTTTGGC-3’
Ruizi Altaba and Melton et al.,
1989
Fw: 5’-CACCAGAACACAGAGTAC-3’Epidermal
Keratin Re: 5’-CAACCTTCCCATCAACCA-3’
Xenopus MMR
Fw: 5’-CCTCCAATCCAAGACTCCAGCAG-3’
chordin
Re: 5’-GGAGGAGGAGGAGCTTTGGGACAAG-3’
Piccolo et al.,1996
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2.2 Embryos and explants manipulation
2.2.1 Preparation of Xenopus laevis embryos
1. Aliquots of 3000-5000 IU of human chorionic gonadotropin (HCG) were kept in
vials at 4ºC. Dissolve an aliquot in 0.4% NaCl solution immediately before the
injection to Xenopus.
2. In the evening before the experiment, inject two adult female frogs with 600-
800 IU (depending on the individual size) of HCG into the dorsal lymph sac, i.e. a
semicircle of small slits on the dorsal side of the frog just above the junction of the
back leg and the body, below which is a membrane joins the outer skin to the body
wall. Hold the syringe such that the needle is almost parallel to the skin and push it
through just on the ‘leg side’ of the marks, ensuring that it stays between the two
layers. Penetrate the membrane under the marks and inject.
3. Keep the injected frogs overnight at 19-21ºC. Generally 6-8 h later, the frogs
begin to lay eggs.
4. Kill an adult male frog, and remove the testes. Trim any extraneous tissue
from them, rinse off any blood, and place in medium, either in 1 ´  MBS (or 1 ´  Barth’s)
solution if they are to be used in the next 3 days or modified L-15 medium if they are
to be kept longer (up to 2 weeks). Store at 4ºC.
5. Crush one piece of the testis in 0.2 mL of 0.1 ´  MBS (or 0.1´  Barth’s) with
forceps and then take the resulting suspension up and down in 1-mL pipette tip until
the tissue is well suspended.
6. Squeeze the female frogs gently but firmly around the abdomen so that they
lay eggs into a Petri dish; move the frog so that the eggs fall into small groups.
7. Using a pipette, squirt the crushed testis over each group of eggs and then
shake the dish to form a single layer of the eggs.
8. Leave the eggs for 5 min, then rinse and incubate in 0.1 ´  MBS (or 0.1´
Barth’s).
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9. After the eggs have rotated and the animal pole is uppermost (about 20-40
min post fertilization), discard the MBS and dejelly eggs with 20 mL of 2% cysteine
solution. Detach the eggs from the plate by swirling the Petri dish vigorously. Notice
that when the jelly coats are removed, the eggs lie close to one another, whereas
before that the thick jelly separates them. Once all are in contact, wash them with at
least four changes of 20 mL of 0.1 ´  MBS (or 0.1´  Barth’s) and keep in a fresh Petri
dish.
10. Incubate the eggs at 14-25ºC until they develop into the desired stages for
microinjection.
1 ´  MBS:
88 mM NaCl
2.4 mM NaHCO3
1 mM KCl
10 mM HEPES
0.82 mM MgSO4
0.41 mM CaCl2
0.33 mM Ca(NO3)2 
pH 7.4
1 ´  Barth’ Solution:
88 mM NaCl
2.4 mM NaHCO3
1 mM KCl
5 mM HEPES
0.82 mM MgSO4
0.41 mM CaCl2
0.33 mM Ca(NO3)2
0.2 mM Na2HPO4
pH 7.4
2% Cysteine
Dissolve cysteine hydrochloride with sterile Millipore H2O to a final concentration of 2% and adjust pH
to 8.0 with 5 M NaOH.
penicillin/streptomycin stock solution (1000 ´ ):
Dissolve penicillin, 100,000 units/mL, and streptomycine sulfate, 100 mg/mL, in sterile Millipore water.
Store frozen.
L-15 solution for testis storage:
5 mL L-15
1 mL calf serum
4 mL sterile Millipore H2O
100 m L penicillin/streptomycin stock solution
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2.2.2 UV, LiCl and ATRA treatments
For UV treatment, fertilized eggs were dejellied thoroughly within about 20 min of
the insemination, then immediately transferred to Petriperm™ Petri dishes with UV-
permeable bottom and treated with UV transilluminator for 45 sec–1 min depending
on the illumination intensity. The eggs were allowed to be settled quietly for 2 h or at
least until the first cleavage at room temperature.
LiCl treatments were carried out with fertilized eggs at the 32-128-cell stage to
obtain the dorsoanterior enhancement. The embryos were treated with 0.3 M LiCl
solved in 0.1 ´  Barth’s solution for 5-10 min, afterwards washed several times with
0.1 ´  MBS and cultured until the desired stages.
All-trans-RA stock (10 -2 M) solved in DMSO was diluted with 0.1´  Barth’s solution
to a final concentration of 10-6 M. Embryos were incubated in this solution from the
stage 8 to stage 11, afterwards were washed several times with 0.1 ´  Barth’s solution
and cultured until the desired stages.
2.2.3 Explantation of animal caps and marginal zones
2.2.3.1 Animal cap
1. Transfer the stage 9 embryos to a Petri dish covered with 1% Agar and filled
with Holtfreter’s solution.
2. Grasp the membrane with the very tips of one pair of forceps in the marginal
or vegetal region while bracing the embryo against the side of the other forceps. With
the other forceps, grasp the membrane close to the place where the first one
penetrates; hold the membrane and pull away to remove it.
3. After the removal of vitelline membrane, roll the embryo animal pole up and
gently push it back into shape in order to maintain a good blastocoel.
4. Insert into the blastocoel with sharp glass needles and excise the cap. Care
must be taken to take only the animal cap tissue and not the marginal zone material.
5. The harvested animal caps finally were transferred into 1 ´  Barth’s solution and
kept until the desired stages.
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Holtfreter’s Solution:
60.00 mM NaCl
0.60 mM KCl
0.90 mM CaCl2
0.20 mM NaHCO3
5 mM HEPES
pH 7.4
2.2.3.2 Dorsal and ventral marginal zone
Dorsal and ventral marginal zones (DMZs and VMZs) were isolated from embryos
at stage 10-10.5 with the blastopore lip marking the dorsal side. Vitelline membrane
was removed from the animal halve and the explants were isolated with glass
needles. DMZs corresponded to an ~60º arc of marginal zone tissue centered on the
dorsal lip midline, and VMZs, analogously the region opposite the DMZs. Both then
were cultured in 1 ´  Barth’s solution till expected stages.
2.2.4 Microinjection
1. Place a needle into the holder on the micromanipulator.
2. Cut off the end of the needle at the point where the needle tip becomes less
flexible using watchmaker forceps under the microscope.
3. Spin mRNA (from 2.5.1) for 5 min in a microcentrifuge to remove any debris
that might block the needle, and then pipette 2-5 m L of the mRNA into the needle.
Take up the RNA sample in to the needle from the back of the needle using a long-tip
microloader.
4. Set the injector to the required volumes. It is suitable to use a volume of
approximately 4 nL for embryos at the 1-4-cell stages. In general, an injection
pressure of 10 psi and an injection time period of 0.3-0.6 sec are required, which
gives excellent survival rates.
5. Transfer embryos used for the injection into a Petri dish covered with 1% agar
and filled with 4% ficoll (dissolved in 1 ´  MBS or 1´  Barth’s solution).
6. Drive the needle tip through surface of the embryo, give pressure to the
needle and inject. Wait for a moment, and then withdraw the needle gently.
7. Once a set of embryos has been injected, pipette the embryo up gently and
place them in the same medium as in step 5 in a fresh Petri dish.
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8. Incubate the embryos at 18-21ºC.
9. After 1-2 h, replace the medium with 0.1 ´  MBS and remove any unhealthy
embryos.
10. Culture as in step 8 for the appropriate cell stages.
Notes:
Dorsal blastomeres determination:
Because of the cortical rotation, the future dorsal side tends to be lighter in colour than the ventral
side, but this difference is an imprecise and unreliable indicator of where the future dorsal side will
form.
Injection volumes determination:
The inject volume must be calibrated carefully. The following protocol describes the calibration
procedure for a pressure injector.
1. Backfill the needle using a microloader fitted with a long narrow tip (of the kind used for
loading sequencing gels) and mount on the injector.
2. Break the needle tip to produce an orifice of approximately 10 m m.
3. Place a small drop of paraffin oil on a microscope slide and mount the slide on the stage of a
dissecting microscope.
4. Calibrate the eyepiece micrometer for the appropriate magnification and perform a trial
injection into the drop of oil. The injected liquid forms a sphere within the oil droplet.
5. Measure the diameter of the sphere using the eyepiece micrometer and calculate the injected
volume (V=4/3 p r3, where V is the volume and r is the radium of the sphere).
The different methods are employed for calibrating the injection volume including deposition of the
drop directly on the stage micrometer (note that micrometer must siliconized for the drop to be near
spherical). The injected volume can then be calibrated as described in step 5 above. Alternatively,
allow the drop to hang at the end of the needle, where its diameter can be measured using an
eyepiece micrometer. The drop must be measured quickly because evaporation causes it to shrink
rapidly. Anther method is to inject the drop into a dish of paraffin oil. Approximate the volume of the
drop by using the equation V=4/3 p r3 (see above) or using the figures shown in Table 2-1 below. Once
the appropriate pressure has been established, the duration of the pressure burst can be used to
control the volume precisely.
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Table 2-1. The injection volume and the corresponding drop diameter and radius.
Diameter of drop (µm) Radius of drop (µm) Volume (nL)
125 62.5 1.03
140 70 1.44
150 75 1.07
160 80 2.15
170 85 2.58
180 90 3.06
200 100 4.20
225 112.5 5.90
250 125 8.20
2.2.5 Morpholino preparation for microinjection
2.2.5.1 Principle
As a new loss-of-function approach, morpholino antisense oligos have been adopted to the
study of gene functions in the recent 3 years. In contrast to the traditional posphorothioate oligos,
the morpholino antisense oligos (Figure 2-1) are non-toxic and when injected into fertilized eggs
they prevent translation of the proteins in both cytosolic and membrane-associated fractions
through the neurula stage (Summerton et al., 1997). Generally, an antisense morpholino oligo,
typically 18 to 25 genetic letters in length, binds the sense mRNA and prevents synthesis of the
protein coded by that mRNA. A normal gene function and the inhibition of this gene function by an
antisense oligo are illustrated in Figure 2-2. This new approach has been successfully used to
deplete the β-catenin in Xenopus laevis (Heasman et al., 2000).
Figure 2-1. The chemical formula of morpholino (MO).
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Figure 2-2. The blockage of protein translation imposed by morpholino. In the absence of
morpholino, the protein will be synthesized by ribosome naturally according to codons in the mRNA.
However in the presence of morpholino designed to bind to the complementary sequence in this
mRNA, the protein initial site will be sequestered by the morpholino, hence no protein product will be
synthesized finally (Cited from protocol of GeneTool.
 2.2.5.2 Experimental procedures
Dissolve the morpholino in 1× Barth’s with a concentration of 4 ng/nL as the stock solution, and
store it at -20ºC. Dilute the stock solution to the working solution with 1× Barth’s just before
microinjection. The microinjection of morpholino was performed the same as that of mRNA.
2.2.6 Embryos fixation with MEMFA or HEMFA
Embryos were fixed in HEMFA or MEMFA at room temperature for 1 h with
shaking, afterwards washed with 100% ethanol twice or three times and stored at
–20ºC in 100% ethanol.
10× MEM: MEMFA:
1M MOPS pH 7.4 0.1M MOPS pH 7.4
20 mM EGTA 2 mM EGTA
10 mM MgSO4 1 mM MgSO4
3.7% formaldehyde
10× HEM: HEMFA:
1M HEPES pH 7.4 0.1M HEPES pH 7.4
20 mM EGTA 2 mM EGTA
10 mM MgSO4 1 mM MgSO4
3.7% formaldehyde
The 10× stock solutions without formaldehyde can be prepared and stored after filtration to
remove bacteria. These solutions turn into yellow if autoclaved or aged.
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2.2.7 LacZ staining
1. Fix embryos in MEMFA for 1 h.
2. After rinsing with 1 ´  PBS twice for 10 min each, transfer the embryos to the X-
gal staining solution and stain for 1.5-6 h at room temperature until the blue appears.
3. Wash the embryos with 1 ´  PBS twice with shaking for 10 min each.
4. Refix the embryos with MEMFA for 40 min.
5. Rinse the embryos with 100% ethanol twice for 5min each, afterwards store
them at –20ºC till whole-mount in situ hybridization.
X-gal staining solution (in 1 ´  PBS, 10 mL):
1 mg/mL X-gal 0.25 mL 40 mg/mL X-gal (in DMSO)
5 mM K3Fe(CN)6 0.10 mL 500 mM K3Fe(CN)6
5 mM K4Fe(CN)6 0.10 mL 500 mM K4Fe(CN)6 
2 mM MgCl2 0.20 mL 100 mM MgCl2
Add 1 ´  PBS to 10 mL
2.3 Bacteria manipulation
2.3.1 Preparation of competent cells
1. Grow a single bacterial colony in 100 mL of fresh LB broth at 37ºC for 16-20 h
with vigorous shaking.
2. Dilute (1:100) the culture above to a certain volume of fresh LB broth and grow
to early log phase (O.D.600 = 0.2-0.4)  at 37ºC for approximately 2-2.5 h with vigorous
shaking.
3. Aseptically transfer the cells to sterile, disposable and ice-cold 50ml-
polypropylene tube (Falcon). Cool the culture to 0ºC by storing the tube on ice for 10
min (This procedure could prolong if the culture volume is very large.). All
subsequent steps were carried out aseptically.
4. Collect cells by centrifugation at 3000 rpm at 4ºC for 10 min.
5. Decant the medium, and stand the tube in an inverted position for 1 min to
allow the last traces of media to drain away.
6. Wash the pellet with 10 mL of ice-cold 0.1 M CaCl2 and keep the cells ice cold
in all further steps.
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7. Collect cells as in step 4 and resuspend the cell pellets with 1/25 original
culture volume of 0.1 M chilled CaCl2.
8. Add 140 m L of DMSO per 4 mL of resuspended cells. Mix gently by swirling
and hold on ice for 15 min. Then add another 140 m L of DMSO to each suspension,
mix gently and keep on ice bath.
9. Dispense aliquots of the suspensions into chilled, sterile 1.5-mL Eppendorf
tube quickly, afterwards fast freeze in liquid nitrogen and store at -70ºC.
2.3.2 Transfomation
1. Thaw 50 -200 uL of bacteria per transformation and keep them on ice.
2. Gently mix cells by hand.
3. Add 0.1ng-50 ng of DNA (or approximately 1/2 ligation) to cells, swirl gently,
and put it on ice for 30 min.
4. Afterwards heat shock at 42ºC for 90 sec and then hold it on ice for 2 min.
5. Add 0.8 mL of LB and shake at 37ºC for 40 min.
6. Plate on LB-agar plates containing antibiotic, and keep the plates overnight at
37ºC.
2.4 DNA techniques
2.4.1 Extraction of plasmid DNA
2.4.1.1 Mini-preparation with TELT
1. Harvest the bacterial cells from a 1.5-mL culture by centrifugation at 6000 rpm
for 5 min at room temperature.
2. Remove supernatant completely with vacuum system and resuspend the
bacterial pellet in 150 m L of TELT solution.
3. Add 15 m L of freshly prepared solution of lysozyme (10 mg/mL in H2O) to the
cells, vortex and incubate at room temperature for 5 min.
4. Keep the cells in boiling water for 2 min and then cool them down on ice for 5
min.
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5. Remove bacterial debris with a sterilized toothpick after full speed
centrifugation at room temperature for 8 min.
6. Extract the supernatant with 100 m L of isopropanol with vortex.
7. Centrifuge with full speed for 15 min at room temperature. Discard the
supernatant with pipette and wash the pellet with 200 m L of 70% ethanol.
8. Centrifuge as in step 7. Suck off the supernatant and dry the pellet in a
vacuum desiccator for 5min.
9. Dissolve DNA in 30 m L of TE (pH 8.0) containing RNAse A (10 ng/ m L).
Incubate first for 2-5 min at room temperature, and then 5 min at 65ºC.
10. Spin down and collect the supernatant.
TELT:
50 mM Tris/HCl pH 7.5
10 mM EDTA
3.2 M LiCl
0.5% Triton X-100
RNase A stock:
1. Dissolve RNAase A in TE (pH7.8) to a final concentration of 10 mg/mL.
2. Boil for 10 minutes before use.
3. Store RNase A stock solution in aliquots of 50 m L at -20ºC.
2.4.1.2 Midi-preparation with Qiagen Kit
Plasmid DNAs midi-preparation was carried out using Qiagen Midi-preparation Kits
and following the supplied protocol.
2.4.2 Recovery of DNAs from gel
The DNAs recovery from agrose gels were carried out using Qiagen QIAquick
purification kits and following the supplied protocol.
2.5 RNA manipulation
2.5.1 Preparation of mRNA for microinjection
Capped mRNAs used for microinjection were in vitro transcripted with the Cap-
Scribe as described below.
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Mix the following component in order on ice:
To a total volume of 20 m L:
4 m L the Cap-Scribe 5 ´  buffer
0.5 ng linearized template DNA
              Add to 18 m L DEPC-H2O
2 m L RNA polymerse
After incubation for 2 h at 37ºC, add 2 m L of a solution of DNase I (10 U/ m L) to
remove the DNA template. Purify the RNA product with Qiagen RNeasy kit and
determine the concentration with spectrum photometer. Aliquot the RNA sample into
convenient volumes (depending on the concentration measured) and place at -70ºC.
2.5.2 Preparation of RNA probe for whole–mount in situ hybridization.
1. Add the following components into a 0.2-mL Eppendorf tube on ice, mix and
then incubate for 2 h at 37ºC.
 To a total volume of 25 m L:
10 m L template (1µg linear DNA)
5 m L 5 ´  transcription buffer
1 m L DTT (0.75 M)
0.5 m L RNase black (40 U/ m L)
4 m L Digoxigenin RNA mix or florescein-mix
0.5 m L RNA polymerase (20 U/ m L)
4 m L DEPC-H2O
2. Add 2 m L of a solution of DNase I (10U/ m L) to digest the template DNA for 15
min at 37ºC.
3. Purify the RNA product with Qiagen RNeasy kit according to its protocol.
2.5.3 Whole-mount in situ hybridization
In principle, whole-mount in situ hybridization was performed as described by
Harland (Harland, 1991) and Oschwald (Oschwald et al., 1991).
2.5.3.1 Preparation of solutions
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PTw:
1 ´  PBS
0.1% Tween 20
20 ´  SSC:
175.3 g sodium chloride
88.2 g sodium citrate
Dissolve in 800 mL of sterile Millipore water, adjust pH to 7.0 with NaOH, and adjust the volume to 1
liter.
100 ´  Denhart’s Solution:
2% BSA
2% polyvinylpyrrolidone (PVP-40)
2% Ficoll 400
Hybridization Buffer:
50% formamid
5 ´ SSC
1 mg/mL Torula RNA (Type IX, Sigma)
100 µg/mL heparin (Sigma)
1 ´ Denhart’s solution
0.1% Tween 20
0.1% CHAPS
10mM EDTA
5 ´  MAB (Maleic Acid Buffer):
0.5 M Maleic acid
0.75 M NaCl
pH 7.5
10% BMB:
Weigh Boehringer Mannheim Blocking Reagent in 1 ´  MAB for a final concentration of 10% (m/v), and
autoclave immediately. The BMB will be dissolved after the autoclave.
APB (Alkaline Phosphatase Buffer):
100 mM Tris/HCl pH 9.5
50 mM MgCl2
100 mM NaCl
0.1%(v/v) Tween20
Freshly prepare the APB immediately before use.
NBT/BCIP:
nitro blue tetrazolium (NBT): 75 mg/mL in 70% dimethylformamide.
5-bromo-4-chloro-3-indolyl-phosphate (BCIP): 50 mg/mL in 100% dimethylformamide.
Goat Serum (GS):
Heat deactivates the complement for 30min at 55ºC. Store as aliquots of 10 mL at -20ºC.
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2.5.3.2 Experimental procedures
Embryos were fixed in MEMFA (or HEMFA) for 1 h at room temperature. Replace
the MEMFA (or HEMFA) with absolute ethanol twice or three times for 5 minutes
each, and store in 100% ethanol at –20ºC.
Day 1:
Rehydration. The embryos were then rehydrated by washing with following
solutions in order.
(1) 100% ethanol 5 min
(2) 75% ethanol 5 min
(3) 50% ethanol 5 min
(4) 25% ethanol in PTw 5 min
(5) 100% PTw 5 min 4 times
Proteinase K treatments. The embryos in each vial were treated with 2 mL of PTw
containing 10 µg/mL proteinase K for 10-30 min at room temperature depending on
the cell stage they were in, the number of embryos and the temperature. It is
approximately 20 min for gastrula-stage embryos, and a long period of 20-30 min for
tailbud-stage embryos.
Acetification. After the proteinase K treatment, the embryos were immediately
subject to the treatment of acetylate which neutralizes free amines and helps to
prevent electrostatic interaction between the probe and basic proteins in the embryo.
(1) 4 mL 0.1 M triethanolamine pH 7.5 5 min twice
(2) 4 mL 0.1 M triethanolamine pH 7.5
+ 12.5 m L acetic anhydride 5 min
+ 12.5 m L acetic anhydride 5 min
(3) PTw 5 min twice
Refixation. The embryos were refixed by incubating with following solutions in
order.
(1) PTw + 4% formaldehyde  20 min
(2) 100% PTw 5 min 5 times.
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Hybridization.
(1) Remove approximately all 1 mL of PTw from the vial and add 250 m L of hybridization buffer
(without mixing).
(2) Once embryos have settled through the dense layer of the buffer, remove the entire buffer and
replace with 0.5 mL of fresh hybridization buffer per vial. Incubate for 10 min at 60ºC in a
shaking water bath.
(3) Replace hybridization buffer and prehybridize for 6 h at 60ºC.
(4) Remove hybridization buffer and replace it with fresh hybridization buffer containing 0.5 µg-
1µg/mL of probes. Hybridize overnight at 60ºC. The rest probe can be stored at -20ºC.
Day2:
Washing the embryos.
(1) Rinse the embryos for 10 min with 2 mL of fresh hybridization buffer and then wash with 4 mL
of 2 ´  SSC three times for 20 min each at 60ºC.
(2) Replace the washing solution with 4 mL 2 ´  SSC containing 20 µg/mL of RNase A and 10 U
RNase T1. Incubate vials for 1 h at 37ºC.
(3) Remove excess RNase by washing the embryos with 4 mL of 2 ´  SSC once for 10 min at room
temperature, and then with 4 mL of 0.2 ´  SSC twice for 30 min each at 60ºC.
(4) Wash with 4 mL of 1 ´  MAB twice for 15 min each at room temperature.
Antibody Incubation. All subsequent steps were carried out at room temperature
except those indicated.
(1) Replace 1 ´  MAB with 4 mL of 1´  MAB + 2% BMB, and keep shaking for 15-60 min.
(2) Change the solution to 4 mL of fresh 1 ´  MAB + 2% BMB + 20% goat serum, and keep it for 1
h.
(3) Replace the solution with 1.5 mL of fresh 1´  MAB + 2% BMB + 20% goat serum containing
1/5000 dilution of the antibody. Rock the vials for 4 h.
(4) Remove the excess antibody by washing with 4 mL of 1 ´  MAB twice for 30 min each.
(5) Change with 40 mL of fresh 1 ´  MAB and keep shaking the vial overnight at 4ºC.
Day 3:
Color reaction.
(1) Wash the embryos with 4 mL of 1 ´  MAB twice for 30 min each at room temperature.
(2) Replace the solution with 4 mL of APB twice for 5 min each at room temperature.
(3) Replace the last washing solution with 0.5-2 mL of BM purple or APB containing 2 µg/mL of
NBT and 3.5 µg/mL of BCIP per vial and incubate at 4ºC until staining becomes apparent.
2. MATERIALS AND METHODS        38
Bleaching.
(1) Wash the embryos with 2 mL of 100% methanol for 1-5 min.
(2) Rinse the sample with 2 mL of Millipore H2O several times for 1-5 min each.
(3) Transfer the embryos to methanol containing 10% H2O2 and keep at 4ºC until pigment
disappears.
(4) Rinse the embryos with 2 mL of Millipore H2O, then keep them in 2 mL of MEMFA or HEMFA.
2.6 RT-PCR
2.6.1 Isolation of total RNA from embryos, animal cap, or marginal zone
explants.
1. Homogenize 10 embryos with 1000 m L of RNA-Clean™, (for minimum RNA
preparation, 2 embryos use 200 m L of RNA-Clean, 20 animal caps, 200 m L, and 10
marginal zone explants, 200 m L). Keep the samples on ice before preparation.
2. Add 100 m L of chloroform per 1000 mL of homogenate, cover the samples
tightly, shake vigorously for 15 sec and hold on ice for 5 min.
3. Spin at 12000g for 15 min at 4 ºC.
4. Transfer the upper aqueous phase to a fresh 1.5-mL Eppendorf tube. Add the
equal volume of isopropanol.
5. Let stand at -20ºC for at least 1 hour or overnight to precipitate the RNAs.
6. Spin the samples at 12000g for 15 min at 4ºC. Carefully remove the
supernatant without disturbing the RNA pellet.
7. Wash the RNAs pellet once with 70% ethanol (0.8 mL of ethanol per 100 µg of
RNA), i.e. vortex the RNAs pellet for several seconds and spin at 7500g for 8 min at
4ºC. Repeat the washing step with 500 m L of prechilled 70% ethanol.
8. Dry the RNAs pellet in air (about 10 min). It is important that the RNAs pellet
does not dry out completely, as this will affect solubility and quality of the RNA.
9. Dissolve the RNAs pellet in 50 m L of DEPC-H20.
10. Determine concentration of the RNAs by spectrum photometer. The
OD260/A280 ratio should be in the range from 1.6 to 1.9.
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11. For the RNAs storage, add 3 volume of prechilled absolute ethanol at -20ºC
and 1/10 volume of 3 M NaAc solutions (pH 5.2). Keep the RNA at -20ºC.
2.6.2 Isolation of total RNA from adult tissues
1. Various organs and tissues were taken from an adult sacrificed frog and then
ground in a meat grinder with liquid nitrogen and stored at -80ºC.
2. Add 500 m L of lysis buffer containing 200 µg/mL of proteinase K for 200 m L of
tissue powder.
3. Thoroughly homogenize the tissue power with the lysis buffer by pipetting with
a fine needle, afterwards incubate for 45 min at 45ºC.
4. Extract the sample once or twice with 0.5 mL of phenol/chloroform and three
times with 0.5 mL of chloroform.
5. Precipitate the RNAs with 3/4 volume of 8 M LiCl at -20ºC.
6. Dissolve the sample in 100 m L of DEPC-H2O after washing with 80% ethanol.
7. Reprecipitate the RNAs with 3 volume of absolute ethanol and 1/10 volume of
3M NaAc (pH 5.2) and resuspende in 45 m L of DEPC-H2O.
8. After centrifugation, treat 40 m L of the samples with 2 m L of DNase I (10 U/ m L)
for 30 min at 37ºC.
9. Store the sample at -20ºC.
2 ´  Lysis Buffer:
1% SDS
10 mM EDTA
100 mM Tris/HCl pH 7.5
100 mM NaCl
Working Lysis Buffer:
2 ´  lysis buffer 5mL
20 µg/ m L Proteinase K 0.5mL (added immediately before use)
DEPC-H2O 4.5mL
2.6.3 Reverse transcription
1. To a total volume of 12 m L, add the following components to a nuclease-free
0.2-mL microcentrifuge tube:
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1 µg total RNA
2 m L 0.1 mM Hexamer random primer
9 m L DEPC-H20
2. Mix well, incubate for 10 min at 70ºC, and then quickly chill on ice. Collect the
contents in the tube by brief centrifugation, to which following components were then
added and incubated for 10 min at 25ºC.
4 m L 5 ´  First strand buffer
2 m L 0.1 M DTT
1 m L 10 mM dNTPs mix
3. Add 1 m L of RNase H-Reverse Transcriptase (200 U/ m L). Mix gently and
incubate for 50 min at 42ºC, then 15 min at 70ºC to inactivate the reverse
transcriptase. Afterwards store the sample at -20ºC.
2.6.4 PCR reaction
At first, the normalization of cDNA samples was carried out with housekeeping
genes such as H4 and ODC using PCR. Keep the sample which gives the weakest
band, and add H2O to those sample that give stronger bands until all samples show
the same amount of PCR products after a proper amplification. The normalized
samples were then applied for PCR with specific primers. Always use 1 m L of reverse
transcripts in the subsequent PCR system.
1. Set up the reaction by mixing the following reagents on ice:
18 m L sterile Millipore H2O
1 m L 2.5 m M Primers (forward, reverse primer together)
2.5 m L 2 mM dNTPs mix
2.5 m L 10 ´  PCR buffer
1 m L reverse transcripts
0.3 m L Taq DNA polymerase
Add one drop of mineral oil or without oil in the case of using thin wall tube.
2. PCR was performed with following cycling parameters (for normal markers
with less than 500 bp of products).
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1 1 ´  denaturation 95ºC 3 min,
2 20-35 ´  cycle: denaturation 95ºC 1 min
annealing 55ºC 1 min (depends on primers)
extension 72ºC 1 min
3 extension 72ºC 10 min
4 end 4ºC
3. PCR products determination
Add 5 m L of loading buffer to a 25 m L of reaction system after PCR, and load 20 m L
of this in 2-2.5% agarose gel. Inspect bands on UV illuminator.
2.7 cDNA screening
A part of the phage cDNA library prepared from activin-treated ectoderm of
Xenopus laevis was converted into a plasmid cDNA library by an in vivo excision of
the pBK-CMV phagemid from the ZAP Express vector according the protocol
provided by the manufacturer (Stratagene). A large-scale whole-mount in situ
hybridization method was then used for screening this plasmid cDNA library.
 After in vivo  excision around 10,000 single colonies were picked up from the LB
agar plates. Grow the single clones overnight in 2´  LB containing 50 µg/mL
kanamycine in the wells of a 96-well titration plate, respectively. The bacteria were
stored at -80ºC.
2.7.1 Inserts amplification of a single clone to obtain templates for in vitro
transcription by PCR
1. Setting up the reaction system for a large-scale screening cDNA.
To one reaction of 20 m L:
2 m L 10 ´  PCR reaction buffer
0.16 m L 25 mM dNTPs mix
0.3 m L 10 m M CMV-F
0.3 m L 10 m M CMV-R
16.14 m L H20
0.1 m L Taq DNA polymerase
1 m L Bacteria culture solution
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2. PCR was carried out with 96-well PCR reaction plates in UNOII thermal cycler
with the following program using a pair of primers: CMV-F and CMV-R.
95ºC 45 sec
40 ´  cycles:95ºC 45 sec
56ºC 45 sec
72ºC 3   min
72ºC 10 min
CMV-F: CGC GCC TGC AGG TCG ACA CTA
CMV-R: GCA AGG CGA TTA AGT TGG GTA
3. Store 5 m L of PCR products for the subsequent transcription. The remaining
20 m L of product was loaded for electrophoresis to determine the efficiency of the
amplification.
2.7.2 Preparation of the fluorescein labeled probes
1. Prepare reagents.
rNTPs mix:
50 m L 10mM rATP
50 m L 10mM rCTP
50 m L 10mM rGTP
32.5 m L 10mM rUTP
17.5 m L 10mM Fluorescein-12-UTP (Roche)
2. Set up the transcription reaction.
Transcription reaction mix (total volume of 20 m L):
5 m L PCR product
0.8 m L 0.75 M DTT
4 m L 5 ´  transcription buffer
2 m L rNTP mix
0.25 m L RNase inhibitor (40 U/ m L)
7.7 m L DEPC-H2O
0.25 m L T7 RNA polymerase(50 U/ m L)
The transcription reaction was carried out with 96-well PCR reaction plate in
UNOII PCR thermo cycler for 4 hours at 37ºC.
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2.7.3 Purification of RNA probe
1. Sephadex G50 preparations: Weigh 40 g of Sephadex G50 into 500 mL of
Sephadex G50 medium solution and autoclave.
2. Pack such Sephadex G50 into a 96-well column plates and spin down the
multi-column plate at 1200-1500 rpm for 30 sec to remove the medium solution.
3. Equilibrate Sephadex G50 column plate with 1 ´  STE (50 m L for each well)
twice.
4. Discard the flow through, and subsequently load the transcripts on the column
plate and place it on a new 96-well microtitration plate (pay attention to the direction).
5. Spin down as in step 2 and the purified transcripts were collected in the
microtitration plate. Usually 20 m L was obtained in each of the wells. Add the same
volume of formamide into each well. Take 5 m L of this mixer from each well
respectively and load on an agarose gel without ethidium bromide to determine the
efficiency of in vitro transcription.
10 ´  STE (50mL):
200 mM Tris/HCl pH 7.5 10 mL 1 M Tris
20 mM EDTA 2 mL 0.5 M EDTA
500 mM NaCl 5 mL 5 M NaCl
Add DEPC-H2O to 50 mL
Sephadex G50 medium:
10 mM Tris/HCl (pH 8.0) 5 mL 1 M Tris/HCl pH 8.0
0.1% SDS 5 mL 10% SDS
0.3 M NaCl 30 mL 5 M NaCl
Add DEPC-H20 to 500 mL
Sephadex G50 40 g
2.7.4 Large- scale whole-mount in situ hybridization
In principle, all steps are similar to the normal whole-mount in situ hybridization
(see 2.5.3). Four sets of a special 24-well device were used for the hybridization
instead of the vials.
To find a compromise between the large-scale throughput and the depth of
analysis, a limit was imposed on embryonic stages to gastrula (stage11), neurula
(stage13-15), and tailbud (stage28-30).
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2.8 Sequences submission
Colonies indicating suggestive expression patterns were selected for sequencing.
The sequence data were used to eliminate redundant clones and to compare to the
DNA and protein sequences in GeneBank with BLAST (NCBI). Those which were not
collected in the database were submitted to GeneBank, and got accession numbers
shown in results.
2.9 Constructs used in this study
2.9.1 Primers design for mutagenesis
Names Primer sequences Notes
Fw: 5’-GCGCGAATTCAATGGTGGTCGTGGGAGCC-3'XXBP-1
subclone Re: 5’-GCGCCTCGAGTTAAAAATGTACATCAAACTC-3’
E.coRI and XhoI
cutting site is in
bold
Fw: 5’-GACTCCCAGCAGCC-3’
VP16
Re: 5’-GCGCTCTAGATTAGTCAATTCCAAGGGCATCGGT-3’
XbaI site and the
stop codon are in
bold
Fw: 5’-AGCACGATCAAGGTGTGG-3'
Eve
Re: 5’-GCGCTCTAGATTACGCCTCAGTCTTGTA GGG-3'
XbaI site and the
stop codon are in
bold
Fw: 5’-GCGCGAATTCAATGGTGGTCGTGGGAGCC-3'
D XXBP-1
Re: 5’-TAGGCCCAATCTTTGGCG-3'
E.coRI cutting site
is in bold
Fw: 5’-GCGCGAATTCAATGGTGGTCGTGGGAGCC-3'Truncated
XXBP1 Re: 5’-GCGCCTCGAGTTATAGGCCCAATCTTTGGCG-3'
E.coRI and XhoI
cutting site is in
bold
Fw: 5’-GCGCGAATTCAATGGCTAGCGTAGAG-3'
XMLP G2A
Re: 5’- GCGCCTCGAGCTATTCCTCCTGTTT -3'
alanine codon is
in bold
Fw: 5’-CTTGAAAGCGAACCTCTT-3'
XMLP S83A
Re: 5’-AACCTGAAGTTCGGTAAT-3'
alanine codon is
in bold
1: 5’-TGCCTGCTTTCCCGGTGG-3'
XMLP ED
2: 5’-TTCAAGAACCTGAAGTTCGGTAAT-3'
Fw: 5’-GCGCGAATTCAATGGGTAGCGT-3'XMLP
subcone Re: 5’-GCGCCTCGAGCTATTCCTCCTG-3'
E.coRI and XhoI
cutting site are in
bold
Fw: 5’-CGCGCCTGCAGGTCGACACTA-3'
CMV
Re: 5’-GCGCCTCGAGCTATTCCTCCTG-3'
XhoI cutting site
are in bold
2: 5’-TTGGTCTGCCTGCTTGTTGCT-3'
SD
3: 5’-AAAACCAATGGCGACGCCCCC-3'
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2.9.2 The constructs for XXBP-1
The coding region of XXBP-1 was subcloned into pCS2+ (Turner et al., 1994) by
PCR with the primers of XXBP-1 subclone Rw and Re.
2.9.2.1 XXBP1-VP16
To construct XXBP1-VP16, the sequences encoding VP16 activation domain and
the sequence encoding the first 126 amino acids of XXBP-1 containing the bZIP were
fused together (Figure 3.2-14).
The sequence of VP16 activation domain (VP16, 261bp, Friedman et al., 1988)
was PCR amplified from VPXvent-1 (Onichtchouk, 1998) by pfu DNA polymerase
with the primers, 5’-phosphorylated VP16 Fw and VP16 Re (see 2.9.1). The amplified
product was XbaI cut and gel purified. The sequence corresponding to the first 126
amino acids containing the bZIP of XXBP-1 was PCR amplified from pCS2-XXBP-1
by pfu DNA polymerase using primers: D XXBP-1 Fw and 5’-phosphorylated D XXBP-1
Re (see 2.9.1). The amplified products were EcoR I cut and gel purified. Afterwards
the VP16- and bZIP-containing fragments were filled in EcoRI –XbaI cut pCS2+ to
get XXBP1-VP16.
2.9.2.2 XXBP1-Eve
To construct XXBP1-Eve, the sequence encoding the even-skipped repression
domain (Han and Manley, 1993) was fused with the sequence from XXBP-1 as that
for constructing XXBP1-VP16. The even-skipped repression domain sequence (Eve,
777bp) was PCR amplified from EveXvent1 (Onichtchouk et al., 1998) with the
primers: 5’-phosphorylated Eve Fw and Eve Re (see 2.8.1). The amplified product
was phosphorylated, XbaI cut and gel purified. Afterwards Eve- and the bZIP-
containing fragments were colligated with EcoRI –XbaI cut pCS2+ to obtain XXBP-
Eve.
2.9.2.3 XXBP1-EnR and truncated XXBP-1
The sequence encoding the first 126 amino acids of XXBP-1 containing the bZIP
region with a stop codon at 3’-end was subcloned to pCS2+ to yield truncated XXBP-
1. In addition, the bZIP-encoded region was also transferred to pCS2MTEnR to
obtain XXBP1-EnR with Drosophila engrailed repressor domain at the carboxyl
2. MATERIALS AND METHODS        46
terminal and 6 myc epitopes tag at the amino terminal.
2.9.3 The constructs for XMLP
The predicted XMLP open reading frame sequence was subcloned into pCS2+
with PCR using the primers of XMLP subcone Fw, and Re.
XMLP G2A mutant was generated from XMLP-pCS2+ with the primers of XMLP
G2A Fw and Re (see 2.9.1) changing glycine at position 2 to alanine. XMLP S83A
mutant was obtained by amplifying XMLP-pCS2+ with long distance PCR using a
pair of 5’-phosphorylated primers: XMLP S83A Fw and Re. The PCR products were
digested with DpnI to remove the parental DNA and afterwards the resultant was
blunt-end ligated with T4 DNA ligase. The supposed phosphorylation site serine at
position 83 was replaced by alanine. For the XMLP ED mutant, the fragment of 5'-ED
was amplified form XMLP-pCS2+ with the primers of XMLP subclone Fw and 5’-
phosphorylated ED primer 1, and the fragment of 3'-ED was amplified with 5-
phosphorylated ED primer 2 and XMLP subclone Re. Afterwards 5'- and 3'-ED were
cut by EcoRI and XhoI, respectively, and then coligated with EcoRI- XhoI- digested
pCS2+. For XMLP SD mutant, the subclone was performed in two steps. First, 5'-SD
was amplified from XMLP-pbk-CMV containing full sequence of XMLP with two
primers: CMV-Fw and 5’-phosphorylated SD primer 2, in turn was cut by EcoRI and
gel purified. 3'-SD was amplified with 5’-phosphorylated SD primer 3 and XMLP
subclone Re, cut by XhoI, gel purified. The 5' and 3' terminal SD were coligated with
EcoRI- and XhoI- cut pCS2+. Second, the resultant was amplified with XMLP
subclone Fw and Re, and subcloned into pCS2+.
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3. Results
3.1 Isolation of novel genes from an activin-treated ectoderm cDNA
library of Xenopus laevis
I have screened a cDNA library prepared from activin-treated Xenopus laevis
ectoderm, using large-scale whole-mount in situ hybridization. Based on the
expression patterns, potentially interesting clones were subsequently sequenced.
The obtained sequences were compared to the DNA and protein sequences in the
GeneBank and 51 novel genes were identified. The novel sequences were then
submitted to the GeneBank and assigned the Accession Numbers listed in Table 3.1-
1. It should be noted that the deposit sequences in GeneBank are updating rapidly
every day, therefore some of genes in the list may have also been isolated by other
groups after my submission. The results shown in Table 3.1-1 were updated on
March 10, 2002.
The cDNA clones encoding the Xenopus X-box binding protein 1 (XXBP-1), the
Xenopus MARCKS like protein (XMLP) and the Xenopus arginine:glycine
amidinotransferase (XAT) were further characterized because their suggestive
expression pattern strongly indicate that they are deeply involved in the early
embryogenesis.
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Table 3.1-1. Novel genes isolated from an activin-treated ectoderm cDNA library of Xenopus
laevis.
Main distribution of blast hit of DNA sequence databaseAccession
Number score E value Homologue in Xenopus or other species
BF348693 178 2e-42 Gallus gallus PR264 mRNA, a potential splicing factor. ACCESSION
X62446
BF348704 42 0.33
Myxoma virus, complete genome, also similar to SW: HCD2_BOVIN
O02691 3-Hydroxyacyl-coa dehydrogenase type II, mRNA sequence.
ACCESSION AF170726
BF348705 313 6e-83 Xenopus gene encoding a HMG1 homologue. ACCESSION D30765
BF348706 42 0.32 Rattus norvegicus Aquaporin 1 (aquaporin channel forming integral
Protein 28 (CHIP) (Aqp1), mRNA. ACCESSION NM_012778
BF348707 172 1e-40 Gallus gallus death associated protein 5-like (DAP5), mRNA
sequence. ACCESSION AF093110
BF348708 42 0.34 Homo sapiens chromosome 16 clone CTD-2270L9, complete
sequence. ACCESSION AC008915
BF348709 40 1.3 Homo sapiens genomic DNA, chromosome 6p21.3, HLA Class I
region, section 13/20. ACCESSION AP000514 BA000025,
BF348710 613 e-173 Xenopus laevis xCIRP2 mRNA for cold-inducible RNA binding protein
2, complete cds. ACCESSION AB044535
BF348711 40 1.3
Homo sapiens NF-E2-related factor 3 gene, complete cds.
ACCESSION AF135116
5' similar to SW: CKR1_human P32246 C-C Chemokine receptor
type 1, mRNA sequence.
BF348712 48 0.005
Homo sapiens 6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase
2(PFKFB2), mRNA. ACCESSION NM_006212
5' similar to TR: Q9V9B6 Q9V9B6 CG9422 PROTEIN, RNA
sequence.
BF348713 42 0.33
Mus musculus GIG18 (Gig18) mRNA, complete cds. ACCESSION
AF374476
BF348714 48 0.005 Xenopus laevis rod arrestin gene, promoter, exons 1 and 2, and
partial cds. ACCESSION AF053942
BF348715 127 7e-27 Homo sapiens similar to RIKEN cDNA 2700064H14 gene
(LOC116225), mRNA. ACCESSION XM_057654
BF348694 42 0.3 Human DNA sequence from clone RP11-166O7 on chromosome 10,
complete sequence. ACCESSION AL607082
BF348695 44 0.085 Human DNA sequence from PAC 76C18 on chromosome 6q16.1-21.
Contains STS. ACCESSION Z98755
BF348696 44 0,085
Homo sapiens 12q22 BAC RPCI11-513P18 (Roswell Park Cancer
Institute Human BAC Library) complete sequence. ACCESSION
AC007564
BF348697 44 0.084
Homo sapiens chromosome 17, clone hRPK, 601_N_13, complete
sequence. ACCESSION AC025775
BF348698 680 0.0
Xenopus X-box binding protein-1 partial sequence. ACCESSION
AF358133
72 4e-10
Mus musculus 10 days embryo cDNA, RIKEN full-length enriched
library, clone: 2610015J01, full insert sequence. ACCESSION
AK01140
BF348699
64 9e-08
Human chromosome 14 DNA sequence BAC R-109N23 of library
RPCI-11 from chromosome 14 of Homo sapiens (Human), complete
sequence. ACCESSION XM_027330
BF348700  632 1e-179
Xenopus laevis mRNA for retinoic acid receptor gamma B.
ACCESSION X59396
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BF348701 42 0.33
Human DNA sequence from clone RP3-401D24 on chromosome 6,
complete sequence. ACCESSION AL137184
5' similar to SW: G731_HUMAN P09758 pancreatic carcinoma
marker protein ga733-1 precursor.
BF348702 103  1e-19
Mus musculus 10 days embryo cDNA, RIKEN full-length enriched
library, clone: 2610528A17, full insert sequence. ACCESSION
AK012159
5' similar to TR: O46084 O46084 EG:63B12.4 PROTEIN mRNA
sequence.
BF348703 668 0.0
Xenopus laevis signal sequence receptor beta subunit mRNA,
complete cds. ACCESSION AF346565
AI880935 56 2e-05
Homo sapiens chromosome X clone RP11-54I20, RP11-66N11 map
q28, complete sequence. ACCESSION AF274858
103 2e
-19 Geodia cydonium mRNA for XPB/ERCC-3-like protein. ACCESSION
Y17148
AI880936
103 2e
-19 Lycopersicon esculentum heat shock protein (HSP21) mRNA.
ACCESSION U66300
AI880937 1043 0.0
Xenopus laevis MARCKS-related-protein protein mRNA, complete
cds. ACCESSION AF187864
AI880938 1423 0.0
Xenopus laevis ATP synthase subunit b  mRNA, complete cds.
ACCESSION AF187862
AI880939 283 1e-73
X.laveis cytokeratin typeII mRNA (cytoskeletal protein). ACCESSION
M13811
111 7e-22
Urechis caupo mRNA for cytoplamic intermediate filament protein
(structure protein). ACCESSION AJ004935
111 7e-22
Homo Sapiens dolichy-phosphate beta-glucosyltranferase.
ACCESSION AF102850
111 7e-22
Lycopersicon esculentum heat shock protein (HSP21) mRNA.
ACCESSION U66300
111 7e-22
Mus musculus mRNA for receptor activity modifying protein 1
(Ramp1 gene). ACCESSION AJ314840
AI880940
111 7e-22
Human mariner-like element-containing mRNA, clone pcHMT1.
ACCESSION U48696
AI880941 1031 0.0
Xenopus laevis glycine amidinotransferase mRNA, complete cds.
ACCESSION AF187863
AI880942 147 1e-32
Rana esculenta mRNA for acidic ribosomal protein 1 (prp1 gene).
ACCESSION AJ298875
AI880943 94 2e-16
Homo sapiens annexin A3 (ANXA3), mRNA. ACCESSION
XM_034350
AI880944 547 1e-153
Xenopus laevis mRNA for high mobility group HMG-17 (hmg-17
gene). ACCESSION AJ272075
58 9e-06
Homo sapiens similar to unnamed protein product (LOC160622),
mRNA. ACCESSION XM_090399
AI880945
44 0.14
Xenopus laevis desmoplakin-related protein mRNA, partial cds.
ACCESSION AF169314
AI880946 58 1e-05 H.sapiens mRNA for sortilin. ACCESSION X98248
AI880947 182 2e-43
Rattus norvegicus protein arginine N-methyltransferase (PRMT1)
mRNA, complete cds (metabolism). ACCESSION NM_02436
AI880948 1031 0.0
Xenopus laevis liver RNA helicase II/Gu mRNA, complete cds.
ACCESSION AF302423
44 0.14
Homo sapiens clone IMAGE: 205156, mRNA sequence.
ACCESSION AF339786
AI880949
44 0.14
Homo sapiens F-box protein FBX10 mRNA, partial cds. ACCESSION
AF176705
AI940806 42 0.57
S.cerevisiae DNA from chromosome XII right arm including ACE2,
CKI1, PDC5, SLS1, PUT1 and tRNA-Asp genes. ACCESSION
X91258
AI940807 113 2e-22
Mus musculus interleukin enhancer binding factor 2 (Ilf2), mRNA.
ACCESSION NM_026374
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44 0.15
Xenopus laevis Nkx2-5 (Nkx2-5) gene, promoter region and partial.
cds. ACCESSION AF283102.
AI940808
44 0.15
Xenopus laevis eomesodermin gene, promoter region. ACCESSION
AF179418
AI940809 56 4e-05
Rattus norvegicus nuclear ubiquitous casein kinase 2 (Nucks),
mRNA. ACCESSION NM_022799
AI940810 147 6e-47 G.gallus PR264 mRNA. ACCESSION X62446
44 0.14
Homo sapiens similar to putative (LOC115098), mRNA. ACCESSION
XM_055230AI940811
44 0.14
Mus musculus cell division cycle 2 homolog (S. pombe)-like 2
(Cdc2l2), mRNA. ACCESSION NM_007661
AI940812 260 1e-66
Homo sapiens oxoglutarate dehydrogenase (lipoamide) (OGDH)
mRNA (metabolism) ACCESSION XM_004889
AI940813 42 2.2
Caenorhabditis elegans cosmid F20C5 complete sequence
ACCESSION Z68161
Full sequence
AF358133 Xenopus laevis X-box binding protein (XXBP) mRNA, complete cds
AF187862 Xenopus laevis ATP synthase subunit b  mRNA, complete cds
AF187863 Xenopus laevis glycine amidinotransferase (XAT) mRNA, complete cds
AF187864 Xenopus laevis MARCKS-related-protein protein (XMLP) mRNA, complete cds
AF346565 Xenopus laevis signal sequence receptor beta subunit mRNA, complete cds
3.2 XXBP-1: a leucine zipper transcription activator involved in
BMP-4 signaling pathway
3.2.1 XXBP-1 is a new member of the basic leucine zipper transcription factors
The sequence of the XXBP-1 cDNA (the GeneBank accession number: AF358133)
revealed an open reading frame encoding a polypeptide of 350 amino acids.
Between amino acids 85 and 121 of the protein, there is a hypothetical leucine zipper
sequence characteristic of basic leucine zipper (bZIP) transcription factors, in which
six leucines are spaced seven residues apart. NH2-terminal flank to these heptad
repeats of leucines, it is a basic domain abundant in arginine or lysine (Figure 3.2-
1A). The predicated amino acid sequence is most similar to human X-Box binding
protein 1 (hXBP-1, NM_005080, 66% amino acid identity; Liou et al., 1990), rat XBP-
1 (JC4857 66% amino acid identity), mouse XBP-1 (NP_038870, 66% amino acid
identity), and Zebrafish Treb5 (AY029577, 59% amino acid identity) as shown in
Figure 3.2-1B. Although the sequences outside the bZIP domain are divergent
compared to these proteins, it shares amino acid sequence of the inside leucine
zipper domain and of the adjacent basic domain with them. Therefore it is likely to be
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the Xenopus homologue and was named as Xenopus X-box binding protein 1
(XXBP-1).
MVVVGAPKVIFIPGNQCEQADALGSVMLPISSPSGPESVSNEQPPRKRQR
LTHLSSEEKALRRKLKNRVAAQTARDRKKARMSELEQQVIDLEMENEKLL
IENQILREKSHGLLTENQELRQRLGLSTLELKKEEEEESQSDLLLGLLES
LDSDLLLAYEGALAGSPDEELKGEESDSISSSPSSPVGTPSAKLDAINEL
IRFDHVYTKPLSTEEDSAQGVETSIVVKMEEASFSPTCEDDLTCVKQEPQ
EDDLVPILGMQSFLPCSENNLEKSSNILDTGSDSGYEGCSSPFSDLSSPL
NSDRVWEDSFSTELFPQLLLSAHMDQSICPSSPVDAVSFWSHSSEFDVHF
(A)
(B)
Figure 3.2-1. XXBP-1 protein sequence and the alignment with its homologues. (A) Deduced
protein sequence of XXBP-1. The bZIP domain is underlined. The DNA sequence of XXBP-1 can be
accessed in GeneBank using accession number: AF358133. (B) The alignment of XXBP-1 and its
homologue in human, mouse, rat, and zebrafish. Black boxes indicate the conserved amino acids,
and the gray boxes, the similar amino acids. Dashes represent gaps introduced into the sequence to
obtain optimal alignment.
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3.2.2 Spatial expression pattern of XXBP-1 suggests a role in BMP-4 signaling
pathway
By whole-mount in situ hybridization (Figure 3.2-2), the expression of XXBP-1 was
first detectable faintly in the animal halve of embryo before the gastrulation. As the
gastrulation proceeded, the staining was intensified, becoming more concentrated on
the dorsal blastopore lip (stage 10, 11; Nieuwkoop and Faber, 1975). In addition, the
signal was also detected on the whole ventral marginal zone and the animal halve.
With the gastrulation ongoing, the staining was graded from the blastopore region
anteriorly. The perspective neural plate appeared devoid of staining, while
concurrently the signal was detected on the ventral side. At the middle neurula
stages, XXBP-1 were expressed ventrolaterlly at a lower level but the signals
stretching from anterior to posterior along the neural crest were concentrated on the
area adjacent to the most anterior of neural plate that corresponds to the cement
gland primordium. This expression pattern is reminiscent of BMP-4, whose
expression signals are also maximal in the cement gland primordium at this stage.
Hence it inspired me to explore whether XXBP-1 is involved in BMP-4 signaling
pathway in further studies. In addition, a signal zone along the bottom of neural plate
was detected on the notochord corresponding to the previous pattern on the dorsal
blastopore lip. In the late neurula or early tailbud stages, the staining was found  to
be strong on the cement gland, stretching weakly to the hatching gland (Figure 3.2-
2L, M). An additional signal territory also extended from the cement gland to the
ventral side as shown in Figure 3.2-2M, and a more ventral view of this embryo was
shown in Figure 3.2-2N. Though there is some evidence that human XBP-1 plays
very important roles in the fetal liver development (Reimold et al., 2000), XXBP-1
expression was not likely correlated with the liver primordium. The transversal section
shown in Figure 3.2-3B indicated that staining zone lay closely under the ventral
ectoderm, but not on the area of perspective liver. In the tailbud stages the signals
lay on the cement gland as well as the pronephros (mainly on the glomus part),
which was then confirmed by histological analyses shown in Figure 3.2-3C. By
deliberately overstaining, the signals were also detected on the ear vesicle and the
upper part of lens in the tailbud stages (3.2-2O—R).
In summary, the expression pattern of XXBP-1 partially overlaps that of BMP-4 and
suggests that XXBP-1 may play a role in dorsoventral patterning.
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Figure 3.2-2. The spatial expression of XXBP-1 revealed by whole-mount in situ hybridization.
The expression of XXBP-1 signal is detectable faintly in the animal halve of embryos at 2-cell stage
(A) and  stage 7 (B) before the gastrulation. (C) is the vegetal view of (B). As gastrulation proceeds,
the staining is intensified, becoming more concentrated on the dorsal blastopore lip, and is also found
on the whole ventral ectoderm (stage 10, D1-D3; stage 11, E1-E3). With the gastrulation going on
(stage 11.5, F1-F3; stage 12, G1-G3 and stage 12.5, H1-H3), the staining is graded from the
blastopore region anteriorly; the perspective neural plate appears devoid of staining, while
concurrently ventral ectoderm is stained. (I), (J) and (K) show the anterior, dorsal and ventral views of
the stage 15 embryo, respectively. Signals are concentrated on the area of the most anterior of neural
plate (the prospective cement gland), stretching posteriorly along the neural crest in gradient. (L) and
(M) display the anterior view of embryo at stage 19 and 20, respectively. The staining was detected
strongly on the cement gland, stretching posteriorly to form weak signal strips on the hatching gland.
An additional signal zone extends from the cement gland to the ventral side (N) (ventral view of the
stage 20 embryo shown in M). (O)—(R) exhibit the expression pattern in a variety of tissues after the
middle tailbud stages: the cement gland, the pronephros (mainly on the glomus part), the ear vesicle
and the upper part of lens. (dor-lat: dorsal-lateral views of the gastrula embryos; veg: vegetal views of
the gastrula embryos; ven: ventral views of the gastrula embryos)
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Figure 3.2-3. Histological analyses of XXBP-1 expression. (A) The transversal section of stage 12
embryo. (A1) The magnification of the framed part shown in (A). Signals are detected on the ventral
ectoderm and dorsal blastopore lip. (B) The view of a sagittal section of stage 18 embryo. Signals lie
on the cement gland and some adjacent ventral mesoderm (arrow indicated). (B1) The magnification
of the framed part shown in (B). (C) The transversal section of stage 28 embryo showing the XXBP-1
expression signals on the pronephros (Abbreviation: ac, archenteron; bt, blastocoel; bl, blastopore lip;
cg, cement gland; ed, ectoderm; en, endoderm; nc, notochord; pn, pronephros; sc, spinal cord; sm,
somite).
3.2.3 The expression  of XXBP-1  in the developing embryo and adult tissues
The temporal expression of XXBP-1 and the expression level in different adult
tissues were studied using RT-PCR analyses, which was performed with RNA
extracted from embryos at different embryonic stages and that from different adult
tissues, respectively, using the XXBP-1 specific primers. The results revealed that
XXBP-1 was a maternal factor which was weakly expressed before the gastrula
stages, up-regulated during the gastrulation and kept in a persistent level in the
following stages (Figure 3.2-4). And XXBP-1 was also shown as a ubiquitous factor
which was expressed in all tested tissues with relatively higher expression level
found in liver, lung and stomach (Figure 3.2-5).
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Figure 3.2-4. The temporal expression pattern of XXBP-1 during the embryonic development
revealed by RT-PCR analysis. 1.0 µg of total RNA extracted from embryos at different embryonic
stages was used for the reverse transcription, and ODC was employed as internal standard for
normalization. XXBP-1 is a maternal factor which is weakly expressed before the gastrula stages, up-
regulated during gastrulation and kept in a persistent level in the following stages. Top: XXBP-1;
bottom: ODC.
Figure 3.2-5. The expression of XXBP-1 in different adult tissues revealed by RT-PCR analysis.
1.0 µg of total RNAs extracted from different adult tissues was used for the reverse transcription, and
H4 was employed as the loading control. The expression of XXBP-1 is found in all tested tissues with
relatively higher expression level in liver, lung and stomach (br, brain; ey, eye; he, heart; in, intestine;
ki, kidney; li, liver; lu, lung; mu, muscle; ne, nerve; ov, ovary; sp, spleen; st, stomach; te, testis).
3.2.4 Down-regulation of XXBP-1 by retinoic acid (RA)
During the embryonic development of Xenopus laevis, RA treatment leads to the
inhibition of anterior axis, and XXBP-1 happens to be expressed on the cement
gland, it is therefore plausible to investigate the effects of RA on XXBP-1 expression.
Embryos were treated with RA (10-6 M) during the stage 8-11 and harvested at the
tailbud and neurula stages for whole-mount in situ hybridization with XXBP-1
antisence RNA (Figure 3.2-6), which showed a significant reduction of XXBP-1
expression in 34 out of 49 RA-treated embryos (87%) compared to the untreated
embryos, indicating that RA can down-regulate XXBP-1 expression in the tailbud and
neurula stages. The staining on the cement gland, the sensitive expression domain
of XXBP-1, was strongly diminished by the RA treatment. This is corresponding to
the reduction of anterior axis. In extreme cases shown in Figure 3.2-6A, the staining
of XXBP-1 on the pronephros was also abolished.
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Figure 3.2-6. Effects of retinoic acid (RA) treatment on XXBP-1 expression revealed by whole-
mount in situ hybridization. Embryos were treated with RA (10-6 M) during the stage 8-11 and
harvested at the tailbud and neurula stages for whole-mount in situ hybridization with XXBP-1
antisence RNA. The signals on the treated embryos (A, tailbud and C, neurula) are strongly reduced
compared to that on the normal embryos (B, tailbud and D, neurula), indicating that retinoic acid can
down-regulate XXBP-1 expression.
3.2.5 Neural inhibitors and MO β-catenin expand the expression zone of XXBP-
1 on the dorsal side of embryo
The lack of XXBP-1 expression on the perspective neural plate during the
gastrulation indicates that it may play negative regulatory roles in the neural
induction. For this consideration, the effects of anti-neural factors such as BMP-4, UV
radiation, Msx1 and Dlx3 on the expression of XXBP-1 were investigated by whole-
mount in situ hybridization. In addition, with respect to the evidences that Wnt/β-
catenin pathway play roles in the dorsal ectoderm patterning (Baker et al., 1999;
Beanan et al., 2000), whether the morpholino (MO) β-catenin which can block the
Wnt/β-catenin signaling pathway has effects on the regulation of XXBP-1 was also
examined. Embryos at the 4-cell stage were injected into two dorsal blastomeres with
MO β-catenin (8 ng/embryo), BMP-4 (1 ng/embryo), Dlx3 (80 pg/embryo) and Msx1
(80 pg/embryo) mRNA, respectively. The UV treatment was performed as described
in 2.2.2. The treated embryos were grown till the gastrula stages (stage 11-12) for
subsequent whole-mount in situ hybridization with XXBP-1 antisense RNA. Figure
3.2-7 shows that all these factors were able to expand the expression region of
XXBP-1 on the dorsal side of the embryos. In the case of BMP-4 (98%, 42 out of 43
embryos), MO β–catenin (100%, 73 out of 73 embryos), UV (100%, 23 out of 23
embryos) treated embryos, XXBP-1  was activated in the dorsal marginal zone ,
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resulting in unrestricted expression of the gene in the entire marginal zone. While
Msx1 (70%, 16 out of 23 embryos) and Dlx3 (100%, 29 out of 29 embryos) could
expand the ventral expression territories of XXBP-1 to the prospective neural plate.
The discernable staining was found covering the perspective neural plate. These
results indicated that XXBP-1 expression could be up-regulated by the known neural
inhibitors; therefore it is likely that XXBP-1 is involved in the differentiation of
epidermis. Moreover, XXBP-1 may also be a negative target of Wnt/β–catenin
pathway because the blockage of this pathway by MO β-catenin also led to the
expansion of expression territories of XXBP-1.
Figure 3.2-7. Neural inhibitors and morpholino β-catenin expand the expression territories of
XXBP-1. 4-cell stage embryos were injected into two dorsal blastomeres with morpholino β-catenin (8
ng/embryo, A), BMP-4 (1 ng/embryo, B), Dlx3 (80 pg/embryo, C) and Msx1 (80 pg/embryo, F) mRNA,
respectively, and were harvested at the gastrula stages for whole-mount in situ hybridization with
XXBP-1 antisence RNA. UV-treated and normal embryos were exemplified in (D) and (E), respectively.
All these factors can expand the expression area of XXBP-1.
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3.2.6 Disruption of neural marker genes by overexpression of XXBP-1
The expression pattern of XXBP-1 suggests a role in antagonizing neural induction
and in 3.2.5 it has been shown that XXBP-1 expression could be up-regulate by
known neural inhibitors. Next it is plausible to ask whether it inhibits neural markers.
To address this issue, 200 pg of XXBP-1 mRNA was co-injected with 100 pg of -
galactosidase (LacZ) mRNA which was served as lineage tracer into one of dorsal
blastomeres of 4-cell stage embryos. Grown to the late neurula stages (stage 18-19),
the injected embryos were fixed and stained with X-gal. Embryos exhibiting b -
galactosidase activity on one side of the neural tube region underwent whole-mount
in situ hybridization (Figure 3.2-8) using probes for XAG2 (cement gland marker,
Aberger et al., 1998), Otx2 (anterior neural marker, Blitz et al., 1995), Rx2A (lens
marker, Yoshitake et al., 1999), En2 (marker for the mid/hindbrain boundary,
Hemmati-Brivanlou et al., 1991), Krox20 (marker for the r3 and r5, Bradley et al.,
1993), Pax6 (neural marker, Hollemann et al., 1998a), and Sox3 (pan neural marker,
Penzel et al., 1997) respectively. One-side XXBP-1 injection resulted in the reduction
of the neural marker Otx2 (60%, 94 out of 156 embryos), Rx2A (41%, 47 out of 116
embryos), En2 (49%, 31 out of 63 embryos), Krox20 (71%, 34 out of 48 embryos),
Pax6 (50%, 28 out of 56 embryos), and Sox3 (58%, 44 out of 76 embryos). The
pronounced suppression was indicated by the diminution or disappearance of the
expression territories of these genes. In contrast to the neural markers, no apparent
expression variation of XAG2 has been found under the same mRNA injection dose.
The inhibition of neural markers suggests that XXBP-1 may play an instructive role in
the formation of epidermal tissue. However, it should be considered that one-side
injection of XXBP-1 could cause wrong morphogenetic movement revealed by the
depression at the injected side or the defect of gastrulation in some cases. Therefore,
it cannot be exclude that the interfered morphogenetic movement may also lead to
the disruption of neural markers. For this consideration, the animal cap assay was
carried out as described in 3.2.10.
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Figure 3.2-8. Overexpression of XXBP-1 suppresses neural marker genes. The one-side
suppression of neural markers was revealed by whole-mount in situ hybridization with antisense
probes of these neural genes. 200 pg of XXBP-1 mRNA together with 100 pg of LacZ mRNA were co-
injected into one dorsal blastomere of 4-cell stage embryos. The surviving embryos developed till the
late neurula stages. The injected side was visualized by lacZ staining. (A) The normal expression
pattern of the cement gland marker, XAG2. (B) XAG2 was not significantly affected under this dose.
(C), (E), (G), (I), (K) and (M): The control expression pattern of Otx2 (anterior neural marker), Rx2A
(lens marker), En2 (marker for the mid/hindbrain boundary), Krox20 (marker for the r3 and r5), Pax6
(neural marker) and Sox3 (pan neural marker), respectively. (D), (F), (H), (J), (L) and (N): The
expression of these neural maker genes (see above in order) were inhibited in the injected side of
embryos.
3.2.7 XXBP-1 suppresses the dorsal mesoderm markers chordin (chd) and
goosecoid (gsc)
Inspection of XXBP-1 expression within the gastrula stages revealed the staining
on the dorsal blastopore lip as described in Figure 3.2-2, which suggests that it may
interact with genes affecting the dorsoventral patterning of the marginal zone. I
therefore studied the interactions between XXBP-1 and the dorsal mesoderm marker
genes chordin (chd) and goosecoid (gsc) using whole-mount in situ hybridization and
dorsal marginal zone (DMZ) analysis. The embryos injected dorsally to the equatorial
region at the 4-cell stage with XXBP-1 mRNA (0.1 ng/blastomere) were harvested at
the stages 11-11.5 for whole-mount in situ hybridization with chd and gsc antisense
RNA. The results showed that the injection of XXBP-1 led to the suppressions of chd
(65%, 37 out of 57 embryos) and gsc (75%, 42 out of 56 embryos) revealed by their
diminished staining on dorsal blastopore lip (Figure 3.2-9I). This was further
confirmed by DMZ analyses (Figure 3.2-9II). Four-cell stage embryos were injected
into the equatorial region of four blastomeres with 0.1 ng/blstomere or 0.4
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ng/blstomere of XXBP-1 mRNA. DMZs were dissected at the early gastrula stage
(stage 10-10.5), and cultured till sibling embryos developed to the stage 11. Using
chd and gsc specific primers, RT-PCR analyses showed that injection of XXBP-1
acted in a dose-dependent manner to down-regulate the dorsal mesoderm markers
chd and gsc in the DMZ.
                              (I)                                                           (II)
Figure 3.2-9. Overexpression of XXBP-1 down-regulates the dorsal mesoderm markers chordin
(chd) and goosecoid (gsc).
(I) Ectopic expression of XXBP-1 suppresses chd and gsc at gastrula stages revealed by
whole-mount in situ hybridization. The embryos were injected into marginal zone at 4-cell stage
with 0.1 ng/blastomere of XXBP-1 mRNA and harvested at stages 11-11.5 for whole-mount in situ
hybridization using chd and gsc antisense RNA, respectively. (A) and (C) Normal gastrula embryos.
(B) and (D) XXBP-1-injected gastrula embryos blotted by chd antisense RNA and gsc antisense RNA,
respectively. The injection of XXBP-1 leads to the suppression of chd and gsc.
(II) Overexpression of XXBP-1 down-regulates chd and gsc revealed by RT-PCR analysis.
Embryos were injected into the equatorial region of four blastomeres at 4-cell stage with 0.1 or 0.4 ng
of XXBP-1 mRNA per blastomere, and DMZ was then dissected and harvested at stage 11 for RT-
PCR analyses. st11, stage 11 embryo (lane 1); DMZ st11, XXBP-1-unjected DMZ (lane 2); 0.1, DMZ
from embryos injected with 0.1 ng/blastomere of XXBP-1 mRNA (lane 3); 0.4, DMZ from embryo
injected with 0.4 ng/blastomere XXBP-1 mRNA (lane 4); RT-, control without reverse transcriptase
(lane 5). The expressinon of chd and gsc is suppressed.
3.2.8 Overexpression of XXBP-1 leads to embryos ventralization
The expression pattern of XXBP-1 shows overlaps to that of BMP-4 and suggests
that XXBP-1 may play a role in dorsoventral patterning of embryonic development,
which inspired me to further investigate this hypothesis using gain-of-function
approach.
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Embryos injected into two dorsal blastomeres at the 4-cell stage with 0.2 ng of
XXBP-1 mRNA per embryo showed a range of ventralization phenotype (93%, 81 out
of 87 embryos, Figure 3.2-10) according to dorsoanterior index 4-2 (DAI, 4-2) (Kao
and Elinson, 1988), which demonstrated the suppression of anterior axis. The most
prominent abnormalities were the suppression of anterior-dorsal structures including
the cement gland, eyes, otic vesicles and in many cases, the entire heard. With a
dose of 0.4 ng of XXBP-1 mRNA per embryo, the injected embryos showed the loss
of head structure and axis defect and most of them could be scored as DAI 2 or 1
(100% ventralization, 99 out of 99 embryos). With the highest dose (0.8 ng/embryo)
injected into either two dorsal or all four blastomeres of 4-cell stage embryos, the
embryos also exhibited ventralization. The extreme cases showed the complete loss
of axial structures characteristic of maximally ventralized embryos with DAI of 0 or 1
(93% ventralization for the dorsal injection, 38 out of 41 embryos; 100%
ventralization for the radial injection, 21 out of 21 embryos). The representative
phenotypes were shown in Figure 3.2-10, whose details were further revealed by
histological analyses. Compared to the normal (Figure 3.2-10G), the injected
embryos (Figure 3.2-10H) demonstrated the reduction of notochord as well as the
indiscernible brain or neural tube. The transversal sections of injected embryos
(shown in Figure 3.2-10E) even indicated the loss of notochord (data not shown).
The effects of injection were dose-dependent and much less pronounced if ventral
blastomeres were targeted. When injected ventrally with 0.2 ng of XXBP-1 mRNA per
embryo, 7 out of 56 embryos (12.5%) appeared normal, 8 (14%) showed
ventralization (DAI 5-4) and 41 (73%) showed posterior enlargement. While when
injected ventrally with 0.8 ng, 17 out of 17 embryos (100%) exhibited mild
microcephcephaly.
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Figure 3.2-10. Phenotypes of XXBP-1-injected embryos. (A)—(C) The range of ventralization
phenotypes of embryos injected dorsally at 4-cell stage with 200 pg of XXBP-1 mRNA. (D) and (E)
The extreme phenotype of embryos injected at 4-cell stage into two dorsal with 400 pg of XXBP-1
mRNA, and into four blastomeres with 800 pg of XXBP-1 mRNA, respectively. The injected embryos
completely lost the anterior-posterior and dorsal-ventral axis. (G) The transversal section of sibling
control embryo. (H) The transversal section of XXBP-1 injected embryo shown in (B). Noted that the
reduction of notochord as well as the indiscernible brain or neural tube (Abbreviation: nt, notochord;
pn, pronephros; sm, somite; sc, spinal cord). Overexpression of XXBP-1 suppresses dorsoanterior
structure of the injected embryos in a dose-dependent manner.
3.2.9 Overexpression of XXBP-1 leads to ventralization of dorsal mesoderm
Ventralization of cell fates was further corroborated by analyses of the expression
of marker genes involved in the dorsoventral patterning. Gastrula-stage ventral
marginal zone (VMZ) and dorsal marginal zone (DMZ) explants were dissected from
embryos microinjected into the equatorial region of four blastomeres at the 4-cell
stage with low and high concentrations of XXBP-1 mRNA, respectively, thereafter
cultured till the stage 22, and assayed by RT-PCR for the relative expression level of
various maker genes (Figure 3.2-11).
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Gsc, a marker for head mesoderm in tailbud embryos, was repressed strongly by
XXBP-1. Likewise, Xnot, a marker for notchord, was also suppressed, but in a less
sensitive manner compared to gsc. This indicates that the formation of both head
mesoderm and notochord is affected by XXBP-1. The suppression of Otx2 was
pronounced, which confirms the results shown in Figure 3.2-8D. Unexpectedly, there
was no significant decrease in the expression of chd, which appears controversial to
the results of whole-mount in situ hybridization with gastrulae injected with XXBP-1
shown in Figure 3.2-9IB. A similar DMZ analysis was then carried out with mRNA
from stage 11 DMZ dissected from XXBP-1 injected embryos (Figure 3.2-9II). The
results were consistent with that of whole-mount in situ hybridization. Considering
that 65% of injected embryos showed decreased expression domain of chd, it is
likely that RT-PCR may not always reflect the insensitive repression. Alternatively the
difference of culture period might account for the indiscernible decrease. The
expression of ADMP varied with different injection doses. It was enhanced when
injected with 0.1 ng of XXBP-1 mRNA per blastomere but attenuated when injected
with 0.4 ng of XXBP-1 mRNA per blstomere, compared to the untreated DMZ. The
loss of dorsal mesoderm marker genes expression paralleled a gain in expression of
intermediate and ventro-posterior mesoderm markers. Cardiac actin, a marker for
dorsolateral mesoderm, was induced by XXBP-1 at low concentration. However the
transcription factor MyoDb was down regulated, indicating that it may be more
sensitive to the induced ventralization. Dose-dependent induction of ventral marker
genes by XXBP-1 was varied for the different markers. Xven-2 was steadily induced,
while Xhox3, Xvent-1, BMP-4 showed dose-dependent inducible fashion. The
expression of XAG1 was kept stably with the low dose injection, but was suppressed
with the high dose injection. Taken together, overexpression of XXBP-1 in the
explanted dorsal marginal zones led to a down-regulation of dorsal marker genes,
and in parallel, up-regulation of ventral marker genes.
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Figure 3.2-11. Overexpression of XXBP-1 leads to ventralization of dorsal mesoderm. 4-cell
stage embryos were either uninjected (st22, DMZ, VMZ, -RT) or microinjected into the equatorial
region of four blastomeres of 4-cell stage embryos with increasing amounts of XXBP-1 mRNA
(indicated on the top in ng mRNA per blastomere). Dorsal marginal zone (DMZ) and ventral marginal
zone (VMZ) were explanted at the early gastrula stage (stage 10-10.5), subsequently incubated until
sibling embryos reached stage 22. 1.0 ng of total RNA was employed for the reverse transcription and
analyzed by RT-PCR for the expression of gsc, chd, Xnot, ADMP, Otx2, cardiac actin, MyoDb, Xhox-3,
Xven-1, Xvent-2, BMP-4, XAG1. ODC served as the loading control. St22, RNA isolated from the
whole embryos at stage 22; RT-, control without reverse transcriptase.
3.2.10 XXBP-1 reverses dorsalization induced by dominant negative BMP-4
receptors
Referred to the expression pattern, both XXBP-1 and BMP-4 are excluded from the
perspective neural plate during the gastrulation, and their expressions in the neurula
stages were quite similar. Moreover, gain-of-function experiments reveal that both of
them can induce the ventralization of embryos. This congruence implies that the two
factors may act in a common pathway. With respect to this, I next tested the
relationship between XXBP-1 and BMP-4 signaling pathway by using the animal cap
assay and gain-of-function assay.
Embryos were injected into four blastomeres at the 4-cell stage with following
mRNAs, respectively: 0.4 ng of XXBP-1, 1.6 ng of tBMPRI (truncate BMP receptor I,
Suzuki et al., 1994), a mixture of 1.6 ng of tBMPRI and 0.4 ng of XXBP-1, and a
mixture of 1.6 ng of tBMPRI, 0.8 ng of tBMPRII (truncte BMP receptor II; Frisch,
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1998) and 0.4 ng of XXBP-1. RT-PCR analyses (Figure 3.2-12I) were carried out with
RNA extracted from animal caps dissected from these embryos. The epidermis
markers epidermal keratin (EK) was strongly expressed in both untreated and XXBP-
1-injected animal caps, while a mild increase expression of XAG1 and a down-
regulation of Otx2 were found in the XXBP-1-injected animal caps. As described
elsewhere (Suzuki et al., 1994; Sasai et al., 1995), ectopic expression of tBMPRI in
ectoderm resulted in neural induction which was revealed by a robustly increase in
the expression of neural markers Otx2 and NCAM, and a decrease in the expression
of EK in the animal cap assay. In the present study, the expression of EK was
partially restored accompanying with decreases in expressions of Otx2 and NCAM
when tBMPRI (1.6 ng) and XXBP-1 (0.4 ng) co-injected into the ectoderm. In the
case of co-injection of tBMPRI (1.6 ng), tBMPRII (0.8 ng), and XXBP-1 (0.4 ng), the
expression levels of NCAM and Otx2 were moderate in between those obtained with
injections of tBMPRI alone and the combination of tBMPRI and XXBP-1. Taken
together, the ectodermal cell receiving mixers of tBMPRs and XXBP-1 adopted a cell
fate prior to epidermis.  XXBP-1 was able to rescue epidermal fate and block neural
induction imposed by tBMPRI in animal cap assay. Thus, XXBP-1 may act
downstream of BMPs receptors.
This was further confirmed by gain-of-function experiments. 4-cell stage embryos
were microinjected either ventrally or radially with mRNA of either tBMPRI alone or a
mixture of tBMPRI and XXBP-1. The ectopic tBMPRI led to the formation of
secondary embryonic axis when injected ventrally (43%, 23 of 53 embryos, Figure
3.2-12IIB) or dorsalization indicated by the enlargement of anterior structure (100%,
27 of 27 embryos, Figure 3.2-12IIE). The phenotype of dorsalization could be
efficiently reversed by the co-injection with XXBP-1. The embryo injected ventrally
with a mRNA mixture of XXBP-1 and tBMPRI (Figure 3.2-12IIC) exhibited similar
phenotype of XXBP-1 ventral injection (94.3%, 82 out of 87 embryos, Figure 3.2-
12IID), showing a slight repression of anterior axis with a significant posterior
enlargement. Additionally the embryos injected radially with XXBP-1 showed a range
of phenotypes of ventralization revealed by the regression of anterior structure (92%,
11 out of 12 embryos; Figure 3.2-12IIF, G).
In summary, these data support the hypothesis that XXBP-1 is a component of the
BMP-4 signaling pathway and acts downstream of BMP-4 receptors.
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                               (I)                                                                          (II)
Figure 3.2-12. XXBP-1 reverses the dorsalization induced by tBMPRI.
(I) Gene expression in animal caps injected with indicated mRNAs. Animal caps were dissected
from stage 9 embryos injected into 4 blastomeres at 4-cell stage with 0.4 ng of XXBP-1 (lane3), 1.6 ng
of tBMPRI (lane4), 1.6 ng of tBMPRI + 0.4 ng of XXBP-1 (lane5), 1.6 ng of tBMPRI + 0.8 ng of
tBMPRII + 0.4 ng of XXBP-1 (lane6), respectively, and were cultured till sibling control reached stage
28. Overexpression of XXBP-1 rescues the neural induction induced by tBMPRI and tBMPRII. The
absence of Xbra signal verified that the animal caps were not contaminated with mesoderm. St28,
RNA isolated from the whole embryos at stage 28 (lane1); AC, RNA isolated from control animal cap
(lane2); RT- (lane7), control without reverse transcriptase; tBMPRI, truncated BMPs receptor I; tBMPR
II, truncated BMPs receptor II.
(II) Microinjection of XXBP-1 rescues dorsalization induced by tBMPRI. (A) The sibling control.
(B) Embryo showing the secondary axis which was microinjected into two ventral blastomeres at 4-cell
stage with 1.6 ng of tBMPRI mRNA. (C) and (D) Embryos microinjected into two ventral blastomeres
at 4-cell stage with a mRNA mixture of 1.6 ng of tBMPRI and 0.2 ng of XXBP-1, and 0.2 ng of XXBP-1
mRNA, respectively. Phenotypes of embryos microinjected into four blastomeres at 4-cell stage were
shown in (E) (1.6 ng of tBMPRI mRNA) and (F, G) (an mRNA mixture of 1.6 ng of tBMPRI and 0.4 ng
of XXBP-1). The dorsalization induced by tBMPRI was rescued by co-injection with tBMPRI and
XXBP-1.
3.2.11 Noggin antagonizes XXBP-1 in animal cap assay
To confirm that XXBP-1 plays a role in BMP-4 signaling pathway, the regulation of
XXBP-1 expression by neuralizing factors such as noggin, Zic3 (Nakata et al., 1997)
and MO β-catenin was studied using the animal cap assay. Embryos were injected
into all four blastomeres at the 4-cell stage with noggin (160 pg/embryo), Zic3 (160
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pg/embryo), as well as MO β-catenin (16 ng/embryo). The XXBP-1 expression
manner was monitored by RT-PCR analysis using the RNA extracted from animal
caps dissected from the injected embryos described above (Figure 3.2-13). The
results indicate that XXBP-1 was in the same way suppressed by noggin as BMP-4
described elsewhere  (Gammill et al., 2000), accompanying with the induction of
NCAM. Both XXBP-1 and BMP-4 could be down-regulated by Zic3 in an insensitive
manner. While the injection  of MO β-catenin had no significant effects on XXBP-1
expression as well as BMP-4 though the expression domain of XXBP-1 can be
expanded to the perspective neural plate with whole-mount in situ hybridization.
Thus, it is suggested that the induction of XXBP-1 by MO β-catenin and BMP-4
requires the involvement of other factors. The differences of the two experimental
approaches may also account for the variation.
Figure 3.2-13. Down-regulation of XXBP-1 by ectopic expression of noggin in animal cap assay.
Animal caps dissected from stage 9 embryos injected into all four blastomeres at the 4-cell stage with
16 ng of morpholino β-catenine, 160 pg of Zic3, and 160 pg of noggin as indicated, respectively, were
assayed by RT-PCR for monitoring the expression of BMP-4, XXBP-1, Vent-1 and NCAM. ODC was
server as loading control. Noggin suppresses simultaneously the expression of XXBP-1 and BMP-4,
but induces NCAM.
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3.2.12 XXBP-1 acts as a transcription activator
The sequence comparison shows that XXBP-1 belongs to basic leucine zipper
transcription factors, it naturally gives rise to a question whether it is responsible for
activating or repressing transcription. Three repressor and activator fusions were
then constructed by fusing the putative DNA–binding domain of XXBP-1 to the
previously characterized sequences encoding activating or repressing domain of
transcription factors, i.e. XXBP1-EnR fused with the repressor domain from
Drosophila engrailed (Jaynes and O’Farrell, 1991), XXBP1-Eve fused with the
repressor domain of even-skipped (Han and Manley, 1993) and XXBP1-VP16 fused
with the activator domain of VP16 (Friedman et al., 1988). The schematic diagram of
the XXBP-1 wild type and fusion constructs were shown in Figure 3.2-14I.
Theoretically the fusion constructs should phenocopy or at least partially mimic
XXBP-1 wild type in the overexpression experiments if they have the same
transcription feathers as XXBP-1. Moreover, as XXBP-1 could mediate BMP-4
signaling, it was expected that the loss of XXBP-1 might lead to neural induction in
animal cap assay or formation of secondary embryonic axis in overexpression
experiments. In addition, based on the expectation that truncated XXBP-1 may
sequester the wild-type XXBP-1 and interfere dimerization, a truncated XXBP-1
containing only the sequence encoding basic leucine zipper domain was also
constructed.
Overexpression of the fusion constructs with high doses caused apoptosis, the
dosages were therefore adjusted to avoid this phenotype. Embryos microinjected
dorsally with the same mRNA dose (0.16 ng/embryo) of XXBP1-Eve, XXBP1-EnR or
truncated XXBP-1 showed either gastrulation defect leading to spina bifida or the
loss of anterior structure which may also be due to the interference of morphogenetic
movement. Embryos with ectopic expression of XXBP1-VP16 (0.04 ng/embryo)
exhibited either the strong loss of dorsal-anterior structure as that with
overexpression of wild-type XXBP-1, or severe gastrulation blockage called
exogastrulation. The results of microinjection were compiled in Table 3.2-1.
The embryos microinjected ventrally with the same dose (0.16 ng/embryo) of
XXBP1-EnR or truncated XXBP-1 also showed spina bifida. However those
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microinjected with XXBP1-VP16 (0.04 ng/embryo) exhibited a similar phenotype of
the posterior axis enlargement as wild-type XXBP-1 (96%, 70 out of 73 embryos),
although the reason is still obscure. Overexpression of XXBP1-Eve led to either the
secondary axis with a low ratio of 10% or gastrulation defect giving rise to spina
bifida (81%, 79 out of 98 embryos) (Figure 3.2-14 and Table 3.2-1). So it is likely that
XXBP-1 functions as a transcription activator.
Figure 3.2-14. Overexpression of  the fusion constructs and the truncated XXBP-1.
(I) Schematic diagrams of the fusion constructs and the truncated XXBP-1. The sequence
(amino acids 1-126) containing the basic leucine zipper DNA binding domain (bZIP) of XXBP-1 is
shown in white box. The remaining sequence (amino acids 127-350) in carboxyl terminal region is
indicated with vertical-dashed box, which was then replaced by VP16 activation domain indicated by
dark-dashed box to form XXBP1-VP16, or by even-skipped repressor domain indicated by dark box to
form XXBP1-Eve. The sequence encoding the amino terminal region (amino acids 1-126) of XXBP-1
was subcloned into pCS2MTEnR containing coding sequence of engrailed repression domain to
obtain XXBP1-EnR. The XXBP1-EnR consists of the Myc domin (write-dashed box), the bZIP domain
(write box) and the engrailed domains (dark box with net). Truncated XXBP-1 containing bZIP (amino
acids 1-126) was also constructed.
(II) Phenotypes of embryos injected with the different constructs. Embryos were injected into two
ventral blastomeres at 4-cell stage with (A) 0.16 ng of truncated XXBP-1 mRNA, (B, C) 0.16 ng of
XXBP1-Eve mRNA, (D) 0.16 ng of XXBP1-EnR mRNA, (E) 0.04 ng of XXBP1-VP16 mRNA, (F) 0.2 ng
of wild-type XXBP-1 mRNA. Note that XXBP1-Eve induces secondary axis in embryos, but XXBP1-
VP16 induces the phenotype as wild-type XXBP-1. The embryos injected with XXBP1-VP16 and
XXBP-1 wild type show the same enlarged posterior part, suggesting the XXBP-1 and XXBP1-VP16
have the same transcription characters.
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Table 3.2-1. Phenotypes of ectopic expression of the XXBP-1 constructs.
mRNA injected
Dose and injection
location Normal Bent axis Twin axis
Gastrulation
defect Microcephalic
Posterior
enlargent
Truncated XXBP-1 0.08 ng, 2/4V 67 (76%) 11 (13%) 10
*
 (11%)
Truncated XXBP-1 0.16 ng, 2/4V 24 (27%) 39 (44%) 26
*
 (29%)
XXBP1-EnR 0.08 ng, 2/4V 5 (8%) 47 (75%) 11
*
 (17%)
XXBP1-EnR 0.16 ng, 2/4V 22 (35%) 40
*
 (65%)
XXBP1-Eve 0.16 ng, 2/4V 9 (9%) 10 (10%) 79
* (81%)
XXBP1-Eve 0.08 ng, 2/8V 20 (61%) 1 (3%) 12
*
 (36%)
XXBP1-VP16 0.08 ng, 4/4 13§ (100%)
XXBP1-VP16 0.04 ng, 2/4V 3 (4%) 70 (96%)
XXBP1-Eve 0.16 ng, 2/4D 2 (2%) 84
*
 (98%)
Truncated XXBP-1 0.16 ng, 2/4D 31 (44%) 39
*
 (56%)
XXBP1-EnR 0.16 ng, 2/4D 13 (18%) 52
*
 (71%) 8 (11%)
XXBP1-VP16 0.04 ng, 2/4D 27
# (54%) 23 (46%)
The results were scored till injected embryo developed into approximately the stage 32. 2/4D: Two dorsal blastomeres of 4-cell
stage embryos were injected; 2/4V: Ventral injection at the 4-cell stage; 2/8V: Two ventral blastomeres were injected at the
8–cell stage; 4/4: all four blastomeres of 4-cell stage embryo were injected. The percentage of the available case is shown in
parenthesis.
* 
the gastrulation defect giving rise to spina bifida.
# 
the gastrulation defect exogatrulation.
§ severe ventralization with DAI (1-0).
The animal cap assay (Figure 3.2-15) was also carried out to further investigate
whether XXBP-1 is transcription activator or not. As expected, neural marker NCAM,
nrp1 and Otx2 were induced in the explants by XXBP1-Eve in a dose-dependent
manner. However only Otx2 could be slightly induced by truncated XXBP-1 and
XXBP1-EnR. Injection of XXBP1-VP16 led to a similar expression manner of the
tested markers as XXBP-1 wild type except a weak up-regulation of XAG1. Therefore
it supports that XXBP-1 functions as a transcription activator during the embryonic
development.
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Figure 3.2-15. Animal caps assay with XXBP-1 constructs. Animal explants were dissected from
embryos with mRNAs of XXBP1-VP16 (0.08 ng/embryo), XXBP1-Eve (0.64 ng/embryo), XXBP1-Eve
(0.32 ng/embryo), truncated XXBP-1 (0.32 ng/embryo), XXBP1-EnR (0.32 ng/embryo) and  tBMPRI
(1.6 ng/embryo), and XXBP-1 (0.32 ng/embryo), respectively, and were culture till sibling embryos
reached stage 27 for RT-PCR analyses. Note that XXBP1-Eve induces neural marker genes NCAM
and nrp1, suggesting that XXBP-1 funcations as a transcription activator. ODC was employed as a
loading control. RT-, samples from the whole uninjected embryo without reverse transcription.
3.3 Isolation and characterization of XMLP
3.3.1 Isolation of the gene encoding Xenopus laevis MARCKS like protein
(XMLP)
Another clone encoding a predicted polypeptide of 187 amino acids has poor
background in the GeneBank. The comparison search indicates that it is most
correlated to MARCKS like proteins (MLP), members of MARCKS family (Figure 3.3-
1). Although it shares a low identity (32% identity) with the MLPs of mouse, rat,
human or rabbit which show a relatively higher identity to each other, the predicted
protein sequence of XMLP contains three domains similar to those which are
conserved in all other members of MARCKS and MLP families: A myristoylated
consensus following the glycine residue at position 2 in the amino terminal region,
the site of intron splicing and the putative phosphorylation site domain (PSD). For this
reason, it is named as Xenopus MARCKS like protein (XMLP). The full sequence
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was submitted to GeneBank and assigned the accession number: AF187864. At the
5' end, 95 untranslated nucleotides precede the translation initiation site (Kozak,
1986) and at the 3' end the coding region ends with an in-frame stop codon at the
position 658, which is followed by a 921-base untranslated sequence. A consensus
polyadenylation signal AATAAA is present upstream from the putative poly (A) tail.
The theoretical isoelectric point (pI) of XMLP is 4.38 and that of PSD are 12.06
(http://www.expasy.ch/tools/pi_tool.html), both of which are similar to the common
character of this protein family (Blackshear, 1993; Ramsden, 2000).
Figure 3.3-1. Comparison of the deduced protein sequence of XMLP with MLPs from human,
mouse and rabbit. The black boxes show the conserve amino acids, and the gray boxes, the similar
amino acids. The dashes present the gap introduced into the sequence in order to obtain optimal
alignment. The similar domains are underlined.
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3.3.2 Spatial and temporal expression of XMLP
The whole-mount in situ hybridization (Figure 3.3-2) revealed that abundant XMLP
maternal transcripts were in the animal halves of embryo during the cleavage stages
(Figure 3.3-2A, B). Until the gastrula stages, the signals were detected in almost all
regions except the yolk plug (Figure 3.3-2C). Histological analyses showed that
XMLP was predominantly expressed in the ectoderm and mesoderm at the stage
11.5 (Figure 3.3-2D). From the late gastrula stages the transcripts decreased and
were restricted to the neural plate (Figure 3.3-2E, F). Transversal section of the
neurula (stage 15) depicted the presence of signals in the neuroectoderm (Figure
3.3-2G). Subsequently, the signals have been located in the neural folds and brain
area at the early tailbud stage (Figure 3.3-2H, I, M). Sagittal and transversal sections
of this stage are shown in Figure 3.3-2J, K and L. At the stage 34 the signals
appeared in the head area, somites, gills, pronephros and renal tube (Figure 3.3-2 O,
P, Q).
The temporal expression of XMLP was studied by RT-PCR analyses (Figure 3.3-3),
which showed that transcripts could be detected in embryos at any stage. The
transcription level was decreased from the uncleaved egg till the stage 23, after
which it again rose slightly in the following stages and finally maintained stable. The
expression of XMLP in different adult tissues revealed by RT-PCR analyses (Figure
3.3-4) indicated that XMLP was abundant in all tested tissues with a relatively low
expression level found in intestine and kidney.
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Figure 3.3-2 The spatial expression of XMLP revealed by Whole-mount in situ
hybridization. (A) and (B) Maternally expressed XMLP is present in cleave stages. (C) In
gastrula stages, signals are detected in the ectoderm and mesoderm. (D) A sagittal section of
stage11.5. (E)—(G) At neurula stages, signals are no longer evenly distributed and restricted to
neural ectoderm only. (H), (I) and (M) At early tailbud stage, XMLP transcripts can only be
detected in the neural folds and presumptive brain area. (J) and (K) The sagittal section of (I). (L)
A transversal section of stage 21 embryo. (N), (O) and (Q) In later stages XMLP is expressed in
ectoderm derivatives and pronephros during stage 27—34. (P) A transversal section of stage 34
embryo (ac, archenteron; bt, blastocoel; bv, brain ventricle; en, endoderm; hm, head
mesenchyme; mc, mesencephalon; md, mesoderm; nc, notochord; ne, neural ectoderm; nt,
neural tube; pn, pronephros; rc, rhombencephalon; sc, spinal chord).
Figure 3.3-3 The temporal expression of XMLP in different embryonic stages analyzed by
RT-PCR. XMLP expression can be detected in embryos at any stage (stage 1—40, Nieuwkoop
and Faber, 1975), especially with a high level in the stage 8, when zygotic gene expression just
starts. While there is a decrease from the uncleaved egg to the stage 23, after which it again rise
slightly in the following stages.
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Figure 3.3-4. The expression of XMLP in different adult tissues revealed by RT-PCR. XMLP
transcripts are detected in all tested tissues, however, with a lower level found in kidney and
intestine (br, brain; ey, eye; he, heart; in, intestine; ki, kidney; li, liver; mu, muscle; ov, ovary; sk,
skin; sp, spleen; st, stomach; te, testis).
3.3.3 Phenotypic effects of XMLP overexpression
XMLP mRNA was injected into one dorsal blastomere of the 4-cell stage embryos.
Inspection of gastrula revealed such phenotypes: with the low injection dose, some
bulged cells were found to distribute around the former injection site (Figure 3.3-5A).
According to the histological analysis (Figure 3.3-5B), these cells contained large
nuclei. Such embryos developed quite normally before neurulation, i.e. both dorsal
blastopore and yolk plug can be formed correctly. When the injection dose was more
than 0.4 ng, bulged cells and mottled surface were shown around the injection area.
Some dead cells were found between the vitelline memberane and embryo. The
embryos can resilient if this phenotype was not severe. As was true in other studies
(Grammer et al., 2000), this is quite similar to the typical phenotype of apoptosis
observed in overexpression experiments, i.e. the epithelia disruption and the
extrusion of dead cells in the vitelline space in the neurula and tailbud stages.
Inspection of tadpoles injected with XMLP mRNA revealed two main morphological
defects (Table 3.1-1). One was the phenotype of a reduced lens size and abnormal
lens shape (Figure 3.3-5C, D, E). Some larvae even showed cyclopia (Figure 3.3-
5F). Transversal sections indicated the reduction of neural retina and a part of the
diencephalon. In contrast to the normal embryos (Figure 3.3-5G), there was less
mesenchyme around the notochord in the forebrain area (Figure 3.3-5H) and smaller
or missing eyes (Figure 3.3-5H, I). The other was the phenotype of a bent body axis
(Figure 3.3-5D). Both phenotypes were occurred simultaneously when injected with
high doses of XMLP mRNA. When 0.2 ng of XMLP mRNA was injected, 44 % (56 out
of 128) of the injected embryos showed lens defects, 1% (1 out of 128) exhibited
3. RESULTS           76
bent axis, and 20% (25 out of 128) occurred two phenotypes simultaneously, while
when the injection dose was doubled, 27% (59 out of 219) displayed lens defects,
1% (3 out of 219) showed bent axis defects and 33% (71 out of 219) showed lens
defects and bent axis defect concurrently. After injection of 0.6 ng, 23% (28 out of
123) showed lens defects, 2% (2 out of 123) exhibited bent axis defects, 70% (86 out
of 123) revealed both phenotypes concurrently. In the case of highest dose (0.8 ng),
14% (15 out of 106) showed lens defect, 17% (18 out of 123) exhibits the bent axis
defects, 68% (72 out of 108) revealed both phenotypes simultaneous. While control
embryos injected with the same quantity of LacZ RNA developed normally.
Table 3.3-1. Effects of overexpression of XMLP in Xenopus laevis at the tadpole stage. XMLP
mRNA was injected in one dorsal blastomere of the four-cell stage embryos. The resulting phenotypes
were checked at the tadpole stage. The figures in parenthesis show the percentage of available
cases.
Injected XMLP
mRNA (ng)
Embryos
available (n) Lens defects Bent axis defects
Lens defects &
bent axis defect
0.2 128 56 (44) 1 (1) 25 (20)
0.4 219 59 (27) 3 (1) 71 (33)
0.6 123 28 (23) 2 (2) 86 (70)
0.8 106 15 (14) 18 (17) 72 (68)
3.3.4 Ectopic expression of XMLP does not change the normal autonomous
differentiation of isolated dorsal blastopore lip
It is well known that the isolated dorsal blastopore lip including parts of dorsal
ectoderm from stage 10 embryos can autonomously differentiate into notochord,
brain structures, and rudimentary eyes (Grunz, 1992, 1999b). This depends on
multiple steps including cell interaction, induction and secondary cell interaction. The
cooperation of genes expressed in the zone of the Spemann organizer including gsc,
chd, Xnr3, and noggin drives ectoderm to differentiate into dorsal structures and the
central nervous system (for review, see Grunz, 1997). To investigate if lens defects in
the XMLP injected embryos are due to the specific inhibition after overexpression of
XMLP, the following experiments were performed. Explants consisting of dorsal
blastopore lip and adjacent dorsal ectoderm were isolated from the injected embryos
at stage 10 and cultured in Holtfreter’s solution until control embryos reached stage
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40. Similar to those from uninjected controls, transversal sections showed that these
explants had also differentiated into notochord, brain, and eye structure (Figure 3.3-5
J, K), suggesting that XMLP does not trigger a specific inhibition of the eye anlage
(Figure 3.3-5 K). Therefore the results support the view that the inhibition of eye
structures in the injected embryos is the result of disturbed morphogenetic
movements rather than a specific inhibition of eye formation.
Figure 3.3-5. Phenotypic effects of overexpression of XMLP. Embryos were injected into one
dorsal blastomere at 4-cell stage. (A) Ectopic XMLP results in protrusions of bulge cells distributing
around the injection site. (B) The section of an XMLP-injected embryo at stage 10 shown in (A). Note
that there are some giant nuclei around the injection area (asterisk) and an arrow indicts a normal
nucleus. (C) LacZ as lineage marker for identifying injected sides of the larva where ectopic XMLP
caused eye defects. The left column of panel (C) shows the injected sides of the larva and the right
column shows the unjected sides of embryos of the same series (compare with larva shown from the
dorsal side in (E)). (D) Larva (injected with XMLP) with bended axis and one eye. (E) Larva with
missing right eye when injected with both XMLP and LacZ. (F) The injected larvae of stage 40 with
one eye only. (G) and (H) The comparison of the histology of notochord in the head area between the
normal larvae (G) and larvae with small eye (H). Note that less mesenchyme in (H) are found in the
injected embryos compared to the normal ones. (I) Transversal section of the tadpole with one eye
shown in (F). (J) and (K) The differentiation of dorsal blastopore lip with adjacent dorsal ectoderm
isolated from normal (J) and injected embryos (K). Note that XMLP-treated embryos differentiated into
notochord and brain structures with a rudimentary eye as the controls. No significant differences have
been found in dorsal blastopore lips isolated from either injected or uninjected embryos (abbreviation:
br, brain; gu, gut; le, lens; me, mesenchyme; nc, notochord; pe, pigmented epithelium; re, retina).
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3.3.5 a morpholino oligo (Mo) against XMLP is effective when injected into
cleaving embryos
The loss-of-function of XMLP was studied by injecting the morpholino oligo (MO) of
XMLP. As a new type of antisense oligos, morpholino provides many advantages
over phosphorothioates such as excellent sequence specificity, reliable activity in cell
and complete resistance to nucleases. MO XMLP was injected into both dorsal
blastomeres of 2-cell stage embryos or two dorsal blastomeres of 4-cell stage
embryos. Most of the injected embryos showed eye defect, shorten anterior axis and
a mild bent axis (Figure 3.3-6 A and Table3.3-2). Up to 24 ng, MO XMLP was
introduced into embryos in order to achieve significant results. No significant toxic
effects were observed after the injection of morpholino negative control. MO b -
catenin was employed as a positive control, injected into two blastomeres of 2-cell
stage embryos or two dorsal animal blastomeres of 8-cell stage embryos. Embryos
injected in two dorsal animal blastomeres at 8-cell stage with 4 ng of b -catenin MO
showed a reduction of the head area and anterior axis (Figure 3.3-6 E). While the
injection into each blastomere of two-cell stage embryos with of 8 ng of MO b -catenin
prevented any axis formation (data not shown).
Since MO XMLP antisense oligo binds the XMLP mRNA with high specificity, MO
XMLP should strictly compensate the phenotype induced by XMLP mRNA. To test
the specificity of the MO XMLP binding to XMLP mRNA, synthetic 0.8 ng of XMLP
mRNA together with 16 ng of MO XMLP was co-injected into the two dorsal
blastomeres of 4-cell stage embryos. The mRNA did not contain the portion of the 5’
UTR of XMLP so that MO XMLP could not bind the foreign XMLP mRNA. Inspecting
the injected embryos at neurula stage, I found that MO XMLP could significantly
rescue the phenotype of apoptosis induced by XMLP (Figure 3.3-6 B, C). No
embryos out of 48 injected embryos showed apoptosis. 15 normal embryos and 15
embryos with eye defect as well as mild bent axis defect out of 30 survived tadpoles
were found in hatched tadpole stages (Figure 3.3-6 D and Table3.3-2). The
phenotype induced by MO XMLP was not found any more.
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Figure 3.3-6. Effects of injection of Morpholino (MO) XMLP and MO β-catenin. (A) Embryos
with shorter anterior axis and eye defects resulted from the injection into both dorsal
blastomeres at 2-cell stage with 24 ng of MO XMLP. (B) The phenotype of apoptosis
induced by overexpression of XMLP (C) The phenotype of apoptosis rescued by MO XMLP
(16 ng of MO XMLP and 0.8 ng of XMLP mRNA co-injected into both dorsal blastomeres at
4-cell stage. (D) Tadpole co-injected with MO XMLP and XMLP mRNA showing relatively
normal morphological phenotype or mild bent axis (the upper one). (E) Larvae with reduced
anterior axis after microinjecting into two dorsal animal blastomeres at 8-cell stage with 4 ng
of MO β-catenin.
Table 3.3-2. Effects of microinjection of Morpholino (MO) XMLP.  The results were scored
when the embryos developed till around stage 40. 2/2: two blastomeres of 2-cell stage embryos
were injected; 2/4d: two dorsal blastomeres of 4-cell stage embryos were injected. The percentage
of the available cases is shown in parenthesis.
Phenotypes of the embryosMO or mRNA
injected
Injection
location Normal
Mild bent axis
only
Shorten trunk, mild bent axis, eye
defects, reduced head area
MO XMLP 16 ng 2/2 63 (46) 13 (9) 61(45)
MO XMLP 24 ng 2/2 0 (0) 7 (23) 23 (77)
MO XMLP 8 ng 2/4d 46 (66) 7 (10) 17 (24)
MO XMLP 16 ng 2/4 d 48 (62) 7 (9) 22 (29)
MO XMLP 24 ng 2/4d 4 (8) 0 (0) 47 (92)
XMLP 0.8 ng + MO
XMLP 16 ng
2/4d 15 (50) 15a (50) _
aThe 15 injected tadpoles with XMLP 0.8 ng together with MO XMLP 16 ng showed lens defect and  mild bent axis
defect simultaneously.
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3.3.6 The glycine residue at position 2 and the PSD (ED) domain are correlated
with apoptosis function in overexpression experiments
To gain insight into the role of functional domains of XMLP, four mutants were
constructed (Figure 3.3-7, see 2.9.3) in which (1) glycine 2 was replaced with alanine
(G2A) in order to introduce adverse effect to the myristoylation consensus; (2) serine
83 was changed into alanine (S83A) to prevent phosphorylation of serines in putative
ED (PSD) since phosphorylation plays a functional role in in vitro experiments of
other members of MARCKS family; (3) the splicing domain from position 22 to 27
was deleted to yield XMLP SD deletion mutant (SD); and (4) the region between
lysine 79 and serine 83 was deleted to yield XMLP ED deletion mutant containing
truncated ED domain (PSD). The mRNAs of XLMP wild type and these mutants were
microinjected into two dorsal blastomeres of 4-cell stage embryos with different
doses. Because apoptosis significantly starts at neurula stages in the overexpression
experiments, these embryos were subject to the inspection at late neurula stages
(Figure 3.3-8 A to F and Table 3.3-3). For XMLP wild tpye, the phenotype of
apoptosis as described above was significant when 0.4 ng of mRNA per embroys
was injected into embryos (75 out of 85 injected embryos, Figure 3.3-8 A). The
mutants S83A, G2A, and ED did not significantly cause apoptosis when injected the
same dose (10 out of 85 for S83A, 8 out of 116 for G2A, and 0 out of 60 for ED),
while all embryos (91 out of 91) injected with 0.4 ng of mutant SD mRNA showed
apoptosis. It is therefore suggested that the mutants S83A, G2A and ED can reduce
apoptosis in overexpression experiments. When injected with the doubled dose (0.8
ng), 40 out of 55 embryos injected with mutant S83A showed the phenotype of
apoptosis, in contrast, only 5 out of 44 embryos injected with mutant G2A and 0 out
of 59 embryos injected with ED mutant showed this phenotype. Moreover, only 7 out
of 69 embroys injected with the 1.6 ng of ED mutant displayed apoptosis. The
phenotypes of tadpole embryos are shown in Figure 3.3-8H to M and Table 3.3-3.
The common features were eye defects, bent axis and in a few cases the severe
reduction of the anterior axis. There was no significant difference between the
mutants and XMLP wild type with exception of apoptosis. However, when 1.6 ng of
ED mutant RNA was injected, the ectoderm in the hind brain area of tailbud stage
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remained open, presumably due to an incomplete closure of neural folds (Figure 3.3-
8L). This phenotype is quite similar to F52 knockout mice that showed exencephaly
and postnatal anencephaly.
Figure 3.3-7. Schematic diagrams of XMLP wile tpye and mutants. Functional PSD (ED) is
indicated as a dark-slashed box, the site of intron splicing as a vertical dashed box, the
glycine at position 2 as black box and the substituted alanine by box with grid (A in both
G2A and S83A mutants). The white-slashed box in XMLP S83A mutant represents the
mutant ED domain with serine replaced by alanine (A).
3.3.7 Ectopic XMLP expression blocks normal rhombomere formation
It has been shown that XMLP transcripts were restricted to the presumptive neural
system during neurulation (3.3.1 and Figure 3.3-2), for which the effect of ectopic
XMLP expression on Krox20, a neural marker, whose expression is used to identify
rhombomere 3 and 5 in the development of hindbrain (Figure 3.3-9A) was
investigated. Overexpression of XMLP was carried out by injecting into one dorsal
blastomere of 4-cell stage embryos with XMLP mRNA synthesized in vitro and LacZ
as a lineage tracer. Ectopic expression of the XMLP resulted in a decreased Krox20
signal in the rhombomere 3 and 5 areas. The stripes appeared irregular and the first
one even disappeared on the injected side (28 out of 48 injected embryos, Figure
3.3-9B).
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Figure 3.3-8. Comparison of phenotypes induced by the overexpression of wild-type and
mutants XMLP. Embryos were injected into two dorsal blastomeres at 4-cell stage with
mRNA of XLMP wild type and mutants, respectively. At neurula stage, the phenotype induced by
0.4 ng of wild-type XMLP, G2A, SD, S83A or ED are shown in (A), (B), (C), (E) and (F),
respectively. Note the apoptosis were induced by 0.4 ng of XMLP wild type (A) and SD (C),
but not by G2A (B), S83A (E) and ED (F). However embryos (D) showed apoptosis when 0.8
ng of S83A was injected. Apoptosis areas are shown by the arrows in (A), (C), and (D).
Larva injected with 0.4 ng of XMLP wild type is shown (G). (H), (J), (K), and (M) indicate the
phenotypes induced by G2A, S83A, ED, and SD, respectively, such as eye defects and a reduced
anterior region. (M) The extreme case of injected embryos with SD mutant. (L) The phenotype induced
by the injection of 1.6 ng of ED, which is quite similar to the phenotype of exencephaly in which the
neural tube was not closed completely, and the epidermis did not cover the internal yolk-rich
tissue either.
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Table 3.3-3. Effects of XMLP wild type and mutants, and the combination with MO
XMLP.  The injected embryos were scored at early tadpole stage, while the results of
overexpression of 1.6 ng of ED mutant were collected at middle tailbud stage. XMLP wild
type and mutant mRNAs and MO XMLP were injected into two dorsal blastomeres of 4-cell
stage embryos. n indicates the number of injected embryos available. The percentage of
the available cases is shown in parenthesis. Embryos with apoptosis were inspected at late
neurula.
RNA injected per
embryos
Normal
(n)
Lens defect
(n)
Bent body axis
(n)
Phenotype showing lens defect,
reduced anterior axis and bent axis
defect simultaneously (n)
Apoptosis
XMLP 0.4 ng 0 (0) 0 (0) 0 (0) 41 (100) 75 (88)
XMLP + MO XMLP
0.8 ng+16 ng
15 (50) 0 (0) 0 (0) 15 (50) 0 (0)
ED 0.4 ng 29 (48) 21 (35) 10 (17) 0 (0) 0 (0)
ED 0.8 ng 5 (7) 39 (53) 12 (16) 18 (24) 0 (0)
ED 1.6 ng 23 (42) 0 (0) 3 (5) 29 a (53) 7 (10)
G2A 0.4 ng 12 (23) 0 (0) 0 (0) 40 (77) 8 (7)
G2A 0.8 ng 0 (0) 0 (0) 0 (0) 26 (100) 5 (11)
S83A 0.4 ng 16 (40) 8 (20) 16 (40) 0 (0) 10 (12)
S83A 0.8 ng 4 (12) 0 (0) 0 (0) 29 (88) 40 (73)
S83A 1.6 ng 0 (0) 0 (0) 1 (3) 31 (97) 48(98)
SD 0.2 ng 0 (0) 15 (45) 0 (0) 18 (55) 18 (49)
SD 0.4 ng 0 (0) 18 (30) 0 (0) 43 (70) 91(100)
a 
The phenotype is quite similar to exencephaly. The result was scored at middle tailbud stage when the eye rudiment has not
yet clearly formed, so the embryos not showing exencephaly were scored as normal.
3.3.8 Retinoic acid hydroxylase (XCYP26) changes the expression pattern of
XMLP
Retinoic acid (RA) is known to participate in the development of the nervous
system and the formation of the limb buds (for review, see Maden et al., 1998; Zile,
1998). To determine whether the RA metabolites affect the expression pattern of
XMLP (Figure 3.3-9C), whole-mount in situ hybridization were performed on stage 20
embryos co-injected into one blastomere at 2-cell stage with 2 ng of XCYP26
(Hollemann et al., 1998b) and 100 pg LacZ mRNA, which revealed that the signal
stripes on the injected side were weaker or even disappeared (57%, 31of 54 cases)
in contrast to the uninjected side (Figure 3.3-9D).
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Figure 3.3-9. Effect of ectopic expression of XMLP on Krox20 and the expression
alternation of XMLP induced by XCYP26. 0.8 ng of XMLP mRNA was injected into one
dorsal blastomere of 4-cell stage embryos. LacZ mRNA was co-injected as a lineage tracer
indicated in light blue. Signals were detected by whole-mount in situ hybridization performed
on XMLP-injected embryos at stage 20 with Krox 20 antisense RNA. (A) The expression of
Krox 20 in the control embryos. (B) The expression of Krox20 disturbed on the injected side.
2 ng of XCYP26 mRNA was injected into one blastomere of 2-cell stage embryos, which was
visualized by LacZ staining. Signals were detected by whole-mount in situ hybridization
performed on XCYP26- injected embryos at stage 20 with XMLP antisense RNA. (C) The
expression of XMLP in the normal embryos. (D) The altered expression of XMLP indicated
by LacZ staining (signal stripes vanished or got smeared) at injected side caused by
overexpression of XCYP26.
3.4 Isolation of XAT and the expression pattern
The clone encoding the X e n o p u s  homologue of arginine:glycine
amidinotransferase (XAT) consists of an open reading frame encoding a protein of
422 amino acids with a predicted molecular weight of 48572.88 Da (GenBank
accession number: AF187863). XAT shares 83% identity of amino acids with its
homologue in chicken, 85% identity to rat AT, and 84% identity to human AT (Figure
3.4-1).
The spatial expression pattern of XAT was analyzed by whole-mount in situ
hybridization (Oschwald et al., 1991; Harland, 1991), which indicated that the signals
were barely detected before the gastrula stages, and successively were around the
yolk plug. The stronger signals were found on the dorsal blastpore zone, but no
transcripts were detected in the animal halve (Figure 3.4-2C, D). At the stage 15, the
signals were restricted to the midline of the neural plate (Figure 3.4-2E, F) and the
corresponding transversal sections showed that the transcripts were located in the
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notochord (Figure 3.4-2G). The signal increased at the ventral-posterior part of the
trunk at the early of tailbud stage together with strong expression in the notochord
(Figure 3.4-2H). At the later tailbud stages and early larvae signals could be seen in
the trunk, especially at the presumptive gut and notochord area (Figure 3.4-2I, J, K).
The temporal profile of XAT expression analyzed by RT-PCR showed that the
expression of this gene started after the stage 8, and was slightly increased during
the gastrula and neurula stages, then maintained stable in the tailbud and later
stages (Figure 3.4-3).
Figure 3.4-1. Alignment of the deduced protein sequence of AT in Xenopus, chicken, rat and
human. Numerical figures indicate amino acid positions starting with the initiation of methionine.
Hyphen represents gaps introduced into the sequences in order to obtain optimal alignment. The black
boxes indicate the conserved amino acids, and the gray box, the similar amino acids. The accession
number for the Xenopus laevis AT (XAT) cDNA sequence is AF187863.
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Figure 3.4-2. The expression of X AT revealed by whole-mount in situ hybridization. XAT
transcripts are barely found from the 2-cell stage to the stage 8 (A, B). In the middle gastrulae stages,
signals are detected around the yolk plug (C, D). In the neurula stage XAT is expressed in the midline
of the medullary plate (E, F). Transversal sections show that the signals are located in the notochord
(G). In the tailbud and tadpole stages transcripts are mainly found in the notochord and the trunk area
(H to K) (Abbreviations: at, archenteron; ed, endoderm; nt, notochord; sm, somite).
Figure 3.4-3. The temporal expression of XAT in different embryonic stages analyzed by RT-
PCR. The stage definition is according to Nieuwkoop and Faber (1975), ODC is indicated as internal
standard control.
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Figure 3.4-4. The expression of XAT shown in explants dissected at the stage 28. Signals in the
head area (I) are much lower than that in dorsal zone of trunk (II) and the remaining ventral parts
including the presumptive gut area (III).
Figure 3.4-5. The expression of X AT in different adult tissues analyzed by RT-PCR. XAT
transcripts are detected in all tested tissues, however, with large abundance in eye, muscle, stomach
and testis. H4 is indicated as internal standard control (Abbreviations: br, brain; ey, eye; he, heart; in,
intestine; ki, kidney; li, liver; mu, muscle; ov, ovary; sk, skin; sp, spleen; st, stomach; te, testis).
By whole-mount in situ hybridization few transcripts of XAT could be found in the
head in contrast to abundant signals in the trunk area. To determine the expression
level in different parts of embryo by RT-PCR, the stage 28 embryos were dissected
into three parts: head (containing cement gland), dorsal zone of trunk (containing
notochord and somites) and the remaining ventral part including the presumptive gut
area as shown in Figure 3.4-4A. The results shown in Figure 3.4-4B revealed that the
expression of XAT in the head area was much lower than in the other two zones,
which was consistent with the data of whole-mount in situ hybridization. RT-PCR
analyses of adult tissues showed a higher expression level in eye, muscle, stomach
and testis (Figure 3.4-5).
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4. Discussion
The discovery of Mendel’s laws of heredity sparked a scientific quest to understand
the content of genetic information in the last hundred years, especially the past
decades when we have advanced from having very little information about the
genetic details of biology to possessing an immense amount of structural information
about individual genes. Currently, the complete genome sequences of humans and
of more than 60 other species are available in databases. The complete of human
genome program will lay the foundation for a broad range of functional genomic tools
to facilitate analyses of individual gene functions. However, it only provides a new
starting point for understanding the basic genetic makeup and variations. Our ability
to deciphering such information remains woefully inadequate. Step by step, the
scientific progresses will naturally focus on gene functional studies which may
depend on the integration of unlimited information from different model organisms.
The use of a combination of different animal models has been proved to be
practicable to complement the deficiency of individual systems. Xenopus laevis is
one of these well-established experimental model system. Screening a cDNA library
of Xenopus  by the large-scale whole-mount in situ hybridization is a good approach
to isolate novel genes because the expression pattern often gives important clues
about the functions of a gene and makes readily testable prediction. So it is a way for
gene identification using characters of functional judgments directly and in this aspect
it is on the further way than the genome project itself. Moreover, for most of all cDNA-
generating ESTs, partially sequencing identified sequence homologies instead of
sequencing full inserts is an efficient compromise in a large-scale approach to assign
potential functions of a gene.
4.1 Why not many endoderm-specific genes in our cDNA library?
The primary goal of this study was to identify novel endoderm genes involved in
the early embryogenesis of Xenopus laevis and subsequently to study their functions.
However most of the new sequences look like ectoderm or mesoderm-correlated
genes though some early endoderm determinants such as Sox17  and Sox17  have
also been isolated from this cDNA library. The tissue prepared for the construction of
this cDNA library was activin-treated ectoderm, showing strong positive signals when
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it was analyzed by whole-mount in situ hybridization with the endodermal marker
endodermin (Edd) (Sasai, 1996). However there were some mesodermal and neural
derived tissues found by the histological inspection. The expression of ectoderm or
mesoderm specific genes in the tissues was also detectable using sensitive
approaches such as RT-PCR. Some endodermal determinants start to be activated
very early. For example, mixer (Henry and Melton, 1998) is turned on and off
specifically during the gastrulation; milk (Ecochard et al., 1998) is first detected at the
stage 9 in the dorsal marginal zone, as the gastrulation proceeds it becomes
undetectable at the late-gastrula stages; Sox17  and Sox17  (Hudson et al., 1997)
are initiated even earlier; Edd expression begins just before the gastrula stages.
While most of the endoderm specific genes initiate expression approximately a day
after the gastrulation ends and just before the conversion of ectoderm to epidermis
from the stage 25 to 30 (Henry and Melton, 1998), such as the liver fatty acid binding
protein (LFABP), an anterior small intestine and liver marker (Gordon et al., 1983),
Xlhbox-8 (Wright et al., 1988), a pancreatic homobox gene (homologous to Pdx1),
and the intestinal fatty acid binding protein (IFABP), a marker of small intestine
(Henry et al., 1996; Shi et al., 1994). Therefore, the period of culture after activin
treatment may be too short to activate most endoderm genes. Alternatively, it also
should be considered that the number of clones analyzed may be inadequate due to
generally low ratio of endoderm determinants during the embryonic development.
4.2 XXBP-1 participates BMP-4 signaling pathway
It is demonstrated that XXBP-1, a leucine zipper transcription factor, is involved in
BMP-4 signaling pathway and functions as a transcription activator. The
overexpression of XXBP-1 in early embryos leads to the ventralization and can
rescue neural induction of ectodermal explants as well as dorsolization of intact
embryos imposed by the dominant negative BMPs receptor I (tBMPRI), suggesting
that XXBP-1 acts downstream of BMP-4 receptor and mediates BMP-4 signaling in
the epidermal induction and the inhibition of neural differentiation.
4.2.1 Expression locations of XXBP-1
According to the whole-mount in situ hybridization, XXBP-1 is expressed in the
dorsal blastopore lip and the ventral ectoderm but not in the perspective neural plate.
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Moreover, it leads to ventralization of the injected embryos in overexpression
experiments and directs epidermal fate in ectoderm in the animal cap assays when
co-injected with tBMPRI. These evidences support that XXBP-1 acts as an epidermal
inducer or a neural inhibitor. Although XXBP-1 is expressed in the dorsal blastopore
lip, it plays a negative role for the dorsalization and neural induction of embryos. This
is reminiscent of ADMP (anti-dorsaling morphogenetic protein, Moos Jr et al., 1995)
which, demonstrating very strong ventralization activities, is also expressed in the
dorsal blastopore lip. They are then unexpected genes in the Spemann organizer in
light of classical embryological evidences that associate dorsalization influences with
this region in the embryos. I also found that XXBP-1 could suppress gsc and chd,
and up-regulate BMP-4, vent-1, vent-2 and Xhox3. Thus, it seems there are negative
regulatory signal pathways affecting on the dorsal mesoderm differentiation. Ectopic
noggin ablates the native expression of XXBP-1 in the animal cap assays,
suggesting that XXBP-1 could be a direct or indirect target gene for noggin. At the
late gastrula and neurula stages the signal staining of XXBP-1 is intensified on the
cement gland primordium and mature cement gland, which is similar to that of BMP-4
(Fainsod et al., 1994; Hemmati-Brivanlou and Thomsen, 1995; Grammill et al., 2000).
This, together with the fact that the signal is excluded from the neural plate at the
gastrula stages and its activity for ventralization, implies that XXBP-1 may involve in
BMP-4 signaling pathway. At the late neurula and early tailbud stage, the staining
strip extends from cement gland to the ventral side (Figure 3.2-2N) and the
corresponding sagittal sections show that the staining lies in the mesoderm closely
adjacent to the epidermis of embryos (Figure 3.2-3B, B1). The expression domain of
XXBP-1 is not the liver primordium (Hausen and Riebesell, 1991) although the
knockout mouse lacking the mouse XBP-1 showed the disruption of liver
development (Reimold et al., 2000). Nevertheless, the dramatic shift of its expression
domain during the embryonic development and its presence in all tested adult tissues
indeed indicate that XXBP-1 must play multiple roles for cell fate determination and
embryogenesis.
4.2.2 XXBP-1 lies the downstream of BMP-4 receptors and up-regulates BMP-4
Bone morphogenetic proteins (BMPs) are typical members of the transforming
growth factor b  (TGF- b ) family with diverse roles in the embryonic development. They
elicit wide biological responses in different biological contexts, which are partially due
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to intracellular cofactors that participate in BMPs and other signaling pathways (for
review, see von Bunoff and Cho, 2001). Signaling pathway involving BMP-4 is
implicated in both the mesoderm induction and the dorsoventral pattering. The
binding of organizer antagonists such as chordin and noggin to BMP-4 appears to be
responsible for the establishing a morphogen gradient of BMP-4 activities, which
specifies different dorsoventral fates in the early gastrulae (for review, see Dale and
Jones, 1999, De Robertis et al., 2000). Moreover, BMPs were strongly involved in the
ectoderm differentiation. In the absence of BMP-4, the ectoderm will give rise to
neural ectoderm. Conversely the ectoderm will differentiate into epidermis (for review,
see Weinstein and Hemmati-Brivanlou, 1997).
In this study, I show evidences that XXBP-1 is involved in BMP-4 pathway. First,
the expression pattern of XXBP-1 at the gastrula stages indicates that it may play a
negative role in the neural induction. And the intensified signal staining on the
cement gland at the neurula stages overlaps that of BMP-4. Second, ectopic
expression of BMP-4 up-regulates the expression of XXBP-1 on the dorsal marginal
zone (Figure 3.2-7A) and vice versa (Figure 3.2-11). Third, overexpression of each of
them leads to ventralization of the injected embryos in a dose-dependent manner,
resulting in phenotypes ranging from micorcephaly to Bauchstück. Fourth, both BMP-
4 and XXBP-1 can suppress gsc (Figure 3.2-9I) while are down-regulated by noggin
in animal cap assay (Figure 3.2-13). Finally, co-injection with XXBP-1 and truncated
BMP receptor I (tBMPRI) can reverse the dorsalization induced by injection with
tBMPRI alone, and direct the epidermal fate in the animal cap assay (Figure 3.2-12).
With respect to the hierarchy, the evidences support that XXBP-1 acts downstream
of the BMPs receptor. tBMPRs are able to interfere with BMPs signaling pathway.
Overexpression of tBMPRs in the ectoderm explants induces neural tissue as
indicated by neural markers NCAM and Otx2. However, the expression of NCAM and
Otx2 is suppressed and that of epidermal keratin is partially restored by the co-
injection with tBMPRs and XXBP-1. This means the treated ectoderm adopts a cell
fate prior to the epidermis and XXBP-1 is sufficient to attenuate the neural induction
imposed by tBMPRI. In overexpression experiments, XXBP-1 can also reverse the
dorsalization induced by tBMPRI. Thus it is suggested that XXBP-1 acts downstream
of BMP-4 receptors, yet the induction of BMP-4 by XXBP-1 in the DMZ analyses
raises the possibility that XXBP-1 is required for the maintenance of BMP-4
expression.
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4.2.3 The correlation between XXBP-1 and Wnt/ -catenin pathway
BMP-4 is repressed at the dorsal side of embryo, including the dorsal mesoderm
and the prospective neural plate during the gastrulation. There are some evidences
that Wnt/b -catenin signaling pathway is involved in this process. In this signaling
pathway, the signaling is mediated by the blockage of activity of glycogen synthase
kinase 3 (Gsk3). The inhibition of Gsk3 stabilizes b -catenin so that it can form
complexes with members of the family of LEF/TCF DNA-binding proteins.
Consecutively the complexes facilitate the nuclear localization of these factors and
therefore activate the target genes (for review, see Moon and Kimelman, 1998).
Wnt/b -catenin signaling cooperates with the neural inducers to specify posterior
versus anterior neural identity (McGrew et al., 1995) and the maternal b -catenin is
required for dorsal mesoderm development between the stage 7 and 9 (Wylie et al.,
1996). In Xenopus laevis, the activation of the Wnt/b -catenin singaling pathway
inhibits BMP-4 transcription in ectodermal explants at the gastrula stages and results
in the induction of neural marker (Baker et al., 1999). The treatment of Xenopus
embryos with LiCl leads to a phenotype of dorsalization with greatly enhanced
forebrain structures (Kao and Elinson, 1988). The treatment also leads to the
differentiation of neurons as well as neural crest in ectodermal explants. LiCl inhibits
the activity of glycogen synthase kinase b  (GSK- 3b ), preventing the degradation of
b -catenin. In this study, I also made attempt to investigate the relations between
Wnt/b -catenin and XXBP-1. The results indicate that the expression locations of
XXBP-1 are expanded to the whole DMZ of embryo in which Wnt/ b -catenin signaling
pathway is blocked by morpholino b -catenin oligos. And this phenotype can be
mimicked by the dorsal overexpression of BMP-4 and the UV treatment. Thus it is
shown here another evidence that there exists crosstalk between BMPs and Wnt/ b -
catenin signaling pathways, and also suggested that the Wnt/ b -catenin pathway is
involved in the neural induction and the neural plate patterning. The blockage of
Wnt/b -catenin signaling path way will lead to the failure of the formation of the
Spemann organizer, which in turn will not emanate the BMPs antagonists. The
patterning of neural plate therefore are interfered. This may be the possible reason
for the expansion of  XXBP-1 expression territories on the dorsal marginal zone of
the embryo injected with MO b -catenin. Alternatively, XXBP-1 may be a direct
negative target of Wnt/b -catenin or a indirect target regulated via BMP-4 signaling
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pathway, repressed from the neural plate by the activation of this pathway as BMP-4.
Similarly, the regression of Dlx3, another anti-neural factor from the prospective
neural plate, is also mediated by b -catenin (Beanan et al., 2000). Neither BMP-4 nor
XXBP-1 is up-regulated in the ectoderm explants injected with MO b -catenin,
suggesting the down-regulation of BMP-4 by Wnt signaling in the prospective neural
plate needs the cooperation with other factors. In agreement with our hypothesis that
Wnt/b -catenin is involved in the neural induction and the neural plate patterning, the
neural induction in the absence of mesoderm can be initiated by the b -catenin
dependent expression of secreted BMP antagonists at the blastula stage in Xenopus
(Wessely et al., 2001).
4.2.4 XXBP-1 functions as a transcription activator
The predicted amino acids sequence reveals that XXBP-1 belongs to the basic
leucine zipper family. In this protein family, the region adjacent to the leucine repeats
is highly basic in each of the members and could comprise a DNA-binding site. The
two leucine zippers in effect form a Y-shaped structure in which the zippers comprise
the stem and the two basic regions bifurcate symmetrically to form the arms that bind
to DNA. This is known as the bZIP. Zippers may be used to sponsor formation of
homodimers or heterodimers (Lewin, 2000).
With the context of the embryos, the constructs fused with protein domains known
to have repressive or activating transcriptional activities—the repressor domains of
the Drosophila engrailed (EnR) and even-skipped proteins (Eve) and the activator
domain of VP16, were employed to characterize the transcription activity of XXBP-1.
This approach has been used successfully for characterization of the activity of
several other transcriptional activators involved in Xenopus development (Conlon et
al., 1996; Horb and Thomsen, 1997; Onichtchouk et al., 1998; Gómez-Skarmeta et
al., 2001). XXBP-1 is demonstrated to have activator activity with several criteria.
First, when fused with the activator domain of VP16, the construct of XXBP1-VP16
showed similar biological activities as the wild-type XXBP-1, i.e. ventralization of the
embryos when injected dorsally and the phenotype of a posterior enlargement when
injected ventrally. Second, both XXBP1-VP16 and XXBP-1 wild type cannot induce
neural markers NCAM and nrp1. Third, when fused with the repressor domain of Eve,
the XXBP1-Eve is able to induce twin axis when ventrally overexpressed though the
ratio was relatively low. Moreover, in contrast to the wild-type XXBP-1, XXBP1-Eve
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can induce neural markers NCAM and nrp-1. Thus XXBP1-Eve up-regulates genes
that would ordinarily be repressed by XXBP-1. The results shown by XXBP1-EnR are
a blur. It cannot induce neural markers and twin axis but leads to the gastrulation
defect giving rise to spina bifida. The obscure results may be due to the addition of 6
Myc domains NH2-terminal flank to the bZIP domain, which may interfere DNA
binding activity of the fusion constructs. It’s worth noting that the gastrulation defect
was observed in the overexpression of each construct. However, the results must be
interpreted with respect to the likely mechanism of the action. The strong
transcriptional activator or repressor domain will act wherever there is an accessible
XXBP-1 binding site and not just in cells that express XXBP-1. This will inevitably
lead to pleiotropic effects on differentiation by altering transcription level in the vicinity
of XXBP-1 biding sites. Alternatively, the fusion constructs may have toxic effects
and interfere with the normal embryonic development.
In the study of the truncated mutant of XXBP-1 containing the first 126 amino acids
(including bZIP), the truncated construct has weak effects on the neural induction as
indicated by the increased expression of Otx2 and NCAM. The overexpression of this
truncated mutant also leads to gastrulation defect giving rise to spina bifida. These
suggest that XXBP-1 forms homodimers to carry out its functions.
4.3 XMLP is involved in the process of morphogenetic movement.
The present data about XMLP shows that XMLP is involved in the normal
development of neural tube and the primordium of the central nervous system. It also
induces apoptosis in overexpression experiments. Data of other members of the
MARCKS family together with my results suggest that XMLP is involved in the
morphogenetic movement during early embryonic development. The disturbance of
morphogenetic movement and induced apoptosis by overpression of XMLP could be
reasons for the reduction of the anterior axis and eye defects.
4.3.1 XMLP and XMARCKS show different temporal expression patterns
The expression pattern of XMLP is different from its homologue MARCKS in
Xenopus (XMARCKS). For XMARCKS, there is a clear decreased level from 4-cell
stage to mid blastula transition (MBT), which reflects the decay of maternal
transcripts. Thereafter, zygotic transcription of the MARCKS appeared to be switched
4. DISCUSSION         95
on and maintained permanently active throughout development (Shi et al., 1997). In
contrast, the reduced level of XMLP is not as significant as that of XMARCKS, i.e.
XMLP is expressed strongly at stage 8. The lowest expression level is reached at the
early tailbud stage and followed by an increase of the XMLP expression and
maintenance of a constant level. The differences between the two homologues may
reflect the expressions of redundancies regulated by different mechanisms. It should
be noted that the primary sequence of XMLP shows a very low similarity to its
homologue in human, mouse and rabbit. Alternatively, it could be a member of other
protein families, which may account for the expression difference. The mice
homologue of XMLP mRNA (F52) is expressed with a high level from 8.5 days post
conception (dpc) through 14.5 dpc. At 17.5 dpc, the mRNA level remains high in the
brain only, and not in other parts of embryos. Thus, F52 mRNA is abundantly
expressed during the period of neurulation (Wu et al., 1996). Similarly, XMLP is also
abundantly expressed in the neural folds in neurula stages, and shows a high
expression level in the brain area of tadpole stage embryos. The signal location
indicates that it plays an important role in the development of the central nervous
system.
4.3.2 The blockage of XMLP can disturb normal anterior axis formation
Embryos with the blocked XMLP by the injection with morpholino (MO) XMLP show
head reduction and eye defects, suggesting that XMLP is involved in anterior axis
formation. This phenotype can be rescued by the injection with XMLP, which
indicates that MO XMLP specifically binds XMLP mRNA. Data from in vitro studies of
other members of this protein family show that they are very important for cell shape
and cell motility. MARCKS is found associated with the plasma membrane and in the
cytosol. The translocation happened prior to changes in cell morphology (Ramsden,
2000). I also suppose that the disturbance of normal morphogenetic movement
cause the abnormal phenotype observed with injection of MO XMLP. If XMLP has a
similar function as other members of this protein family, it is reasonable that the
elimination of XMLP will change the cell morphology inevitably followed by a change
of incident processes downstream in the embryonic development.
4.3.3 The function of XMLP is correlated with its ED domain and glycine at
position 2— overexpression of XMLP can induce apoptosis
Apoptosis is a part of the developmental program of an organism. At the beginning
4. DISCUSSION         96
it could not be surely distinguished if the phenotype of overexpression experiments
was due to RNA toxicity or specific functions of XMLP. LacZ, therefore, was
microinjected as a control strictly under the same experimental conditions as that for
XMLP capped mRNA. Since such phenotypes were not found in LacZ injected
embryos, I could exclude the possibility of toxic effects (data not shown). The results
from other studies also support my view with regard to this phenotype (Grammer et
al., 2000). Many cDNAs encoding factors which cause cell damage or inhibit normal
cell cycle progression (transcription inhibitors, translation inhibitors and mitosis
blocking agents) can lead to the phenotype of apoptosis described above. Although
there exist some reliable methods to show apoptosis in Xenopus, e.g. TUNEL or
ELISA, it is important to focus the interest on the apoptosis observed in
overexpression experiments. This is beneficial in identification and characterization of
cell death inducers and effectors, and in distinction it from phenotypes caused by
direct inhibition or cell death.
The results here indicate that the ED domain (PSD) and the glycine at position 2 of
XMLP are important for its function properties. The substitution of alanine for serine
at the position 83 can reduce but not abolish XMLP apoptosis inducing activity in
overexpression experiments because significant apoptosis is found only when the
injection dose of S83A is increased as shown in Table 3.3-3. However, the intact ED
domain is essential for this function. No significant differences were found between
the SD mutant and XMLP wild type in overexpression experiments. But this highly
conserved domain contained in MARCKS family must presumably have a certain
function though so far no experimental evidence exists. Overexpression of MARCKS
in tumor-derived choroidal melanoma cells, where the amount of the endogenous
protein is very low, can significantly decrease cell proliferation (Manenti et al., 1998).
Ectopic apoptosis may be one of the reasons for eye defects and the reduction of
anterior in overexpression experiments, since normal embryonic development could
be inhibited by severe ectopic apoptosis (Grammer et al., 2000). Overexpression of
XMLP alone without any apoptosis does not inhibit the histolotypic differentiation of
isolated dorsal blastopore lip.
 4.3.4 Overexpression of mutant ED inhibits the closure of neural tube
Interestingly, embryos injected with 1.6ng of XMLP ED mutant mRNA showed a
phenotype which is quite similar to exencephaly in mice. In contrast to wild-type
4. DISCUSSION         97
XMLP, it does not cause apoptosis, but aberrant tissue morphogenesis including
abnormalities in eye formation and neural tube closure. These data are in agreement
with observations in the mice that knockout XMLP homologues leads to embryonic
exencephaly and postnatal anencephaly. Probably XMLP acts like F52, MARCKS
and other PKC substrates such as GAP43 by mediating cytoskeletal changes and
controlling of morphogenesis in different tissues. I suppose that adverse ED mutant
molecules have a strong influence on cellular architecture. The introduced ED mutant
molecules can compete with the native XMLP in vivo. They could be adulterated the
cellular architecture during embryonic development, therefore must presumably alter
the cellular architecture, influence the motility, and alter the mutual cell affinity to the
surrounding cells resulting in a failure of neural tube closure. In contrast, MO XMLP
does not cause such significant phenotype. This may be due to the partial
compensation by other redundant molecules. It is also possible that abundant XMLP
is already present in the embryos when MO XMLP was injected. The data support
the view that XMLP participates in morphogenetic movements. Morphogenesis
including neurulation requires multiple cellular processes such as cell proliferation,
cell shape change and cell migration (Schoenwolf, 1990). All these processes
depend on the reorganization of the cytoskeleton, cell-cell signaling and mutual cell
affinity. Ectopic expression of XMLP and morpholino injection had no obvious effects
on morphogenetic movements during gastrulation since injected embryos showed
normal blastopore and yolk plug formation. It could then be argued that non-
significant effects on embryonic development may be partially correlated with still
high levels of maternal XMLP transcripts and their long half-life.
4.3.5 Ectopic expression of XCYP26 affects the expression pattern of XMLP
Several experiments have shown that RA can alter the positional values of cells in
limb development and in the anterior-posterior axis formation (Conlon, 1995). The
effects of RA are mediated at different levels, but mainly by gene transcription and
interactions with multiple nuclear receptors (RARS and RXRs). RAR-RXR
heterodimer binds to RA response elements (RARES) in the promoter regions of
target genes and regulate transcription in a ligand-dependent manner. XCYP26 is a
RA hydroxylase, which could rescue RA induced developmental defect and alter the
expression patterns of some other molecular markers for neural development
(Hollemann et al., 1998b). In this study, I also find that XCYP26 can influence the
4. DISCUSSION         98
XMLP expression pattern. The signal stripe in stage 20 embryos on the injected side
in contrast to that on the uninjected side gets diffused or even disappears. Therefore
I suggest that RA participates in the regulation of XMLP and may be involved in
anterior-posterior axis formation.
4.4 Expression of XAT in dorsal blastopore lip
Our results show that during embryogenesis, XAT is preferentially expressed
around the blastpore and later in the notochord of neurula and tailbud stages. These
data of the spatial and temporal expression of a gene encoding an enzyme close
related to energy metabolism confirms classical experiments on the molecular level,
which suggested that certain enzymes are active in form of a gradient-like pattern
especially around the blastopore and in those parts of the embryo, where cell
activities including cell division are most prominent (Sáxen and Toivonen, 1962). In
addition, XAT was posteriorly intensified in the tailbud stage, showing much strong
expression than the cranial part. This implies XAT may correlated with the FGF
pathway because FGF is known to be essential for posterior patterning. Further
functional experiments especially on the protein level will be essential to get a better
understanding about the temporal and spatial control mechanisms of this enzyme.
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5. Summary
In this study, the large-scale whole-mount in situ hybridization was employed to
screen an activin-treated ectoderm cDNA library of Xenopus laevis, leading to the
isolation of 51 novel cDNA sequences of Xenopus. So this approach turned out to be
practicable for identification of new genes from a cDNA library in a large scale.
XXBP-1, XMLP and XAT were selected for further functional studies based on their
suggestive expression pattern.
XXBP-1 is a novel basic leucine zipper transcription factor in Xenopus. It is a
maternal factor and expressed on the dorsal blastopore lip and ventral ectoderm with
exception of perspective neural plate in gastrula stages. RT-PCR indicated that
XXBP-1 is weakly expressed before gastrula stages, afterwards is up-regulated and
kept in a persistent level during the embryonic development. Overexpression of
XXBP-1 leads to ventralization of the injected embryos as described for BMP-4.
Moreover, XXBP-1 and BMP4 interact in a positive feedback loop. Consistent with
mediating BMP-4 signaling, the ectopic expression of XXBP-1 partially recovers the
expression of epidermal keratin in animal cap assay and converses the dorsolizaiton
imposed by truncate BMP receptor I. Thus, we propose that the XXBP-1 is
downstream of BMP receptors, and plays roles in the inhibition of neural
differentiation.
XXBP-1 functions as a transcriptional activator. When overexpressed ventrally, the
effect of wild type XXBP-1 can be phencopied by the XXBP1-VP16 containing the
activator domain VP16 and the DNA binding domain of XXBP-1. Another fusion
construct, XXBP1-Eve containing the DNA binding domain of XXBP-1 and even-
skipped repression domain induce neural markers NCAM and nrp1 in animal cap
assay and leads to the secondary axis when overexpressed ventrally in a low ratio
(10%). This confirms that XXBP-1 acts as an activator, playing negative roles in
neural induction.
The XMLP may be a new number of the small MLP protein family. Using whole-
mount in situ hybridization and RT-PCR, XMLP maternal transcripts were detected
during the cleavage stages. After MBT the signals are restricted to the neural plate.
Subsequently XMLP is expressed predominantly in the brain, somites, and
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pronephros. Ectopic expression of XMLP results in eye and axis defects and as well
as a change of the expression pattern of Krox 20. Apoptosis was induced by the
injection of XMLP. Overexpression of mutant XMLPs indicated that this phenotype is
correlated with its putative PSD domain and glycine at position 2. The loss-of-
function of XMLP was studied by injection with a morpholino oligo complementary to
XMLP mRNA, which revealed the malformations of anterior axis and eye defects.
According to extirpation experiments the phenotypes might be correlated with
disturbed morphogenetic movements rather than an inhibition of induction process.
Overexpression of XCYP26 resulted in a shift of the expression pattern of XMLP,
showing the signal stripe of XMLP in injected half of the embryo getting diffuse or
even disappeared. This observation suggests that retinoic acid plays an important
role in the XMLP regulation. Taken together, XMLP may participate in pattern
formation of the embryonic axis and the central nervous system.
XAT encodes Xenopus amidinotransferase which shares a highly conserved
sequence with the homologues of human, chick and rat. Characterization of
embryonic expression indicates that XAT is differentially expressed around the yolk
plug including the dorsal blastopore area at early gastrula stages and is extensively
expressed in the midline of the neural plate of early neurula stages. Sections reveal
that its transcripts are located in the notochord. In the tailbud stage signals are found
both in the notochord and the trunk area, whereas faint signals can be found in the
cephalic part only.
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6. Zusammenfassung
In dieser Arbeit wurde in großem Maßstab mittels Random Screening und whole-
mount in situ Hybridisierung von Genen einer Bibliothek von aktivin-behandelten
Ektoderm durchgeführt. Auf diese Weise wurden 51 neuen cDNA-Sequenzen von
Xenopus laevis isoliert. Aufgrund ihres sehr interessanten Expressionsmusters
wurden dann XXBP-1, XMLP und XAT für weitere funktionelle Studien ausgewählt.
XXBP-1 ist ein neuer basischer Leucine Zipper Transkriptionsfaktor bei Xenopus
laevis. Es handelt sich um einen maternalen Faktor, der auf der dorsalen Seite der
Urmundlippe und ventralen Ektoderm exprimiert wird mit Ausnahme der zukünftigen
Neuralplatte im Gastrula-Stadium. RT-PCR Analyse konnte zeigen, dass XXBP-1 vor
Beginn der Gastrulation schwach, während der weiteren Embryonalentwicklung aber
dann kontinuierlich exprimiert wird. Eine Überexpression von XXBP-1 führt zur
Ventralisierung der injizierten Embryonen wie es von BMP-4 bekannt ist. Weiterhin
interagiert XXBP-1 und BMP-4 in Form einer positiven Rückkoppelung. Im Rahmen
der BMP-4 Signalkette bewirkt die ektopische Expression von XXBP-1 eine partielle
Rekonstitution von epidermalem Keratin im Animalen Kappen-Assay (animal cap
assay) und inhibiert die Dorsalisierung hervorgerufen durch Rumpf (truncated)-BMP-
Rezeptor I. Die Ergebnisse deuten daraufhin, dass XXBP-1 downstream vom BMP-
Rezeptor wirkt und eine bedeutsame Rolle in der Hemmung der neuralen
Differenzierung spielt.
XXBP-1 funktioniert als Transkriptionsaktivator. Bei einer ventralen Überexpression
kann sein Effekt durch eine VP 16 Aktivatordomäne, die mit der DNA-bindenden
Domäne des XXBP-1 fusioniert ist, simuliert werden. Ein Konstrukt, das die DNA-
bindende Domäne XXBP-1 und even-skipped Repressionsdomäne enthält, induziert
den neuralen Marker NCAM and nrp1 im Animalen Kappen-Assay und führt zur
Bildung einer sekundären Achse bei einer ventralen Überexpression. Diese
Ergebnisse bestätigen, dass XXBP-1 als ein Aktivator fungiert und eine Hemmung
der neuralen Induktion bewirkt.
Das von uns ebenfalls charakterisierte Gen XMLP gehört zu der kleinen
Proteinfamilie MLP. Durch whole-mount in situ Hybridisation und RT-PCR konnte
nachgewiesen werden, dass XMLP maternal während der frühen Teilungsstadien
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exprimiert wird. Nach der MBT (midblastula transition) sind die Signale beschränkt
auf die Neuralplatte. In der weiteren Entwicklung ist XMLP exprimiert vor allen
Dingen im Gehirn, Somiten und Vornieren (pronephros). Ektopische Expressionen
von XMLP führt zu Augen- und Achsendefekten und zu einer Veränderung des
Expressionsmusters von Krox20. Injiziertes XMLP mRNA führt zur Apoptosis.
Ergebnisse aus Überexpressionsexperimenten mit XMLP-Mutanten weisen darauf
hin, dass dieser Phänotype auf die putativen PSD Domäne und dem Glycin in
Position 2 zurückzuführen ist. Injizierte Morpholino Oligos komplementär zu XMLP
mRNA bewirken Deformationen der anterioren Achse und Augendefekte.
Extirpationsexperimente weisen darauf hin, dass dieser Phentotyp eher auf gestörte
morphogenetische Bewegungen als auf eine Inhibition des Induktionsprozesses
zurückgeht. Eine Überexpression von XCYP26 ergab eine Veränderung des
Expressionsmusters von XMLP; der Signalstreifen von XMLP in der injizierten Hälfte
des Embryos wurde diffus oder verschwand sogar. Diese Beobachtung deutet darauf
hin, dass Retinsäure eine wichtige Rolle spielt in der XMLP Regulation.
Zusammenfassend kann man sagen, dass XMLP eine wichtige Rolle in der
Musterbildung der embryonalen Achsenbildung und des zentralen Nervensystems
spielt.
Ein weiteres untersuchtes Gen XAT weist Sequenzen auf, die hochkonservierte
Bereiche zu menschlichen, Hühner- und Ratten- Amidinotransferase enthält. Wir
konnten zeigen, dass XAT differenziell in der Zone des Dotterpfropfes einschließlich
der dorsalen Urmund-Region in der frühen Gastrula exprimiert wird. In frühen
Neurula-Stadien finden sich Signale in der Mittellinie der Neuralplatte. Histologische
Schnitte zeigten, dass das Gen in der Chorda exprimiert wird. Im
Schwanzknospenstadien können die Signale in der Chorda und in der Rumpfregion
nachgewiesen werden. Schwache Signale fanden sich in der Kopfregion.
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7. Synopsis
Nach der Sequenzzierung des Genoms des Menschen und anderer Organismen ist
es nun von Interesse die Funktionen der Gene während der Embryonalentwicklung
besser zu verstehen. Dieses Verständnis wird große Auswirkungen haben auf die
biomedizinische Forschung und die angewandte Medizin.
Xenopus laevis  ist ein exzellentes Vertebraten-Modellsystem, dessen Embryonen in
großer Zahl das ganze Jahr über zur Verfügung stehen. Es erlaubt die Analyse der
zeitlichen und räumlichen Wirkungsweise von Genen und ihren Signalketten.
Die Untersuchungen in der Entwicklungsbiologie haben sich vom zellulären zum
molekularbiologischen Level verschoben. Eine große Zahl von Genen konnten
mittlerweile während der frühembryonalen Entwicklung identifiziert und charakterisiert
werden. Die Embryonalprozesse können einfach bezeichnet werden als an- oder
abschalten von Genen. In der frühen Embryonalentwicklung von Xenopus findet sich
zunächst eine animale-vegetative Polarität. Nach der Befruchtung kommt es zur
differenziellen Aktivierung des Wnt/ b -catenin Signalweges. auf der zukünftigen
Dorsalseite des Embryos. Die Kooperation mit TGF-b  führt zur Spezifizierung der
dorsalen und ventralen Achse und zur Ausbildung des Spemannschen Organisators.
TGF-b  ist bei der Ausbildung des Entoderms beteiligt und bei der Bildung des
Mesoderms in der marginalen Zone. Das in der animalen Hälfte lokalisierte Ektoderm
differenziert sich in Abwesenheit von BMP-4 in neurale Richtung und zu Epidermis in
seiner Anwesenheit.
Aktivin spielt eine wichtige Rolle bei der mesodermen und entodermen
Musterbildung. Disaggregierte Zellen der animalen Kappe, welche mit niedrigen
Konzentrationen von Aktivin behandelt werden, differenzieren sich zu Mesoderm-
Derivaten, während sie sich bei höheren Konzentrationen von Aktivin zu entodermen
Derivaten differenzieren (Grunz 1983, Ariizumi et al ., 1991). In diesem Labor wurde
ausgehend von RNA prepariert, von Aktivin-behandelten Ektoderm, eine cDNA-
Bibliothek konstruiert, die eine effiziente Isolierung von Genen erlauben sollte, die für
die Bildung der mesodermalen/entodermalen Musterbildung verantwortlich sind. Mit
random screening wurde die cDNA-Bibliothek analysiert. 51 neue Gene wurden
isoliert und bei der Gen-Bank mit entsprechender Accession-Number angemeldet.
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Mit 3 Genen XXBP-1, XMLP und XAT mit besonders ausgeprägten
Expressionsmuster wurden weitere funktionelle Studien durchgeführt.
7.1 XXBP-1: Ein Transkriptionsaktivator beteiligt am BMP-4
Signalweg
Identifzierung des Xenopus X-box binding protein 1 (XXBP-1)
Die Sequenz des XXBP-1 cDNA (GeneBank accession number: AF358133) weist
einen offenen Leserahmen auf der für ein Polypeptide von 350 Aminosäuren codiert
und eine basische leucine zipper (bZIP) Domäne enthält. Die abgeleitete
Aminosequenz ist weitgehend identisch mit dem Transkriptionsfaktor X-box binding
protein 1 beim Menschen (hXBP-1, NM_005080, 66% amino acids identity; Liou et
al., 1990), Ratte (JC4857, 66% amino acids identity), Maus (NP_038870, 66% amino
acids identity) und Zebrafisch (AY029577, 59% amino acids identy).
Zeitliche und räumliche Expression von XXBP-1
Mittels whole-mount in situ Hybridisierung (Fig. 3.2-2) konnten wir zeigen, dass
XXBP-1 in der animalen Hälfte des Embryos vor der Gastrula nur schwach exprimiert
ist. Während der Gastrulation finden sich Signale in der dorsalen Urmundlippe und
im ganzen ventralen Ektoderm, aber nicht in der zukünftigen Neuralplatte. Während
der mittleren Neurula-Stadien wird XXBP-1 schwach ventrolateral exprimiert. Die
Signale werden in anterior/posterioren Richtung entlang der Neuralleisten- und in der
Haftdrüsen (cement gland)-Region gefunden. Im Schwanzknospenstadium finden
sich Signale in der Hafttdrüse und den Vornieren (hauptsächlich im Glomerulus-
Bereichl). Die RT-PCR Analyse zeigt, dass XXBP-1 ein maternaler Faktor ist, der vor
der Gastrulation schwach exprimiert wird, dann aber während der weiteren
Embryonalentwicklung kontinuierlich vorhanden ist (Fig. 3.2-4).
Down-Regulation der XXBP-1 mittels Retinsäure (RA)
In den Stadien von 8-11 wurde der Effekt einer RA-Behandlung (10-6 M) auf die
Expression von XXBP-1 mittels whole-mount in situ Hybridisierung durchgeführt
getestet. Im Vergleich zu unbehandelten Kontrollen wiesen RA-behandelte
Embryonen eine verringerte XXBP-1 Expression in Neurula- und Schwanzknospen-
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Stadien auf (87%, 34 von 49 Embryonen zeigten signifikante Signal-Reduktion; Fig.
3.2-6).
Neurale Inhibitoren und MO -catenin können die Expressionsbereiche von
XXBP-1 auf der Dorsalseite des Embryos vergrößern
Es wurden die Effekte von neuralen Inhibitatoren, wie BMP-4, UV-Bestrahlung, Msx1
und Dlx3, und morpholino (MO) b -catenin auf die Expression von XXBP-1 mittels
whole-mount in situ Hybridisierung untersucht (Fig. 3.2-7). Es ergab sich, dass
XXBP-1 in der dorsalen Marginalzone durch BMP-4 (98%, 42 von 43 Embryonen),
MO b -catenin (100%, 73 von 73 Embryonen) oder UV (100%, 23 von 23 Embryonen)
aktiviert wird. Das Ergebnis ist eine Expression in der gesamten Marginalzone. Msx1
und Dlx3 führten zu einer Ausdehnung der ventralen Expressionen des XXBP-1 über
die gesamte prospektive Neuralplatte. Zusammenfassend kann man feststellen, dass
all diese neuralen Inhibitoren und MO b -catenin die Expressionsregion des XXBP-1
ausweiten.
Hemmung von neuralen Markergenen induziert durch Mikroinjektion von
XXBP-1
Einseitige Injektion von XXBP-1 (1 Blastomere im 2-Zellstadium) ergab die Reduktion
der neuralen Marker wie Otx2 (60%, 94 von 156 Embryos), Rx2A (41%, 47 von 116
Embryos), En2 (49%, 31 von 63 Embryos), Krox20 (71%, 34 von 48 Embryos), Pax6
(50%, 28 von 56 Embryos), and Sox3 (58%, 44 von 76 Embryos) (Abb. 3.2-8). Der
Effekt der XXBP-1 Injektion wurde sichtbar durch das Verschwinden der Expression
dieser Gene. Anderseits wurde die Expression von XAG2 (Haftdrüsen [cement gland]
spezifisches Gen) nicht beeinflusst.
Hemmung der dorsalen mesodermalen Marker chordin (chd) und gooescoid
(gsc) durch XXBP-1
Whole-mount in situ Hybridisierung ergab, dass die Injektion von XXBP-1 mRNA zur
Unterdrückung von chd (65%, 37 von 57 Embryos) und gsc (75%, 42 von 56
Embryonen) führt (Abb. 3.2-9l). Die Analyse der dorsalen Marginalzone ergab
Hinweise, daß diese down-regulation dosisabhängig ist (Abb. 3.2-9II).
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Überexpression von XXBP-1 führt zur Ventralisierung der Embryonen
Besonders ausgeprägte Abnormalitäten ergaben sich durch Überexpression von
XXBP-1 in Form der Unterdrückung der anterioren-dorsalen Strukturen einschließlich
der cement gland, Augen, Ohrvesicle und in vielen Fällen des gesamtes
Kopfbereiches. Die histologische Analyse dieses Phänotypes der Ventralisierung
(Abb. 3.2-10) ergab eine Reduktion der Chorda und der Gehirnstrukturen (Abb. 3.2-
10H).
Überexpression von XXBP-1 ventralisiert dorsales Mesoderm
Ventrale Marginalzone (VMZ) und dorsale Marginalzone (DMZ) früher
Gastrulastadien von XXBP-1 injizierten Embryonen wurden isoliert und bis zum
Stadium 22 in Kultur gehalten. Danach erfolgte die RT-PCR Analyse verschiedener
Markergene (Abb. 3.2-11). Gsc and Xnot, aber nicht chd, werden inhibiert, was
darauf hinweist, dass die Bildung von Kopfmesoderm und Chorda durch XXBP-1
beeinflusst wird. Der Verlust der Expression der dorsalen mesodermen Markergene
geht einher mit dem Anstieg der Expression intermediärer und ventro-posteriorer
mesodermaler Markerwie Herzaktin (cardiac actin). Der ventrale mesoderme Marker,
Xvent-2 wurde bei allen Knzentrationen, Xhox3, Xvent-1 und BMP-4 in einer
dosisabhängigen Weise induziert. Zusammenfassend kann man sagen, dass die
Überexpression von XXBP-1 in der isolierten dorsalen marginalen Zone zu einer
down-regulation von dorsalen Markergenen und parallel zu einer up-regulation von
ventralen Markergenen führt.
XXBP-1 hebt die Dorsalisierung auf, die durch dominant negative BMP-4
Rezeptoren induziert wird
Das Animale Kappen-Assay wurde durchgeführt mittels RNA isoliert aus animalen
Kappen von Embryonen nach Injektion von mRNAs von 0,4 ng XXBP-1, 1,6 ng
tBMPRI (Suzuki et al., 1994), eine Mischung von 1,6 ng tBMPRI und 0,4 ng XXBP-1
und eine Mischung von 1,6 ng tBMPRI, 0,8 mg tBMPRII (Frisch, 1998) und 0,4 ng
von XXBP-1 (Abb. 3-12l). Im Gegensatz zu Ektodermzellen mit tBMPRI alleine,
differenzieren sich Ektodermzellen nach Injektion einer Mischung von tBMPR und
XXBP-1 in epidermale Richtung. Dies deutet darauf hin, dass XXBP-1 die durch
tBMPRs hervorgerufene Neuralinduktion inhibiert. Somit dürfte XXBP-1 downstream
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des BMP-Rezeptor wirksam sein. Dies wurde weiterhin bestätigt durch
Überexpressions-Experimente, in denen XXBP-1 die durch Injektion von tBMPRI
bewirkte Dorsalisation aufhebt (Abb. 3.2-12II).
Noggin ist ein Antagonist von XXBP-1 im Animalen Kappen-Assay
Im Animalen Kappen-Assay wurde XXBP-1 in der gleichen Weise durch Noggin
unterdrückt wie BMP-4. XXBP-1 und BMP-4 konnten durch Zic3 inhibiertwerden,
während MO b -catenin keinen signifikanten Effekt hatte.
Zusammenfassend kann man sagen, dass XXBP-1 beteiligt ist am BMP-4 Signalweg
aus folgenden Gründen: Erstens, das Expressionsmuster von XXBP-1 in der
Gastrula deutet darauf hin, dass es eine negative Rolle spielt in der neuralen
Induktion (Abb. 3.2-2). Zweitens, ektopische Expression von BMP-4 steigert die
XXBP-1 Expression in der dorsalen marginalen Zone (Abb. 3.2-7) und vice versa
(Abb. 3.2-11). Drittens, Überexpression von beiden führt zur Ventralisierung der
Embryonen in einer dosisabhängigen Weise, was in den Phänotypen von
Microcephalie bzw. Bauchstücken resultiert (Abb. 3.2-10). Viertens, XXBP-1 kann
gsc unterdrücken (Abb. 3.2-9), während beide—BMP-4 und XXBP-1 durch Noggin im
Animalen Kappen-Assay inhibiert werden (Abb. 3.2-13). Viertens, Koinjektion von
mRNA von XXBP-1 und tBMPRI kann die Dorsalisierung der Embryonen verhindern,
die durch Injektion von tBMPRI alleine hervorgerufen wird (Abb. 3.2-12II), und
bewirkt weiterhin eine direkte Epidermalisierung im Animalen Kappen-Assay (Abb.
3.2-12I).
Die Ergebnisse deuten darauf hin, dass XXBP-1 downstream der BMP-4 Rezeptoren
wirkt. Überexpression von tBMPRs in ektodermalen Explantaten induzieren neurale
Gewebe, nachgewiesen durch neurale Marker wie NCAM und Otx2. Andererseits
wird die Expression von NCAM und Otx2 unterdrückt und epidermales Keratin durch
Koinjektion von tBMPRI und XXBP-1 induziert. Das bedeutet, dass XXBP-1 in der
Lage ist, die neurale Induktion, die durch tBMPR hervorgerufen wird, zu inhibieren. In
Überexpressions-Experimenten kann XXBP-1 die Dorsalisierung, die durch tBMPRI
hervorgerufen wird, inhibieren. Diese Ergebnisse zeigen, dass XXBP-1 downstream
der BMP-4 Rezeptoren wirkt. Die Induktion von BMP-4 durch XXBP-1 in DMZ ergibt
Hinweise darauf, dass XXBP-1 notwendig ist für die Aufrechterhaltung der BMP-4
Expression.
7. SYNOPSIS       108
XXBP-1 wirkt als ein Transkriptionsaktivator
Die putative DNA-Bindungsdomäne des XXBP-1 wurde fusioniert mit der vorher
charakterisierten Sequenz, die entweder den Repressor oder den Aktivatordomäne –
wie die Repressordomäne von Drosophila engrailed (Jaynes and O’ Farrell, 1991)
oder die Repressordomäne von even-skipped (Han and Manley, 1993) bzw. die
Aktivatordomäne von VP16 repräsentiert (Friedmann et al., 1988). Die
schematischen Darstellung des Wildtypes XXBP-1 und der Fusionskonstrukte sind in
Abbildung 3.2-14I gezeigt. Überexpressionsexperimente mit XXBP1-V16, das die
Aktivatordomäne enthält, imitiert den Effekt des XXBP1-Wildtyp. Es resultierte eine
Ventralisierung des Embryos nach einer dorsalen Injektion bzw. eine posteriore
Vergrößerung des Embryos nach ventraler Injektion. Andererseits bewirkt XXBP1-
Eve mit der Repressionsdomäne die Bildung einer Doppelachse nach ventraler
Injektion (Fig. 3.2-14II). Im Gegensatz zu XXBP-1-Wildtyp und XXBP1-VP16 kann
XXBP1-Eve die neuralen Marker NCAM und nrp1 induzieren (Abb. 3.2-15). Deshalb
kann XXBP1-Eve Gene aktivieren, die normalerweise durch XXBP-1 reprimiert
werden und folglich XXBP-1 als ein Transkriptionsaktivator fungiert. Die
Rumpfmutante von XXBP-1, die die ersten 126 Aminosäuren (einschließlich bZIP)
enthalten, hat einen schwachen Effekt auf die neurale Induktion wie es sich in der
erhöhten Expression von Otx2 äußert. Die Überexpression dieser Rumpfmutante
führt während der Gastrulation zu Defekten, insbesondere zu spina bifida. Diese
Ergebnisse deuten darauf hin, dass XXBP-1 Homodimere bildet, um seine
Funktionen auszuüben.
7.2 XMLP ist bei morphogenetischen Prozessenbeteiligt
 Identifizierung eines Xenopus MARCK verwandten Proteins (XMLP)
Der isolierte Klon kodiert für ein Protein mit 187 Proteinen, das mit der MARCKS-
ähnlichen Proteinfamilie (MLP)verwandt ist. In Hormologie-Vergleichen konnte eine
32%ige Identität mit MLP der Maus, Ratte, Mensch und Kaninchen, nachgewiesen
werden (Abb. 3.3-1). Die abgeleitete Protein-Sequenz enthält drei konservierte
Domänen, die auch bei den anderen Mitgliedern der MARCKS und MLP-Familie zu
finden sind; es handelt sich dabei um eine myristilierte Consensus-Sequenz, die
einem Glycine-Rest in Position 2 in der Amino-terminalen-Region folgt, und zwar in
der Region des intron splicing und der putativen Phosphorylierungsdomäne (PSD).
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Der theoretisch isoelektrische Punkt (pI) von XMLP (4.38) und der PSD-Domaine
(12.06) sind typisch diese Proteinfamilie. Die volle Sequenz wurde eingereicht unter
der Accession-Number: AF187864 in der Gen-Bank.
Räumliche und zeitliche Expression von XMLP
Maternale Transkripte von XMLP wurden während der Furchungsstadien in der
animalen Hälfte des Embryos mittels whole-mount in situ Hybridisierung
nachgewiesen (Abb. 3.3-2A, B). In der Gastrula wurden Signale in fast allen
Regionen mit Ausnahme der Dotterpfropfregion gefunden (Abb. 3.3-2C). Im Stadium
11.5 wurde XMLP hauptsächlich im Ektoderm und Mesoderm exprimiert (Abb. 3.3-
2D). Ab der späten Gastrula fanden sich Transkripte nur im Bereich der
präsumptiven der Neuralpatte(Abb. 3.3-2E-G). In der weiteren Entwicklung fanden
sich Signale in der Neuralfalten und in der Gehirnregion des
Schwanzknospenstadiums (Abb. 3.3-2H, I, M). Im Stadium 34 wurden Signale in der
Kopfregion, Somiten, Vornierenkanälchen und Harnleiter gefunden (Abb. 3.3-2O-Q).
Transkripte konnten in allen Stadien mittels RT-PCR nachgewiesen werden. Der
Transkriptionslevel nahm vom ungefurchten Ei und während der Furchungsstadien
bis zum Stadien 23 ab, während in den folgenden Stadien leicht anstieg und
schließlich eine stabile Höhe erreichte (Abb. 3.3-3). Mittels RT-PCR wurde die
XMLP-Expression in allen untersuchten adulten Geweben gefunden. Eine relativ
niedrige Expression wurde im Darm und in der Niere nachgewiesen (Abb. 3.3-4).
Phänotypische Effekte durch XMLP Überexpression
Embryos zeigten nach Injektion von XMLP mRNA in eine dorsale Blastomere des 4-
Zell-Stadiums den Phänotyp Apoptose (Abb. 3.3-5A, B). Zwei Haupttypen
morphologischer Defekte wurden nach Injektionen bei der Inspektion der Larven
beobachtet. Ein Typ wies Reduktion und eine abnormale Struktur der Linse auf (Abb.
3.3-5C, D, E). Einige Larven zeigten sogar Cyclopie (Abb. 3.3-5F). Andere
Embryonen wiesen eine gebogene Körperachse auf. Bei höheren Injektionsdosen
zeigten die Embryonen eine Kombination beider Phänotypen. Die Ergebnisse der
Injektionsversuche sind in Tabelle 3.3-1 dargestellt.
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Ektopische Expression von XMLP änderte nicht die normale autonome
Differenzierung von isolierter dorsaler Urmundlippe
Explantate bestehend aus dorsaler Urmundlippe und daran anschließendes dorsales
Ektoderm wurden von injizierten Embryonen und Kontrollen im Stadium 10 isoliert
und anschließend bis zum Stadium 40 aufgezogen. Wie die uninjizierten Kontrollen
entwickelten sich die Explantate injizierter Embryonen in gleicher Weise in Chorda,
Gehirn und Augenstrukturen (Abb. 3.3.-5 J, K). Dies deutet darauf hin, dass die
Augendefekte nicht auf eine spezifische Inhibition der Augenanlage durch XMLP
(Abb. 3.3-5) sondern auf eine Störung der morphogenetische Bewegungen
zurückzuführen sind.
Der Effekt von morpholino oligo (MO) XMLP nach Injektion in
Furchungsstadien
Der Verlust der Funktion XMLP (loss-of-function) wurde durch Injektion von
Morpholino Oligos (MO)- XMLP in eine Blastomere des 2-Zell-Stadiums oder zwei
dorsale Blastomeren im 4-Zell-Stadium untersucht. Keine signifikanten toxischen
Effekte wurden nach der Injektion von Morpholino bzw. Negativkontrollen
beobachtet. MO-XMLP injizierte Embryonen zeigten Augendefekte, verkürzte
anteriore Achse und eine schwache Körperachsenkrümmung (Abb. 3.3-6A und
Tabelle 3.3-2). Weiterhin konnten MO-XMLP signifikant den Phänotyp der Apoptose,
induziert durch XMLP, rückgängig machen (Abb. 3.3-6B, C).
Das Glycine in Position 2 und die PSD (ED) Domäne sind korreliert mit der
Apoptose in Überexpressionsexperimenten
Zum Studium der Rolle der funktionellen Domäne von XMLP wurden vier Mutanten
SD, S83A, G2A, ED konstruiert (Abb. 3.3-7, siehe auch 2.9.3) und in
Überexpressionsexperimenten eingesetzt. Im Gegensatz zum Wildtyp XMLP, riefen
die Mutanten S83A, G2A und ED keine signifikante Apoptose hervor. Die
Phänotypen der Larven nach Injektion in zwei dorsale Blastomeren des 4-Zell-
Stadiums sind in Abb. 3.3-8H bis M gezeigt. Alle zeigten Augendefekte, gebogene
Körperachse und in wenigen Fällen eine starke Reduktion der vorderen
Körperachse. Insbesondere wenn 1,6 ng ED-Mutanten RNA injiziert wurde, blieb der
ektodermale Bereich der Hinterhirnregion der Schwanzknospenstadien offen,
wahrscheinlich zurückzuführen auf einen unvollständigen Verschluß der
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Neuralwülste (Abb. 3.3-8L). Dieser Phänotyp ist vergleichbar mit dem der F52
Knockout-Maus, die Exencephalie und postnatale Anencephalie zeigt. Die
Ergebnisse sind in Tabelle 3.3-3 dargestellt.
Ektopische XMLP Expression inhibiert die normale Rhombomerenbildung
Überexpression von XMLP wurde realisiert durch Injektion in eine dorsale
Blastomere des 4-Zell-Stadiums und gleichzeitig von LacZ mRNA als Lineage tracer.
Die anschließende whole-mount in situ Hybridisierung deutet darauf hin, dass
ektopische Expression des XMLP eine Auslöschung des Krox20 Signals in den
Rhombomeren 3 und 5 bewirkt (Abb. 3.3-9B).
Retinsäure Hydroxylase (XCYP26) verändert das Expressionsmuster von XMLP
Nach Co-Injektion von 2 ng XCYP26 und 100 pg LacZ capped RNA in eine
Blastomere des 2-Zell-Stadiums erfolgte die Analyse mit XMLP antisense im Stadium
20 mittels whole-mount in situ Hybridisierung. Die Signalstreifen auf der injizierten
Seite waren schwächer oder waren überhaupt nicht mehr vorhanden (31 von 54
Fällen) im Gegensatz zur uninjizierten Seite (Abb. 3.3-9D).
Zusammenfassend kann festgestellt werden, dass XMLP beteiligt ist an der
normalen Entwicklung des Neuralrohres und der Anlage des Zentralen
Nervensystems. Weiterhin induziert XMLP Apoptose in
Überexpressionsexperimenten. Im Vergleich zu anderen Mitgliedern der MARCKS-
Familie kann man annehmen, dass XMLP bei morphogenetischen Bewegungen
während der embryonalen Entwicklung beteiligt ist. Die gestörten
morphogenetischen Bewegungen und die induzierte Apoptose könnten Gründe für
eine Reduktion der anterioren Körperachse und der Augendefekte sein. Weiterhin ist
das Expressionsmuster von XMLP durch die ektopiche Expression von XCYP26
betroffen. Dies deutet darauf hin, dass RA an der Regulation von XMLP und bei der
anterior/posterioren Körperachsenbildung beteiligt ist.
7.3 Zeitliche und räumliche Expression von XAT
XAT besitzt eine hoch konservierte Sequenzregion einer Amidinotransferase, die
auch beim Menschen, Huhn und Ratte vorhanden ist (Abb. 3.4-1). XAT wird in der
frühen Gastrula in der Region des Dotterpfropfes einschließlich der dorsalen
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Urmundlippenregion differenziell exprimiert. Signale finden sich dann in der Mittellinie
der Neuralplatte der frühen Neurulastadien (Abb. 3.4-2). Die Auswertung
transversaler histologischer Schnitte (Abb. 3.4-2G) ergab, dass die Transkripte in der
Chorda lokalisiert sind. Im Schwanzknospenstadium werden die Signale sowohl in
der Chorda als auch in der Rumpfregion gefunden, während nur schwache Signale in
der Kopfregion vorhanden sind (Abb. 3.4-2 und 3.4-4). Die RT-PCR Analyse (Abb.
3.4-3) ergab die Expression des Gens ab Stadium 8, gefolgt mit einem leichten
Anstieg während der Gastrula und Neurula bzw. gleichbleibendem Niveau im
Schwanzknospenstadium und späteren Embryonalstadien. RT-PCR adulter
Geweben zeigt eine höhere XAT Expression vor allem im Auge, Muskel, Magen und
Hodengewebe (Abb. 3.4-5).
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